



Morphological, Cellular and Proteomic Features of 





Richard I-Ming Han 




Thesis presented for the degree of  
 
 





Division of Veterinary Clinical Studies 
Royal (Dick) School of Veterinary Sciences 
College of Medicine and Veterinary Medicine 
University of Edinburgh 
 
Submitted January 2009 




Professor Brendan M Corcoran  




I hereby declare that all the work included in this thesis, submitted for 
the degree of Doctorate of Philosophy at the University of Edinburgh, is my 
own original work and no part of of this work has been, or will be, submitted for 
















Undertaking this doctoral research project was a life changing decision. I 
have abandoned my comfortable life in South Africa and came to study and living in 
a foreign land. The whole process has been a challenging and often overwhelming 
experience. Sometimes it is hard to know whether it has been grappling with enough 
money to survive after paying the totally rip-off £12,000 annual tuition fees, or stay 
on track of the erratic Lothian bus timetable, or grappling with how to write 
articulately, squatting in other people’s lab, embarking on a new experiment, trying 
to understand bioinformatics, battling with computer software, and… stay motivated. 
I would like to thank the following people, without whose support the 
completion of this project would not have been made possible: 
My utmost gratitude goes to my principal supervisor Prof Brendan Corcoran 
for his excellent guidance, wonderful support and always needed encouragement. I 
have been very privileged to have a smart and easy-going supervisor anyone could 
ask for. I have been stimulated and excited by his good ideas. At the same time, I 
was allowed the freedom to develop my own thinking and pursuing own research 
interests.  Brendan has the unique ability to grasp the key concepts of complicated 
matters that I always admire, I learned a great deal of how to present my results 
clearly from him. His brilliant leadership has been the driving force in this project. 
His dedication and enthusiasm in heart valve research has inspired me in this project.  
Throughout my doctoral study period, the Kennel Club and the Cavalier King 
Charles Club, through the generosity of my supervisor Brendan, supported the 
project. 
My second supervisor Dr Alan Pemberton for introduced me to proteomics. 
Alan was very kind to provided me with his equipments to perform all the necessary 
experiments. He was always patiently listen to my problems and guiding me to the 
right directions. His most valued comments and suggestions were vital in this 
project. His input has contributed greatly to success of my project. 
Dr Andy Cronshaw for taught me the skill of using mass spec. Andy has 
relentlessly showed me each step of the process plus the trick of the trade. His 
 iv 
expertise in protein analysis and his knowledge on bioinformatics contributed 
enormously in the analysis. I really appreciated that Andy has looked after me while 
I was working in King’s Building. I enjoyed the coffee time chatting with him on the 
top floor of Swann Building looking over the Edinburgh skyline. 
Mr Craig Devine and Mr Geoffrey Culshaw for assisted me in animal surgery 
and tissue collection. 
Mr Alex Black, Brendan’s collaborator at National University of Ireland, 
Galway. Alex has contributed in the early formatting of this project and his 
comments were really welcome. 
Wendy of Edinburgh Dog & Cat Home for her support and coordination. 
Ms Jean Samuel for helping me in the preparation of histology stains and 
showed me the fun side of histological staining.  
Dr Pam Knight was generously provided me with her protocol and a bench 
space in her lab to enable me to perform molecular biology experiments.  
Dr Jeremy Brown taught me how to perform immunohistochemistry, Jeremy 
is a gold mine of knowledge, and he was always the first one I came to for trouble-
shooting. His advice and suggestion have been most valuable.  
Dr Cali Ingham was very kind to allow me to use her special microscope to 
capture some images. Ms Ann Wright and Ms Lasani Wijetunge gave me good 
guidance on microscope operations. 
Dr Gaetano Impoco was very generous to send me a copy of his 
microstructure analysis software. We had numerous email discussions; I really 
appreciate his prompt replies to all my questions.  
Mr Steven Mitchell for helping me a lot with the electron microscopy work 
and all the technical support. I admired his never say die attitude when he facing the 
uphill battle against the aging machines. 
Dr Anne French for her support and interest shown in my work. 
Dr Darren Shaw for giving me advice on statistics. 
Drs Raanan Tal, Jacqui Ross and Toby Cornish replied to my pleadings for 
help and gave me very useful tips on colour imaging.  
 v 
Ms Liz Thorton, Mr Steven Wright and Ms Judith Pate for their constant 
assistance in the lab. 
Everyone in the Hospital for Small Animals, for his or her assistance, 





“Have you your stethoscope? Might I ask you-would you have the kindness? I have 
grave doubts as to my mitral valve, if you would be so good. The aortic I may rely 
upon, but I should value your opinion upon the mitral.” I listened to his heart, as 
requested, but was unable to find anything amiss, save, indeed that he was in an 
ecstasy of fear, for he shivered from head to foot… Sir Arthur Conan Doyle, The 





DECLARATION ....................................................................................................................................... II 
ACKNOWLEDGEMENTS ....................................................................................................................III 
LIST OF FIGURES ...................................................................................................................................X 
LIST OF TABLES..............................................................................................................................XVIII 
ABBREVIATIONS .................................................................................................................................XX 
ABSTRACT..................................................................................................................................................1 
1 CHAPTER 1 BACKGROUND INFORMATION ON MITRAL VALVE DISEASE ..............2 
1.1 INTRODUCTION................................................................................................................................2 
1.1.1 Mitral valve anatomy .............................................................................................................3 
1.1.2 Annulus ...................................................................................................................................3 
1.1.3 Leaflets ....................................................................................................................................4 
1.1.4 Tendinous chords ...................................................................................................................5 
1.1.5 Papillary muscles ...................................................................................................................7 
1.1.6 Pathology of myxomatous mitral valve disease ...................................................................7 
1.1.7 Epidemiology ..........................................................................................................................8 
1.1.8 Lesion grades..........................................................................................................................8 
1.1.9 Diagnosis ............................................................................................................................. 10 
1.1.10 Valvular interstitial cells (VIC)........................................................................................ 10 
1.1.11 Valvular endothelial cells (VEC) ..................................................................................... 11 
1.1.12 Extracellular matrix (ECM) ............................................................................................. 11 
1.1.13 Matrix metalloproteinases (MMP)................................................................................... 11 
1.1.14 Main objectives of this thesis............................................................................................ 11 
2 CHAPTER 2 MORPHOLGICAL ASSESSMENT OF THE CHANGES IN 
MYXOMATOUS MITRAL VALVE DISEASE ................................................................................. 13 
2.1 INTRODUCTION............................................................................................................................. 13 
2.2 MATERIALS AND METHODS......................................................................................................... 14 
2.2.1 Mitral valve procurement ................................................................................................... 14 
2.2.2 Tissue dissection.................................................................................................................. 14 
2.2.3 Histology.............................................................................................................................. 14 
2.2.4 Microscopy and photography............................................................................................. 15 
2.2.5 Image analysis ..................................................................................................................... 15 
2.2.6 Leaflet length ....................................................................................................................... 15 
2.2.7 Leaflet thickness .................................................................................................................. 16 
2.2.8 Cell density .......................................................................................................................... 16 
2.2.9 Cell circularity .................................................................................................................... 16 
2.2.10 Connective tissue............................................................................................................... 16 
2.2.11 Glycosaminoglycan (GAG) .............................................................................................. 17 
2.2.12 Statistical analysis............................................................................................................. 18 
2.2.13 Transmission electron microscopy (TEM) ...................................................................... 20 
2.2.14 Quantitative stereology..................................................................................................... 22 
2.2.15 Circularity of endothelium and valvular interstitial cell ................................................ 22 
2.2.16 Scanning electron microscopy (SEM).............................................................................. 22 
2.2.17 Image analysis of cell-macerated connective tissue using SEM imagery ..................... 23 
2.3 RESULTS ....................................................................................................................................... 25 
2.3.1 Breed .................................................................................................................................... 25 
2.3.2 Age........................................................................................................................................ 25 
2.3.3 Murmur ................................................................................................................................ 27 
2.3.4 Gross pathology .................................................................................................................. 27 
2.3.5 Light Microscopy Study ...................................................................................................... 28 
2.3.6 Leaflet length ....................................................................................................................... 31 
2.3.7 Leaflet thickness ratio ......................................................................................................... 32 
2.3.8 Cell density .......................................................................................................................... 34 
2.3.9 Circularity............................................................................................................................ 36 
 viii 
2.3.10 Connective tissue............................................................................................................... 37 
2.3.11 Glycosaminoglycan........................................................................................................... 39 
2.3.12 Transmission electron microscopy (TEM) ...................................................................... 48 
2.3.13 Quantitative Stereology .................................................................................................... 61 
2.3.14 Scanning electron microscopy of cell macerated samples ............................................. 68 
2.3.15 Quantitative connective tissue micro-structural analysis .............................................. 74 
2.4 DISCUSSION .................................................................................................................................. 80 
3 CHAPTER 3 IMMUNOHISTOCHEMISTRY AND IMMUNOPHENOTYPING OF 
MYXOMATOUS MITRAL VALVE DISEASE IN THE DOG ....................................................... 96 
3.1 INTRODUCTION............................................................................................................................. 96 
3.2 MATERIALS AND METHODS......................................................................................................... 97 
3.2.1 Mitral valve procurement ................................................................................................... 97 
3.2.2 Tissue dissection.................................................................................................................. 97 
3.2.3 Immunohistochemistry ........................................................................................................ 97 
3.2.4 Statistical analysis............................................................................................................. 100 
3.3 RESULTS ..................................................................................................................................... 101 
3.3.1 Vimentin ............................................................................................................................. 101 
3.3.2 Adipocyte ........................................................................................................................... 109 
3.3.3 α-Smooth muscle actin (α-SMA)...................................................................................... 111 
3.3.4 Desmin ............................................................................................................................... 120 
3.3.5 Smooth muscle myosin ...................................................................................................... 127 
3.3.6 Fibrillin .............................................................................................................................. 130 
3.3.7 MMP-2 ............................................................................................................................... 132 
3.3.8 MMP-9 ............................................................................................................................... 132 
3.3.9 MMP-13 ............................................................................................................................. 134 
3.3.10 Fibronectin ...................................................................................................................... 136 
3.3.11 Macrophage..................................................................................................................... 136 
3.3.12 Mast cells ......................................................................................................................... 141 
3.3.13 CD34 ................................................................................................................................ 145 
3.3.14 Von Willebrand factor .................................................................................................... 147 
3.4 DISCUSSION ................................................................................................................................ 148 
4 CHAPTER 4 PROTEOMICS ....................................................................................................... 158 
4.1 INTRODUCTION........................................................................................................................... 158 
4.2 MATERIALS AND METHODS....................................................................................................... 159 
4.2.1 Protein Extraction ............................................................................................................. 159 
4.2.2 1-D SDS-PAGE ................................................................................................................. 159 
4.2.3 2-D SDS-PAGE ................................................................................................................. 159 
4.2.4 2D Gel Staining ................................................................................................................. 160 
4.2.5 Image Analysis .................................................................................................................. 161 
4.2.6 Trypsin Digestion .............................................................................................................. 161 
4.2.7 MALDI-TOF MS Analysis ................................................................................................ 162 
4.2.8 LC-MS/MS Analysis .......................................................................................................... 163 
4.3 RESULTS ..................................................................................................................................... 165 
4.3.1 1-D SDS-PAGE LS-MS/MS and MALDI-ToF-MS.......................................................... 165 
4.3.2 2-D SDS-PAGE and MALDI-MS ..................................................................................... 171 
4.4 DISCUSSION ................................................................................................................................ 179 
5 CHAPTER 5 POLYMERASE CHAIN REACTION................................................................ 191 
5.1 INTRODUCTION........................................................................................................................... 191 
5.2 MATERIALS AND METHODS....................................................................................................... 192 
5.2.1 Total RNA isolation........................................................................................................... 192 
5.2.2 RNA quantification............................................................................................................ 193 
5.2.3 Reverse transcription of RNA........................................................................................... 193 
5.2.4 Primer design .................................................................................................................... 193 
5.2.5 Polymerase chain reaction (PCR) ................................................................................... 194 
5.2.6 PCR analysis by electrophoresis...................................................................................... 195 
5.2.7 Semi-quantitative PCR by densitometry .......................................................................... 195 
5.2.8 Statistical analysis............................................................................................................. 195 
 ix 
5.3 RESULTS ..................................................................................................................................... 197 
5.3.1 RNA quantification............................................................................................................ 197 
5.3.2 Glyceraldehyde 3-phosphate dehydrogenase (GAPDH)................................................ 197 
5.3.3 Ribosomal protein L19...................................................................................................... 197 
5.3.4 18S ribosomal RNA........................................................................................................... 198 
5.3.5 Vimentin ............................................................................................................................. 199 
5.3.6 Smooth muscle α-actin (α-SMA)...................................................................................... 200 
5.3.7 Tropomyosin (TPM).......................................................................................................... 201 
5.3.8 Myosin light polypeptide 4 (MYL-4) ................................................................................ 202 
5.3.9 Biglycan ............................................................................................................................. 203 
5.3.10 Fibronectin (FN) ............................................................................................................. 204 
5.3.11 Fibrillin (FBN) ................................................................................................................ 205 
5.3.12 MMP-13........................................................................................................................... 206 
5.4 DISCUSSION ................................................................................................................................ 207 
6 CONCLUSION ................................................................................................................................ 209 
7 REFERENCES ................................................................................................................................ 213 
8 APPENDIX....................................................................................................................................... 234 
8.1 PUBLICATIONS............................................................................................................................ 234 
8.1.1 Journal Articles ................................................................................................................. 234 
8.1.2 Proceedings ....................................................................................................................... 234 
 
 x 
List of figures 
FIGURE 1.1. DIAGRAM TO SHOW THE ANATOMY OF THE HEART AND LOCATION OF 
THE MITRAL VALVE. .....................................................................................................................3 
FIGURE 2.1. A SCHEMATIC DIAGRAM SHOWS HOW THE CENTRAL AXIS IS PLOTTED 
FOR LEAFLET LENGTH MEASUREMENT.............................................................................. 15 
FIGURE 2.2. A SCHEMATIC DIAGRAM SHOWS THE POSITIONS OF THE THREE CROSS-
SECTIONAL THICKNESS ARE TAKEN FOR LEAFLET THICKNESS MEASUREMENT.
........................................................................................................................................................... 16 
FIGURE 2.3. FEATURES OF THE MEANS DIAMONDS DISPLAY USED IN CHARTS............. 19 
FIGURE 2.4. DIAGRAM OF HOW TO INTERPRET THE SIGNIFICANT DIFFERENCE IN 
COMPARISON CYCLES. .............................................................................................................. 19 
FIGURE 2.5. COMPARISON OF DOG AGE TO MITRAL VALVE LESION GRADE. THE 
RESULTS FROM ANOVA, T-TEST, AND WILCOXON RANKED TEST ARE 
PRESENTED. THE AGE IS INCREASED DURING THE PROGRESSION OF THE 
DISEASE. ......................................................................................................................................... 26 
FIGURE 2.6. THE DISTRIBUTION OF DOG AGE ACCORDING TO THE LESION GRADE. THE 
BEST LINE FIT INTERCEPTS WITH THE AGE ON THE Y-AXIS AT 4.08 YEAR OF AGE.
........................................................................................................................................................... 27 
FIGURE 2.7. COMPARISON OF MURMUR TO MITRAL VALVE LESION GRADE. THE BEST 
LINE FIT INTERCEPTS WITH THE LESION GRADE X-AXIS AT 0.9. ............................... 27 
FIGURE 2.8. PHOTOGRAPHS OF MITRAL VALVES AT NECROPSY SHOWING LESION 
GRADES 1-4. ................................................................................................................................... 28 
FIGURE 2.9. REPRESENTATIVE OF HEMOTOXYLIN AND EOSIN STAINED CROSS-
SECTIONAL MITRAL VALVE LEAFLET TISSUES. BAR = 1MM. ...................................... 29 
FIGURE 2.10. H&E STAINED SECTION OF A NORMAL MITRAL VALVE LEAFLET SHOWN 
CRIMPS ON THE ATRIALIS SURFACE. BAR = 50µM........................................................... 30 
FIGURE 2.11. H&E STAINED SECTION OF A NORMAL MITRAL VALVE LEAFLET SHOWN 
THE MUSCLE AT THE BASE. BAR = 50µM. ........................................................................... 30 
FIGURE 2.12. H&E STAINED SECTION OF A DISEASED MITRAL VALVE LEAFLET SHOWN 
THE VESSEL IN THE LEAFLET. BAR = 20 µM....................................................................... 31 
FIGURE 2.13. H&E STAINED SECTION OF A DISEASED MITRAL VALVE LEAFLET SHOWN 
THE FAT CELL LAYER. BAR = 100 µM. .................................................................................. 31 
FIGURE 2.14. THE COMPARISON OF SEPTAL/MURAL RATIO BETWEEN MITRAL VALVE 
LESION GRADE. THE RESULTS FROM ANOVA, T-TEST, AND WILCOXON RANKED 
TEST ARE PRESENTED. .............................................................................................................. 32 
FIGURE 2.15. COMPARISON OF SEPTAL LEAFLET THICKNESS RATIO BETWEEN MITRAL 
VALVE LESION GRADE. THE RESULTS FROM ANOVA, T-TEST, AND WILCOXON 
RANKED TEST ARE PRESENTED. ............................................................................................ 33 
FIGURE 2.16. COMPARISON OF MURAL LEAFLET THICKNESS RATIO BETWEEN MITRAL 
VALVE LESION GRADE. THE RESULTS FROM ANOVA, T-TEST, AND WILCOXON 
RANKED TEST ARE PRESENTED. ............................................................................................ 33 
FIGURE 2.17. AN H&E HISTOLOGICAL SECTION OF A MYXOMATOUS MITRAL VALVE 
TISSUE SHOWS THE VARIATION IN CELL DENSITY. THE AREA PERIPHERY (P) TO 
MYXOMATOUS AREA (M) CONTAINS HIGHER CELL DENSITY. BAR = 50 µM. ........ 34 
FIGURE 2.18. COMPARISON OF CELL DENSITY IN SEPTAL LEAFLET MYXOMATOUS 
AREA BETWEEN MITRAL VALVE LESION GRADE. THE RESULTS FROM ANOVA, T-
TEST, AND WILCOXON RANKED TEST ARE PRESENTED. .............................................. 35 
FIGURE 2.19. COMPARISON OF CELL DENSITY IN MURAL LEAFLET MYXOMATOUS 
AREA BETWEEN MITRAL VALVE LESION GRADE. THE RESULTS FROM ANOVA, T-
TEST, AND WILCOXON RANKED TEST ARE PRESENTED. .............................................. 36 
FIGURE 2.20. COMPARISON OF CIRCULARITY IN SEPTAL AND MURAL LEAFLETS 
MYXOMATOUS AREA BETWEEN MITRAL VALVE LESION GRADE. THE 
CIRCULARITY MEANS ARE PRESENTED.............................................................................. 37 
FIGURE 2.21. MASSON’S TRICHROME STAINING OF A DISEASED MITRAL VALVE 
LEAFLET. MYXOMATOUS AREA SHOWS DESTRUCTION OF COLLAGEN (GREEN) 
AND ELASTIN (DARK BLUE). BAR = 100 µM........................................................................ 38 
FIGURE 2.22. COMPARISON OF CONNECTIVE TISSUE IN SEPTAL LEAFLET 
MYXOMATOUS AREA BETWEEN MITRAL VALVE LESION GRADE. THE RESULTS 
 xi 
FROM ANOVA, WILCOXON RANKED TEST AND STUDENT’S T-TEST ARE 
PRESENTED.................................................................................................................................... 39 
FIGURE 2.23. COMPARISON OF CONNECTIVE TISSUE IN MURAL LEAFLET 
MYXOMATOUS AREA BETWEEN MITRAL VALVE LESION GRADE. THE RESULTS 
FROM ANOVA, WILCOXON RANKED TEST AND STUDENT’S T-TEST ARE 
PRESENTED.................................................................................................................................... 39 
FIGURE 2.24. ALCIAN BLUE GAG STAINING OF A GRADE 0 NORMAL MITRAL VALVE 
SEPTAL LEAFLET. ........................................................................................................................ 40 
FIGURE 2.25. ALCIAN BLUE GAG STAINING OF A GRADE 4 DISEASED MITRAL VALVE 
SEPTAL LEAFLET. ........................................................................................................................ 40 
FIGURE 2.26. COMPARISON OF THE PERCENTAGE OF BLUE AREA OF GAG IN LEAFLET 
BETWEEN MITRAL VALVE LESION GRADE USING K-MEANS CLUSTERING 
METHOD. SEPTAL LEAFLET IS ON THE LEFT AND THE MURAL LEAFLET IS ON 
THE RIGHT. .................................................................................................................................... 41 
FIGURE 2.27. COMPARISON OF THE PERCENTAGE OF BLUE AREA OF GAG IN LEAFLET 
BETWEEN MITRAL VALVE LESION GRADE USING RGB SPLIT METHOD. SEPTAL 
LEAFLET IS ON THE LEFT AND THE MURAL LEAFLET IS ON THE RIGHT. ............... 41 
FIGURE 2.28. COMPARISON OF THE PERCENTAGE OF BLUE AREA OF GAG IN LEAFLET 
BETWEEN MITRAL VALVE LESION GRADE USING DECONVOLUTION METHOD. 
SEPTAL LEAFLET IS ON THE LEFT AND THE MURAL LEAFLET IS ON THE RIGHT.42 
FIGURE 2.29. COMPARISON OF THE PERCENTAGE OF BLUE AREA OF GAG IN LEAFLET 
BETWEEN MITRAL VALVE LESION GRADE USING THRESHOLD COLOUR METHOD. 
SEPTAL LEAFLET IS ON THE LEFT AND THE MURAL LEAFLET IS ON THE RIGHT.43 
FIGURE 2.30. COMPARISON OF THE PERCENTAGE OF BLUE AREA OF GAG IN LEAFLET 
BETWEEN MITRAL VALVE LESION GRADE SHOW IN MEAN ERROR BAR WITH 
(CLOCKWISE FROM TOP LEFT) BLUE CLUSTER OF K-MEAN CLUSTERING, BLUE 
CHANNEL OF RGB SPLIT, BLUE DECONVOLUTION AND THRESHOLD OF HSB 140-
200. THE BLUE AREA OF GAG ARE ALL BETWEEN THE RANGE OF 20-44%.............. 44 
FIGURE 2.31. COMPARISON OF THE STANDARDISED MEAN BLUE VALUE IN LEAFLET 
BETWEEN MITRAL VALVE LESION GRADE. THE SEPTAL LEAFLET IS ON THE LEFT 
AND THE MURAL LEAFLET IS ON THE RIGHT. .................................................................. 45 
FIGURE 2.32. CONTINGENCY TABLES SHOW THE COMPARISON OF MEAN BLUE 
RANKING BETWEEN MITRAL VALVE LESION GRADE. SEPTAL LEAFLET IS ON THE 
LEFT AND THE MURAL LEAFLET IS ON THE RIGHT. ....................................................... 46 
FIGURE 2.33. COMPARISON OF STANDARDISED MEDIAN BLUE VALUE BETWEEN 
MITRAL VALVE LESION GRADE. THE SEPTAL LEAFLET IS ON THE LEFT AND THE 
MURAL LEAFLET IS ON THE RIGHT. ..................................................................................... 46 
FIGURE 2.34. COMPARISON OF STANDARDISED MODAL BLUE VALUE BETWEEN 
MITRAL VALVE LESION GRADE. THE SEPTAL LEAFLET IS ON THE LEFT AND THE 
MURAL LEAFLET IS ON THE RIGHT. ..................................................................................... 47 
FIGURE 2.35. COMPARISON OF INTEGRATED BLUE INTENSITY BETWEEN MITRAL 
VALVE LESION GRADE. THE SEPTAL LEAFLET IS ON THE LEFT AND THE MURAL 
LEAFLET IS ON THE RIGHT....................................................................................................... 48 
FIGURE 2.36. TRANSMISSION ELECTRON MICROGRAPH OF AN ENDOTHELIAL CELL (E) 
FROM NORMAL MITRAL VALVE. BASEMENT MEMBRANE (BM), COLLAGEN (CO), 
EXTRACELLULAR MATRIX (ECM), DESMOSOME JUNCTION (D). BAR = 2 µM......... 49 
FIGURE 2.37. TRANSMISSION ELECTRON MICROGRAPH SHOWS AN ENDOTHELIAL 
CELL (E2) UNDERGOING APOPTOSIS NEAR THE SURFACE AND IS WITH BULGE 
NUCLEUS (NU) AND LARGE VACUOLE (VA). A HEALTHY ENDOTHELIAL CELL (E1) 
IS UNDERNEATH IT. THE SUB-ENDOTHELIAL TISSUE IS FILLED WITH COLLAGEN 
(CO). BAR = 4µM. .......................................................................................................................... 50 
FIGURE 2.38. TRANSMISSION ELECTRON MICROGRAPH SHOWS A MULTI-NUCLEATED 
INTERSTITIAL CELL (IC) SITUATED VERY CLOSE TO AN ENDOTHELIAL CELL (E). 
SMALL CYTOPLASMIC PROCESSES ARE SEEN ON THE INTERSTITIAL CELL. THE 
SUB-ENDOTHELIAL SPACE IS FILLED WITH GROUND SUBSTANCE AND 
COLLAGEN BUNDLES (CO). BAR = 4µM................................................................................ 51 
FIGURE 2.39. TRANSMISSION ELECTRON MICROGRAPH SHOWING AN ENDOTHELIAL 
CELL WITH A LARGE FLOCCULATED NUCLEUS (NU) HAS STARTED TO DETACH 
FROM THE TISSUE. THE CYTOPLASMIC MATERIAL HAS BEEN DEGRADED, BUT 
 xii 
THE MITOCHONDRIA (M) ARE VISIBLE. THE NEIGHBOURING ENDOTHELIAL 
CELLS (E) LAY FLAT ON THE SURFACE. BAR = 4 µM....................................................... 52 
FIGURE 2.40. TRANSMISSION ELECTRON MICROGRAPH SHOWS TWO ENDOTHELIAL 
CELLS SIDE BY SIDE AT THE SURFACE OF THE TISSUE, THEIR NUCLEI (NU) 
LABELLED. THE ATTACHMENT BETWEEN THEM IS BREAKING DOWN; THERE 
ARE NOW LARGE INTERCELLULAR SPACES (IS) AND THE CELLS ARE JOINED 
ONLY BY DESMOSOMES (D). THE LOWER CELL HAS ALSO LOST ITS 
ATTACHMENT TO ITS OTHER NEIGHBOUR, LEAVING A GAP (G) IN THE 
ENDOTHELIAL SURFACE. BENEATH THE CELLS IS AN EXPANDED 
EXTRACELLULAR MATRIX (ECM) AND A FEW SPARSE COLLAGEN BUNDLES (CO) 
IN BETWEEN. BAR = 3 µM.......................................................................................................... 53 
FIGURE 2.41. TRANSMISSION ELECTRON MICROGRAPH SHOWS THE 
DISCONTINUATION OF ENDOTHELIUM (E), A LARGE GAP IS SEEN. THE 
BASEMENT MEMBRANE (BM) HAS BROKEN DOWN, ALLOWING EXTRACELLULAR 
MATRIX (ECM) MATERIAL TO ESCAPE THROUGH THE GAP. BAR = 1 µM. ............... 54 
FIGURE 2.42. TRANSMISSION ELECTRON MICROGRAPH SHOWS AN ENDOTHELIAL 
CELL (E) UNDERGOING DEGENERATIVE PROCESS IN A DISEASED VALVE. MANY 
CYTOPLASMIC BUDS (CB) CREATED A RAGGED APICAL SURFACE. THE NUCLEUS 
(NU) AND VESICLES (VE) CAN BE SEEN WITHIN THE CELL. UNDERNEATH, AN 
INTERSTITIAL CELL  (IC) IS IN CLOSE PROXIMITY TO THE ENDOTHELIUM. THE 
INTERSTITIAL CELL HAS CYTOPLASMIC PROCESSES THAT EXTEND TOWARDS 
THE ENDOTHELIUM. BAR = 3µM............................................................................................. 55 
FIGURE 2.43. TRANSMISSION ELECTRON MICROGRAPH SHOWS AN ENDOTHELIAL 
CELL (E) IS DETACHING ITSELF FROM THE BASEMENT MEMBRANE (BM). A GAP 
(G) BETWEEN THE CELL MEMBRANE AND BASEMENT MEMBRANE CAN BE SEEN. 
THE EXTRACELLULAR MATRIX (ECM) CONTAINS ABUNDANT GROUND 
SUBSTANCE AND SPARSE COLLAGEN BUNDLES (CO). BAR = 3 µM. .......................... 56 
FIGURE 2.44. TRANSMISSION ELECTRON MICROGRAPH SHOWS AN ENDOTHELIAL 
CELL (E) IN A DISEASED VALVE IS DETACHING ITSELF FROM THE SURFACE OF 
THE TISSUE. BAR = 3 µM............................................................................................................ 56 
FIGURE 2.45. TRANSMISSION ELECTRON MICROGRAPH SHOWS BASEMENT 
MEMBRANE (BM) HAS BECOME DOUBLE LAYERED. THERE IS A GAP (G) 
BETWEEN THE ENDOTHELIAL CELL (E) AND THE BASEMENT MEMBRANE. THE 
EXTRACELLULAR MATRIX (ECM) CONTAINS COLLAGEN BUNDLES (CO). BAR = 
1µM. .................................................................................................................................................. 57 
FIGURE 2.46. TRANSMISSION ELECTRON MICROGRAPH SHOWS AN INTERSTITIAL CELL 
(IC) IS SQUEEZING BETWEEN TWO ENDOTHELIAL CELLS (E). THE 
EXTRACELLULAR MATRIX (ECM) CONTAINS SPARSE COLLAGEN. BAR = 2 µM. .. 58 
FIGURE 2.47. TRANSMISSION ELECTRON MICROGRAPH SHOWS THE COLLAGEN (CO) 
IN THE DISEASED VALVE ARE BENT. THE COLLAGEN ARE ASSOCIATED WITH 
FILAMENTOUS PROTEOGLYCANS (F). BAR = 0.5 µM. ...................................................... 59 
FIGURE 2.48. TRANSMISSION ELECTRON MICROGRAPH SHOWS A TWIN NUCLEATED 
(NU) INTERSTITIAL CELL WITH AN ELONGATED SHAPE SECRETING VESICLES. 
BAR = 2 µM. .................................................................................................................................... 60 
FIGURE 2.49. TRANSMISSION ELECTRON MICROGRAPH SHOWS A ROUND SHAPED 
INTERSTITIAL CELL IS IN CLOSE CONTACT WITH COLLAGEN (CO). THE 
CYTOPLASMIC VESICLES CONTAIN PRO-COLLAGEN. BAR = 2 µM. ........................... 61 
FIGURE 2.50. COMPARISON OF ENDOTHELILUM AS ASSESSED BY QUANTITATIVE 
STEREOLOGY BETWEEN NORMAL AND DISEASED MITRAL VALVE......................... 62 
FIGURE 2.51. COMPARISON OF VALVULAR INTERSTITIAL CELL AS ASSESSED BY 
QUANTITATIVE STEREOLOGY BETWEEN NORMAL AND DISEASED MITRAL 
VALVE. ............................................................................................................................................ 63 
FIGURE 2.52. COMPARISON OF COLLAGEN AS ASSESSED BY QUANTITATIVE 
STEREOLOGY BETWEEN NORMAL AND DISEASED MITRAL VALVE......................... 63 
FIGURE 2.53. COMPARISON OF EXTRACELLULAR MATRIX AS ASSESSED BY 
QUANTITATIVE STEREOLOGY BETWEEN NORMAL AND DISEASED MITRAL 
VALVE. ............................................................................................................................................ 64 
FIGURE 2.54. COMPARISON OF CICULARITY BETWEEN ENDOTHELIUM AND 
INTERSTITIAL CELL IN NORMAL MITRAL VALVE. .......................................................... 66 
 xiii 
FIGURE 2.55. COMPARISON OF CICULARITY BETWEEN ENDOTHELIUM AND 
INTERSTITIAL CELL IN DISEASED MITRAL VALVE. ........................................................ 67 
FIGURE 2.56. COMPARISON OF ENDOTHELIUM CICULARITY BETWEEN NORMAL AND 
DISEASED MITRAL VALVE. ...................................................................................................... 68 
FIGURE 2.57. COMPARISON OF VALVULAR INTERSTITIAL CELL CICULARITY BETWEEN 
NORMAL AND DISEASED MITRAL VALVE.......................................................................... 68 
FIGURE 2.58. SCANNING ELECTRON MICROGRAPH OF A NORMAL MITRAL VALVE 
SEPTAL LEAFLET AT THE MID ZONE. THE THREE LAYERS ATRIALIS (A), 
SPONGIOSA (S) AND FIBROSA (F) ARE DISTINGUISHABLE. BAR = 0.1 MM............... 69 
FIGURE 2.59. SCANNING ELECTRON MICROGRAPH OF A NORMAL MITRAL VALVE 
SEPTAL LEAFLET AT THE DISTAL ZONE. ATRIALIS SURFACE (A) AND 
VENTRICULARIS SURFACE (V). BAR = 0.1 MM................................................................... 70 
FIGURE 2.60. SCANNING ELECTRON MICROGRAPH OF A NORMAL MITRAL VALVE 
SEPTAL LEAFLET AT THE DISTAL ZONE IN CLOSE UP. THE COLLAGEN FIBRIL 
(CO), LATERAL STRUTS (*) AND PROTEOGLYCAN NETWORK (PG) ARE VISIBLE. 
BAR = 10 µM................................................................................................................................... 70 
FIGURE 2.61. SCANNING ELECTRON MICROGRAPH OF A NORMAL MITRAL VALVE 
SEPTAL LEAFLET AT THE FREE EDGE SURFACE. BAR = 5 µM...................................... 71 
FIGURE 2.62. SCANNING ELECTRON MICROGRAPHS OF DISEASED MITRAL VALVE 
SEPTAL LEAFLETS AT THE MID ZONE. DISRUPTION OF THE CONNECTIVE 
STRUCTURE DURING THE DISEASE PROGRESSION IS EVIDENT. THE THREE 
LAYERS ATRIALIS (A), SPONGIOSA (S) AND FIBROSA (F) ARE LABELLED. BAR = 
0.1 MM.............................................................................................................................................. 72 
FIGURE 2.63. SCANNING ELECTRON MICROGRAPHS OF DISEASED MITRAL VALVE 
SEPTAL LEAFLETS AT THE DISTAL ZONE. THERE WERE DEEP GROOVE LINES 
DIVIDING THE AREAS INTO “LOBE-LIKE” STRUCTURES. SOME LOBES HAD VEIN 
LIKE CRACK LINES, ATRIAL SIDE (A) AND VENTRICULAR SIDE (V). BAR = 1 MM.72 
FIGURE 2.64. SCANNING ELECTRON MICROGRAPHS OF DISEASED MITRAL VALVE 
SEPTAL LEAFLETS AT THE DISTAL ZONE IN CLOSE UP. THE COLLAGEN FIBRES 
ARE THICKEN, AND SOME WITH FRAYED ENDS. BAR = 10 µM.................................... 73 
FIGURE 2.65. SCANNING ELECTRON MICROGRAPHS OF A DISEASE MITRAL VALVE 
SEPTAL LEAFLET SHOWS AMASSED COLLAGEN FIBRES IN DISTAL ZONE. BAR = 5 
µM. .................................................................................................................................................... 73 
FIGURE 2.66. SCANNING ELECTRON MICROGRAPHS SHOWS A DISEASED MITRAL 
VALVE SEPTAL LEAFLET AT THE FREE EDGE SURFACE. THE MESH-LIKE 
APPEARANCE OF COLLAGEN FIBRES WAS NOT EVENLY SPACED, WITH VOIDS OF 
IN DIFFERENT SIZES VISIBLE. BAR = 0.5 µM....................................................................... 74 
FIGURE 2.67. QUANTITATIVE CONNECTIVE TISSUE MICRO-STRUCTURAL ANALYSIS 
DISTRIBUTION CHARTS. FROM TOP, BINARISED IMAGES, PORE AREA, PORE 
FORM FACTOR, PORE ROUNDNESS, PORE ASPECT RATIO, PORE PERIMETER, PORE 
DIAMETER, PORE MIN DIAMETER, PORE DIRECTIONALITY AND PORE 
DIRECTIONALITY ANGLE. ........................................................................................................ 79 
FIGURE 3.1. A SCHEMATIC DIAGRAM SHOWS A MITRAL VALVE LEAFLET DIVIDED 
INTO THREE ZONES BASAL, MID AND DISTAL AND THREE LAYERS ATRIALIS, 
SPONGIOSA AND FIBROSA FOR IMMUNOHISTOCHEMISTRY SCORING.................... 99 
FIGURE 3.2. VIMENTIN STAINING IN NORMAL VALVE DISTAL ZONE. THE VIMENTIN 
POSITIVE CELLS ARE MORE ELONGATED IN SHAPE. BAR = 10 µM. ......................... 101 
FIGURE 3.3. VEIMENTIN POSITIVE CELLS ARE  ASSOCIATED WITH CONNECTIVE 
TISSUE AND VIMENTIN NEGATIVE CELLS ARE ASSOCIATED WITH 
MYXOMATOUS TISSUE. BAR = 10 µM. ................................................................................ 101 
FIGURE 3.4. VIMENTIN SCORES IN SEPTAL LEAFLETS. THREE DIFFERENT COLUMNS 
REPRESENT THE THREE ZONES AND THREE DIFFERENT COLOURS REPRESENT 
THE THREE LAYERS. EACH ZONE AND EACH LAYER COULD HAVE A MAXIMAL 
SCORE OF 3, THE COMBINED SCORE FOR A LAYER OR ZONE COULD HAVE A 
MAXIMAL SCORE OF 9. ............................................................................................................ 103 
FIGURE 3.5. VIMENTIN SCORES IN MURAL LEAFLETS. THREE DIFFERENT COLUMNS 
REPRESENT THE THREE ZONES AND THREE DIFFERENT COLOURS REPRESENT 
THE THREE LAYERS. EACH ZONE AND EACH LAYER COULD HAVE A MAXIMAL 
SCORE OF 3, THE COMBINED SCORE FOR A LAYER OR ZONE COULD HAVE A 
MAXIMAL SCORE OF 9. ............................................................................................................ 104 
 xiv 
FIGURE 3.6. THE ADIPOCYTES ARE MODERATELY POSITIVE TO VIMENTIN. BAR = 10 
µM. .................................................................................................................................................. 109 
FIGURE 3.7. FAT SCORE IN SEPTAL AND MURAL LEAFLETS. THREE DIFFERENT 
COLUMNS REPRESENT THE THREE ZONES. EACH ZONE COULD HAVE A 
MAXIMAL SCORE OF 3, ............................................................................................................ 110 
FIGURE 3.8. α-SMA POSITIVE CELLS IN LAYERED FORMATION NEAR THE 
ENDOTHELIUM. BAR = 50 µM................................................................................................. 112 
FIGURE 3.9. A CLUSTER OF α-SMA POSITIVE CELLS ASSOCIATED WITH CONNECTIVE 
TISSUE. BAR = 10 µM................................................................................................................. 112 
FIGURE 3.10. α-SMOOTH MUSCLE ACTIN SCORES IN SEPTAL LEAFLETS. THREE 
DIFFERENT COLUMNS REPRESENT THE THREE ZONES AND THREE DIFFERENT 
COLOURS REPRESENT THE THREE LAYERS. EACH ZONE AND EACH LAYER 
COULD HAVE A MAXIMAL SCORE OF 3, THE COMBINED SCORE FOR A LAYER OR 
ZONE COULD HAVE A MAXIMAL SCORE OF 9................................................................. 114 
FIGURE 3.11. α-SMOOTH MUSCLE ACTIN SCORES IN MURAL LEAFLETS. THREE 
DIFFERENT COLUMNS REPRESENT THE THREE ZONES AND THREE DIFFERENT 
COLOURS REPRESENT THE THREE LAYERS. EACH ZONE AND EACH LAYER 
COULD HAVE A MAXIMAL SCORE OF 3, THE COMBINED SCORE FOR A LAYER OR 
ZONE COULD HAVE A MAXIMAL SCORE OF 9................................................................. 115 
FIGURE 3.12. DESMIN POSITIVE CARDIC MYOCYTE SHOWS FILAMENTOUS BANDING. 
BAR = 10 µM................................................................................................................................. 120 
FIGURE 3.13. DESMIN POSITIVE CHONDROCYTES IN THE FIBROSA LAYER. BAR = 10 
µM. .................................................................................................................................................. 120 
FIGURE 3.14. DESMIN SCORES IN SEPTAL LEAFLETS. THREE DIFFERENT COLUMNS 
REPRESENT THE THREE ZONES AND THREE DIFFERENT COLOURS REPRESENT 
THE THREE LAYERS. EACH ZONE AND EACH LAYER COULD HAVE A MAXIMAL 
SCORE OF 3, THE COMBINED SCORE FOR A LAYER OR ZONE COULD HAVE A 
MAXIMAL SCORE OF 9. ............................................................................................................ 121 
FIGURE 3.15. DESMIN SCORES IN MURAL LEAFLETS. THREE DIFFERENT COLUMNS 
REPRESENT THE THREE ZONES AND THREE DIFFERENT COLOURS REPRESENT 
THE THREE LAYERS. EACH ZONE AND EACH LAYER COULD HAVE A MAXIMAL 
SCORE OF 3, THE COMBINED SCORE FOR A LAYER OR ZONE COULD HAVE A 
MAXIMAL SCORE OF 9. ............................................................................................................ 122 
FIGURE 3.16. MICROPHOTOGRAPH SHOWING THE ARTERIOLE WALL STAINED 
POSITIVE FOR SMOOTH MUSCLE MYOSIN. BAR = 10 µM. ............................................ 127 
FIGURE 3.17. MICROPHOTOGRAPH SHOWING A VESSEL WALL STAINED POSITIVE FOR 
SMOOTH MUSCLE MYOSIN. BAR = 10 µM.......................................................................... 127 
FIGURE 3.18. SMOOTH MUSCLE MYOSIN SCORE IN SEPTAL LEAFLETS. THREE 
DIFFERENT COLUMNS REPRESENT THE THREE ZONES AND THREE DIFFERENT 
COLOURS REPRESENT THE THREE LAYERS. EACH ZONE AND EACH LAYER 
COULD HAVE A MAXIMAL SCORE OF 3, THE COMBINED SCORE FOR A LAYER OR 
ZONE COULD HAVE A MAXIMAL SCORE OF 9................................................................. 128 
FIGURE 3.19. SMOOTH MUSCLE MYOSIN SCORE IN MURAL LEAFLETS. THREE 
DIFFERENT COLUMNS REPRESENT THE THREE ZONES AND THREE DIFFERENT 
COLOURS REPRESENT THE THREE LAYERS. EACH ZONE AND EACH LAYER 
COULD HAVE A MAXIMAL SCORE OF 3, THE COMBINED SCORE FOR A LAYER OR 
ZONE COULD HAVE A MAXIMAL SCORE OF 9................................................................. 129 
FIGURE 3.20. FIBRILLIN SCORES IN SEPTAL AND MURAL LEAFLETS. THREE DIFFERENT 
COLUMNS REPRESENT THE THREE ZONES AND THREE DIFFERENT COLOURS 
REPRESENT THE THREE LAYERS. EACH ZONE AND EACH LAYER COULD HAVE A 
MAXIMAL SCORE OF 3, THE COMBINED SCORE FOR A LAYER OR ZONE COULD 
HAVE A MAXIMAL SCORE OF 9. ........................................................................................... 131 
FIGURE 3.21. ENDOTHELIAL CELLS LINING THE VESSEL AND THE PARA-LUMIN SPACE 
ARE POSITIVE FOR MMP-9. BAR = 10 µM............................................................................ 132 
FIGURE 3.22. THE INTERCELLULAR SPACE NEAR THE POLAR ENDS OF INTERSTITIAL 
CELLS ARE MMP-9 POSITIVE. BAR = 10 µM. ...................................................................... 132 
FIGURE 3.23. MMP-9 SCORES IN SEPTAL AND MURAL LEAFLETS. THREE DIFFERENT 
COLUMNS REPRESENT THE THREE ZONES AND THREE DIFFERENT COLOURS 
REPRESENT THE THREE LAYERS. EACH ZONE AND EACH LAYER COULD HAVE A 
 xv 
MAXIMAL SCORE OF 3, THE COMBINED SCORE FOR A LAYER OR ZONE COULD 
HAVE A MAXIMAL SCORE OF 9. ........................................................................................... 133 
FIGURE 3.24. MMP-13 POSITIVE IN SUB-ENDOTHELIAL SPACE. BAR = 10 µM. ................ 134 
FIGURE 3.25. MMP-13 POSITIVE AREA ASSOCIATED WITH A NODULE. BAR = 10 µM. .. 134 
FIGURE 3.26. MMP-13 SCORES IN SEPTAL AND MURAL LEAFLETS. THREE DIFFERENT 
COLUMNS REPRESENT THE THREE ZONES AND THREE DIFFERENT COLOURS 
REPRESENT THE THREE LAYERS. EACH ZONE AND EACH LAYER COULD HAVE A 
MAXIMAL SCORE OF 3, THE COMBINED SCORE FOR A LAYER OR ZONE COULD 
HAVE A MAXIMAL SCORE OF 9. ........................................................................................... 135 
FIGURE 3.27. MAC-387 POSITIVE MACROPHAGES ASSOCIATED WITH LUMINAL SIDE OF 
A VESSEL. BAR = 10 µM............................................................................................................ 136 
FIGURE 3.28. MAC-387 POSITIVE MACROPHAGES ASSOCIATED WITH TISSUE. BAR = 10 
µM. .................................................................................................................................................. 136 
FIGURE 3.29. COMPARISON OF MACROPHAGE NUMBER IN MITRAL VALVE BETWEEN 
MITRAL VALVE LESION GRADE. THE RESULTS FROM ANOVA, WILCOXON 
RANKED TEST, STUDENT’S T-TEST, AND LSN ARE PRESENTED. .............................. 137 
FIGURE 3.30. COMPARISON OF MACROPHAGE NUMBER IN SEPTAL LEAFLET (LEFT) 
AND MURAL LEAFLET (RIGHT) BETWEEN MITRAL VALVE LESION GRADE. THE 
RESULTS FROM ANOVA, WILCOXON RANKED TEST, STUDENT’S T-TEST, AND LSN 
ARE PRESENTED. ....................................................................................................................... 138 
FIGURE 3.31. COMPARISON OF MACROPHAGE NUMBER PER MM2 AREA BETWEEN 
MITRAL VALVE LESION GRADE. THE RESULTS FROM ANOVA, WILCOXON 
RANKED TEST, STUDENT’S T-TEST, AND LSN ARE PRESENTED. .............................. 138 
FIGURE 3.32. COMPARISON OF MACROPHAGE NUMBER PER AREA IN SEPTAL LEAFLET 
(LEFT) AND MURAL LEAFLET (RIGHT) BETWEEN MITRAL VALVE LESION GRADE. 
THE RESULTS FROM ANOVA, WILCOXON RANKED TEST, STUDENT’S T-TEST, AND 
LSN ARE PRESENTED. .............................................................................................................. 139 
FIGURE 3.33. DISTRIBUTION OF MACROPHAGE AS A PERCENTAGE IN SEPTAL LEAFLET 
(LEFT PANEL) AND MURAL LEAFLET (RIGHT PANEL). THREE DIFFERENT 
COLUMNS REPRESENT THE THREE ZONES AND THREE DIFFERENT COLOURS 
REPRESENT THE THREE LAYERS. ........................................................................................ 140 
FIGURE 3.34. MAST CELL WITH PUNCTUATED DENSE ORGANELLES BY TOLUIDINE 
BLUE STAIN. BAR = 10 µM....................................................................................................... 141 
FIGURE 3.35. COMPARISON OF MAST CELL NUMBER IN MITRAL VALVE BETWEEN 
MITRAL VALVE LESION GRADE. THE RESULTS FROM ANOVA, WILCOXON 
RANKED TEST, STUDENT’S T-TEST, AND LSN ARE PRESENTED. .............................. 141 
FIGURE 3.36. COMPARISON OF MAST CELL NUMBER IN SEPTAL LEAFLET (LEFT) AND 
MURAL LEAFLET (RIGHT) BETWEEN MITRAL VALVE LESION GRADE. THE 
RESULTS FROM ANOVA, WILCOXON RANKED TEST, STUDENT’S T-TEST, AND LSN 
ARE PRESENTED. ....................................................................................................................... 142 
FIGURE 3.37. COMPARISON OF MAST CELL NUMBER PER AREA BETWEEN MITRAL 
VALVE LESION GRADE. THE RESULTS FROM ANOVA, WILCOXON RANKED TEST, 
STUDENT’S T-TEST, AND LSN ARE PRESENTED.............................................................. 142 
FIGURE 3.38. COMPARISON OF MAST CELL NUMBER PER AREA IN SEPTAL LEAFLET 
(LEFT) AND MURAL LEAFLET (RIGHT) BETWEEN MITRAL VALVE LESION GRADE. 
THE RESULTS FROM ANOVA, WILCOXON RANKED TEST, STUDENT’S T-TEST, AND 
LSN ARE PRESENTED. .............................................................................................................. 143 
FIGURE 3.39. DISTRIBUTION OF MAST CELL AS A PERCENTAGE IN SEPTAL LEAFLET 
(LEFT PANEL) AND MURAL LEAFLET (RIGHT PANEL). THREE DIFFERENT 
COLUMNS REPRESENT THE THREE ZONES AND THREE DIFFERENT COLOURS 
REPRESENT THE THREE LAYERS. ........................................................................................ 144 
FIGURE 3.40. NUMBER OF SEPTAL LEAFLETS (LEFT) AND MURAL LEAFLETS (RIGHT) 
FOUND WITH AND WITHOUT CD34+ CELLS. .................................................................... 145 
FIGURE 3.41. COMPARISON OF CD34+ CELL NUMBER IN MITRAL VALVE BETWEEN 
MITRAL VALVE LESION GRADE. THE RESULTS FROM ANOVA, WILCOXON 
RANKED TEST, STUDENT’S T-TEST, AND LSN ARE PRESENTED. .............................. 146 
FIGURE 3.42. COMPARISON OF CD34+ NUMBER IN SEPTAL LEAFLET (LEFT) AND 
MURAL LEAFLET (RIGHT) BETWEEN MITRAL VALVE LESION GRADE. THE 
RESULTS FROM ANOVA, WILCOXON RANKED TEST, STUDENT’S T-TEST, AND LSN 
ARE PRESENTED. ....................................................................................................................... 146 
 xvi 
FIGURE 4.1. REPRESENTATIVE 1D SDS-PAGE GEL FROM THE NORMAL GROUP WHICH 
WAS DIVIDED INTO 5 STRIPS OF EQUAL THICKNESS FOR LC-MS/MS. THE 
MOLECULAR WEIGHT (MW) MARKERS ARE INDICATED ON THE LEFT. ................ 165 
FIGURE 4.2. REPRESENTATIVE MASCOT SEARCH RESULTS SHOWING THE 
PROBABILITY BASED MOWSE SCORE. THE RED BARS OUTSIDE THE GREEN AREA 
INDICATES THE MATCHES WERE SIGNIFICANT. ............................................................ 165 
FIGURE 4.3. REPRESENTATIVE OF A MALDI-MS PEAKS CHART FROM A STRIP OF 
TRYPSIN DIGESTED 1D SDS-PAGE. ...................................................................................... 166 
FIGURE 4.4. THE DISTRIBUTION OF PROTEIN SPOTS FOUND TO BE SIGNIFICANTLY 
DIFFERENT BETWEEN NORMAL AND MODERATE GROUPS. THE PLOT SHOWS THE 
FOLD CHANGE OF PROTEIN SPOTS FROM NORMAL GROUP TO MODERATE 
GROUP. THE X-AXIS IS THE FOLD CHANGE IN DENSITY VOLUME AND Y-AXIS IS 
THE NUMBER OF COUNTS (N=25). ........................................................................................ 171 
FIGURE 4.5. THE DISTRIBUTION OF PROTEIN SPOTS FOUND TO BE SIGNIFICANTLY 
DIFFERENT BETWEEN MODERATE AND SEVERE GROUPS. THE PLOT SHOWS THE 
FOLD CHANGE OF PROTEIN SPOTS FROM MODERATE TO SEVERE GROUP. THE X-
AXIS IS THE FOLD CHANGE IN DENSITY VOLUME AND Y-AXIS IS THE NUMBER 
OF COUNTS (N=25). .................................................................................................................... 172 
FIGURE 4.6. THE DISTRIBUTION OF PROTEIN SPOTS FOUND TO BE SIGNIFICANTLY 
DIFFERENT BETWEEN NORMAL AND SEVERE GROUPS. THE PLOT SHOWS THE 
FOLD CHANGE OF PROTEIN SPOTS FROM NORMAL TO SEVERE GROUP. THE X-
AXIS IS THE FOLD CHANGE IN DENSITY VOLUME AND Y-AXIS IS THE NUMBER 
OF COUNTS (N=37). .................................................................................................................... 172 
FIGURE 4.7. TWO-DIMENSIONAL ELECTROPHORETIC MAP FOR NORMAL CANINE 
MITRAL VALVE. FIRST-DIMENSIONAL SEPARATION WITH IMMOBILIZED PH 
GRADIENT STRIPS (18 CM, PH RANGE: 3–10); SECOND DIMENSION WAS BY SDS-
PAGE (10% ACRYLAMIDE; 16 × 20 CM GELS); PROTEINS WERE VISUALIZED BY 
SILVER STAINING. PROTEIN SPOTS WERE IDENTIFIED BY TRYPTIC PEPTIDE 
MAPPING FROM MATCHED COOMASSIE BLUE-STAINED AND SILVERQUEST 
STAINED GELS. IDENTIFIED PROTEINS ARE LABELED IN WITH THE 
CORRESPONDING SWISSPROT GENE NAME: SEE TABLE 4.2 BELOW FOR KEY. ... 173 
FIGURE 4.8. TWO-DIMENSIONAL ELECTROPHORETIC MAP FOR MODERATELY 
DISEASED MITRAL VALVE. FIRST-DIMENSIONAL SEPARATION WITH 
IMMOBILIZED PH GRADIENT STRIPS (18 CM, PH RANGE: 3–10); SECOND 
DIMENSION WAS BY SDS-PAGE (10% ACRYLAMIDE; 16 × 20 CM GELS); PROTEINS 
WERE VISUALIZED BY SILVER STAINING......................................................................... 175 
FIGURE 4.9. TWO-DIMENSIONAL ELECTROPHORETIC MAP FOR SEVERELY DISEASED 
MITRAL VALVE. FIRST-DIMENSIONAL SEPARATION WITH IMMOBILIZED PH 
GRADIENT STRIPS (18 CM, PH RANGE: 3–10); SECOND DIMENSION WAS BY SDS-
PAGE (10% ACRYLAMIDE; 16 × 20 CM GELS); PROTEINS WERE VISUALIZED BY 
SILVER STAINING. PROTEIN SPOTS WERE IDENTIFIED BY TRYPTIC PEPTIDE 
MAPPING FROM MATCHED SILVERQUEST STAINED GELS. IDENTIFIED PROTEINS 
FROM CANINE GENOME SEQUENCE ARE LABELED IN WITH THE 
CORRESPONDING SWISSPROT GENE NAME: SEE TABLE BELOW FOR KEY. ......... 176 
FIGURE 4.10. DYMENSION SOFTWARE GENERATED 2-D PROTEIN SPOT PATTERN FROM 
SUPERIMPOSED AVERAGE SPOTS IN NORMAL AND SEVERELY DISEASED 
GROUPS. THE GREEN COLOUR SHOWS THE SPOTS INCREASED IN INTENSITY, THE 
RED COLOUR SHOWS THE SPOTS IN DECREASED IN INTENSITY, AND THE BLACK 
REPRESENTS UNCHANGED SPOTS....................................................................................... 177 
FIGURE 4.11. PANEL SHOWING HOW THE TROPOMYSIN SPOT WAS PRESENT IN THE 
NORMAL, DOWN REGULATED IN THE MODERATE AND ABSENT IN THE 
SEVERELY DISEASED............................................................................................................... 178 
FIGURE 4.12. PANEL SHOWING HOW THE MYOSIN REGULATORY LIGHT CHAIN 2 SPOT 
WAS PRESENT IN THE NORMAL, DOWN REGULATED IN THE MODERATE AND 
ABSENT IN THE SEVERELY DISEASED. .............................................................................. 178 
FIGURE 5.1. THE GEL ELECTROPHORESIS PICTURE SHOWS THE RT-PCR PRODUCTS FOR 
THE HOUSEKEEPING GENE GAPDH (464 BP) AFTER 29 CYCLES. THE VARIABLE 
EXPRESSION OF GAPDH BETWEEN SAMPLES WAS VISIBLE; ONE SAMPLE IN THE 
SEVERE GROUP HAS VIRTUALLY NO VISIBLE MRNA. ................................................. 197 
 xvii 
FIGURE 5.2. THE GEL ELECTROPHORESIS PICTURE SHOWS THE RT-PCR PRODUCTS FOR 
THE HOUSEKEEPING GENE RPL19 (479 BP) AFTER 32 CYCLES. THE BANDS ON THE 
GEL SHOW A CONSISTENT RPL19 EXPRESSION ACROSS ALL SAMPLES. ............... 198 
FIGURE 5.3. DENSITOMETRIC ANALYSIS OF THE RPL19 GENE EXPRESSION. THE 
RESULTS FROM ANOVA, T-TEST, WILCOXON RANKED TEST AND LSN ARE 
PRESENTED.................................................................................................................................. 198 
FIGURE 5.4. THE GEL ELECTROPHORESIS PICTURE SHOWS THE RT-PCR PRODUCTS FOR 
THE HOUSEKEEPING GENE 18S RRNA (273 BP) AFTER 22 CYCLES. THE BANDS ON 
THE GEL SHOW A CONSISTENT 18S RRNA EXPRESSION ACROSS ALL SAMPLES.199 
FIGURE 5.5. DENSITOMETRIC ANALYSIS OF THE 18S RRNA GENE EXPRESSION. THE 
RESULTS FROM ANOVA, T-TEST, WILCOXON RANKED TEST AND LSN ARE 
PRESENTED.................................................................................................................................. 199 
FIGURE 5.6. THE GEL ELECTROPHORESIS PICTURE SHOWS THE RT-PCR PRODUCTS FOR 
THE VIMENTIN GENE (490 BP) AFTER 28 CYCLES........................................................... 200 
FIGURE 5.7. DENSITOMETRIC ANALYSIS OF THE NORMALIZED VIMENTIN GENE 
EXPRESSION. THE RESULTS FROM ANOVA, T-TEST, WILCOXON RANKED TEST 
AND LSN ARE PRESENTED. .................................................................................................... 200 
FIGURE 5.8. THE GEL ELECTROPHORESIS PICTURE SHOWS THE RT-PCR PRODUCTS FOR 
THE α-SMA GENE (449 BP) AFTER 28 CYCLES. ................................................................. 200 
FIGURE 5.9. DENSITOMETRIC ANALYSIS OF THE NORMALIZED SMOOTH MUSCLE α-
ACTIN GENE EXPRESSION. THE RESULTS FROM ANOVA, T-TEST, WILCOXON 
RANKED TEST AND LSN ARE PRESENTED. ....................................................................... 201 
FIGURE 5.10. THE GEL ELECTROPHORESIS PICTURE SHOWS THE RT-PCR PRODUCTS 
FOR THE TROPOMYOSIN GENE (279 BP) AFTER 30 CYCLES. ....................................... 201 
FIGURE 5.11. DENSITOMETRIC ANALYSIS OF THE NORMALIZED TROPOMYOSIN GENE 
EXPRESSION. THE RESULTS FROM ANOVA, T-TEST, WILCOXON RANKED TEST 
AND LSN ARE PRESENTED. .................................................................................................... 202 
FIGURE 5.12. THE GEL ELECTROPHORESIS PICTURE SHOWS THE RT-PCR PRODUCTS 
FOR THE MYOSIN LIGHT POLYPEPTIDE 4 GENE (426 BP) AFTER 28 CYCLES......... 202 
FIGURE 5.13. DENSITOMETRIC ANALYSIS OF THE NORMALIZED MYOSIN LIGHT 
POLYPEPTIDE-4 GENE EXPRESSION. THE RESULTS FROM ANOVA, T-TEST, 
WILCOXON RANKED TEST AND LSN ARE PRESENTED. ............................................... 203 
FIGURE 5.14. THE GEL ELECTROPHORESIS PICTURE SHOWS THE RT-PCR PRODUCTS 
FOR THE BIGLYCAN GENE (486 BP) AFTER 31 CYCLES................................................. 203 
FIGURE 5.15. DENSITOMETRIC ANALYSIS OF THE NORMALIZED BIGLYCAN GENE 
EXPRESSION. THE RESULTS FROM ANOVA, T-TEST, WILCOXON RANKED TEST 
AND LSN ARE PRESENTED. .................................................................................................... 204 
FIGURE 5.16. THE GEL ELECTROPHORESIS PICTURE SHOWS THE RT-PCR PRODUCTS 
FOR THE FIBRONECTIN GENE (307 BP) AFTER 28 CYCLES........................................... 204 
FIGURE 5.17. DENSITOMETRIC ANALYSIS OF THE NORMALIZED FIBRONECTIN GENE 
EXPRESSION. THE RESULTS FROM ANOVA, T-TEST, WILCOXON RANKED TEST 
AND LSN ARE PRESENTED. .................................................................................................... 205 
FIGURE 5.18. THE GEL ELECTROPHORESIS PICTURE SHOWS THE RT-PCR PRODUCTS 
FOR THE FIBRILLIN GENE (318 BP) AFTER 31 CYCLES. ................................................. 205 
FIGURE 5.19. DENSITOMETRIC ANALYSIS OF THE NORMALIZED FIBRILLIN GENE 
EXPRESSION. THE RESULTS FROM ANOVA, T-TEST, WILCOXON RANKED TEST 
AND LSN ARE PRESENTED. .................................................................................................... 206 
FIGURE 5.20. THE GEL ELECTROPHORESIS PICTURE SHOWS THE RT-PCR PRODUCTS 
FOR THE MMP-13 GENE AFTER 55 CYCLES. THE NORMAL (N) CONTAINS TWO 
BANDS, THE EXPECTED 496 BP AND A FRAGMENT ABOUT 310 BP. THE 
MODERATELY DISEASED LACKING THE EXPECTED 496 BP FRAGMENT BUT 
PRODUCED A 310 BP FRAGMENT INSTEAD. THE SEVERELY DISEASE ALSO 
LACKING THE EXPECTED 496 BP FRAGMENT BUT IT PRODUCED A UNIQUE 
FRAGMENT ABOUT 600 BP...................................................................................................... 206 
 xviii 
List of tables 
TABLE 2.1. BACKGROUND INFORMATION ABOUT THE DOGS THAT SAMPLES WERE 
OBTAINED FROM. ........................................................................................................................ 21 
TABLE 2.2: SHAPE QUANTITATIVE DESCRIPTORS. MEANINGS OF THE PARAMETERS. A: 
NET AREA; ACONVEX : AREA OF THE CONVEX HULL; AF ILL AREA OF THE 
FILLED POLYGON; P: PERIMETER; PCONVEX : PERIMETER OF THE CONVEX HULL; 
DMAX , DMIN : MAXIMUM AND MINIMUM DIMENSION; DINSCR AND DCIRCUM: 
DIAMETERS OF THE INSCRIBED AND CIRCUMSCRIBED CIRCLE; L: LENGTH OF 
THE FEATURE ALONG THE FARTHEST POINTS IN THE CONVEX HULL; LF , WF : 
FIBER LENGTH AND FIBER WIDTH (MEASURED FROM THE SKELETON OF THE 
FEATURE). ...................................................................................................................................... 24 
TABLE 2.3. BREED DISTRIBUTION OF DOGS. ................................................................................ 25 
TABLE 2.4. MEDIANS, MEANS AND QUARTILE VALUES FOR THE QUANTITATIVE 
STEREOLOGY OF ENDOTHELIUM, INTERSTITIAL CELLS, COLLAGEN AND 
EXTRACELLULAR MATRIX DATA SETS............................................................................... 61 
TABLE 2.5. MEDIANS, MEANS AND QUARTILE VALUES FOR THE CIRCULARITY OF 
ENDOTHELIUM AND INTERSTITIAL CELL. ......................................................................... 65 
TABLE 2.6. PREVIOUS STUDIES INVESTIGATED THE MITRAL VALVE LEAFLETS 
LENGTH AND THEIR CALCULATED SEPTAL/MURAL RATIO. ....................................... 89 
TABLE 3.1. DETAILS OF ANTIBODIES USED.................................................................................. 97 
TABLE 3.2. VIMENTIN POSITIVE CELL DISTRIBUTION PATTERNS IN SEPTAL LEAFLETS. 
THEY ARE PRESENTED IN A HIERARCHAL ORDER. THE MOST FREQUENTLY 
OCCURRING DISTRIBUTION PATTERN IS AT THE TOP OF EACH BLOCK. .............. 105 
TABLE 3.3. VIMENTIN POSITIVE CELL DISTRIBUTION PATTERNS IN MURAL LEAFLETS. 
THEY ARE PRESENTED IN A HIERARCHAL ORDER. THE MOST FREQUENTLY 
OCCURRING DISTRIBUTION PATTERN IS AT THE TOP OF EACH BLOCK. .............. 106 
TABLE 3.4. VIMENTIN POSITIVE CELL MORPHOLOGIES IN SEPTAL LEAFLETS. THEY 
ARE PRESENTED IN A HIERARCHAL ORDER. THE MOST FREQUENTLY 
OCCURRING CELL SHAPE IS AT THE TOP OF EACH BLOCK........................................ 107 
TABLE 3.5. VIMENTIN POSITIVE CELL MORPHOLGIES IN MURAL LEAFLETS. THEY ARE 
PRESENTED IN A HIERARCHAL ORDER. THE MOST FREQUENTLY OCCURRING 
CELL SHAPE IS AT THE TOP OF EACH BLOCK. ................................................................ 108 
TABLE 3.6. ADIPOCYTE DISTRIBUTION PATTERNS IN SEPTAL LEAFLETS. THEY ARE 
PRESENTED IN A HIERARCHAL ORDER. THE MOST FREQUENTLY OCCURRING 
DISTRIBUTION PATTERN IS AT THE TOP OF EACH BLOCK. ........................................ 111 
TABLE 3.7. ADIPOCYTE DISTRIBUTION PATTERNS IN MURAL LEAFLETS. THEY ARE 
PRESENTED IN A HIERARCHAL ORDER. THE MOST FREQUENTLY OCCURRING 
DISTRIBUTION PATTERN IS AT THE TOP OF EACH BLOCK. ........................................ 111 
TABLE 3.8. α-SMOOTH MUSCLE ACTIN POSITIVE CELL DISTRIBUTION PATTERNS IN 
SEPTAL LEAFLETS. THEY ARE PRESENTED IN A HIERARCHAL ORDER. THE MOST 
FREQUENTLY OCCURRING DISTRIBUTION PATTERN IS AT THE TOP OF EACH 
BLOCK. .......................................................................................................................................... 116 
TABLE 3.9. α-SMOOTH MUSCLE ACTIN POSITIVE CELL DISTRIBUTION PATTERNS IN 
MURAL LEAFLETS. THEY ARE PRESENTED IN A HIERARCHAL ORDER. THE MOST 
FREQUENTLY OCCURRING DISTRIBUTION PATTERN IS AT THE TOP OF EACH 
BLOCK. .......................................................................................................................................... 117 
TABLE 3.10. α-SMOOTH MUSCLE ACTIN POSITIVE CELL MORPHOLGIES IN SEPTAL 
LEAFLETS. THEY ARE PRESENTED IN A HIERARCHAL ORDER. THE MOST 
FREQUENTLY OCCURRING SHAPE IS AT THE TOP OF EACH BLOCK....................... 118 
TABLE 3.11. α-SMOOTH MUSCLE ACTIN POSITIVE CELL MORPHOLGIES IN MURAL 
LEAFLETS. THEY ARE PRESENTED IN A HIERARCHAL ORDER. THE MOST 
FREQUENTLY OCCURRING CELL SHAPE IS AT THE TOP OF EACH BLOCK. .......... 119 
TABLE 3.12. DESMIN POSITIVE CELL DISTRIBUTION PATTERNS IN SEPTAL LEAFLETS. 
THEY ARE PRESENTED IN A HIERARCHAL ORDER. THE MOST FREQUENTLY 
OCCURRING DISTRIBUTION PATTERN IS AT THE TOP OF EACH BLOCK. .............. 123 
TABLE 3.13. DESMIN POSITIVE CELL DISTRIBUTION PATTERNS IN MURAL LEAFLETS. 
THEY ARE PRESENTED IN A HIERARCHAL ORDER. THE MOST FREQUENTLY 
OCCURRING DISTRIBUTION PATTERN IS AT THE TOP OF EACH BLOCK. .............. 124 
 xix 
TABLE 3.14. DESMIN POSITIVE CELL MORPHOLGIES IN SEPTAL LEAFLETS. THEY ARE 
PRESENTED IN A HIERARCHAL ORDER. THE MOST FREQUENTLY OCCURRING 
CELL SHAPE IS AT THE TOP OF EACH BLOCK. ................................................................ 125 
TABLE 3.15. DESMIN POSITIVE CELL MORPHOLGIES IN MURAL LEAFLETS. THEY ARE 
PRESENTED IN A HIERARCHAL ORDER. THE MOST FREQUENTLY OCCURRING 
CELL SHAPE IS AT THE TOP OF EACH BLOCK. ................................................................ 126 
TABLE 3.16. MORPHOLOGICAL FEATURES OF VEC AND ENDOTHELIAL LINING DURING 
THE DISEASE PROGRESSION.................................................................................................. 147 
TABLE 4.1. LIST OF SIGNIFICANT PROTEINS FROM 1-D GELS IDENTIFIED BY LCMS AND 
MALDI-MS THROUGH MASCOT SEARCH AGAINST SWISSPROT................................ 167 
TABLE 4.2. PROTEIN IDENTIFICATION FOR NORMAL CANINE MITRAL VALVE. ........... 174 
TABLE 4.3. PROTEINS IDENTIFIED VIA SEARCHING AGAINST ENSEMBL CANINE 






ABC ammonium bicarbonate 
ANOVA analysis of variance 
BB blood borne 
CAN acetonitrile 





ECM extracellular matrix 
FBN fibrillin 
FGF-2 fibroblast growth factor 2 




GAPDH glyceraldehydes 3-phosphate dehydrogenase 
H&E hematoxylin and eosin 




IgG immunoglobulin G 
LC liquid chrmatography 
LDL low-density lipoprotein 
Lrp5 low-density lipoprotein receptor 
LSN least significant number 
M mass value 
MALDI-TOF matrix-assisted laser desorption ionisation time of flight  
MLC myosin light chain  
MMP matrix metalloproteinase 
MMVD myxomatous mitral valve disease 
MR mitral regurgitation 
MS/MS  tandem mass spectometry 
MSDB Mass Spectrometry Protein Sequence Database 
MVP mitral valve prolapse 
MYL-4 Myosin light polypeptide 
N normal 
NaOH sodium hydroxide 
NCBInr National Centre of Biotechnology Information non-redundant 
NOS nitric oxide synthase 
OD optical density 
PBS phosphate buffered saline 
RGB red green blue 
RPL19 ribosomal protein L19 
RT-PCR reverse transcription polymerase chain reaction 
SDS-PAGE sodium dodecyl sulphate polyacrylamide gel electrophoresis 
SEM scanning electron microscope 
SLRP small leucine rich proteoglycans 
TEM transmission electron microscope 
 xxi 
TGF-b1 transforming growth factor-b1 
TIMP tissue inhibitors of metalloproteinase 
TPM tropomyosin 
TRRAP transformation transcription domain associated protein 
VEC valvular endothelial cell 
VIC valvular interstitial cell 




Myxomatous mitral valve degeneration (MMVD) is the single most common 
cardiac disease of the dog, and is analogous to Mitral Valve Prolapse in humans. 
Very little is known about the aetiopathogenesis of this disease or the changes in 
valvular interstitial cell populations in diseased valves. The aim of this study was to 
identify morphological, cellular and molecular changes associated with MMVD. 
Mitral valve leaflets from both normal and varying grades (Whitney’s 1-4) of 
diseased dogs were subject to image analysis, immunophenotyping, proteomics and 
RT-PCR. 
Image analysis - leaflet thickening due to accumulation of 
glycosaminoglycan was significant in this disease. MMVD is associated with loss of 
connective tissue, reduction in cell numbers but no change in cell shape in the 
overtly myxomatous area. Near the surface, increase in valvular interstitial cells 
(VIC) towards the damaged endothelium in concert with destruction of collagen and 
building up of ground substance was manifested during the disease process.  
Immunophenotyping - activated myofibroblasts were increased and 
fibroblast-like VICs were reduced without any change in desmin and myosin 
expression in MMVD compared to clinical normal dogs. In addition, other cell types 
like macrophage, adipocyte, chondrocyte, mast cell, and stem cell were identified 
and their possible role in MMVD is discussed. 
Proteomics - a protein expression profile was established, with 64 proteins 
being positively identified from dog’s mitral valve using 1-D SDS PAGE LC/MS. 
Amongst them 44 proteins were differentially expressed comparing normal and 
severely diseased. Two actin binding proteins, tropomyosin alpha and myosin light 
chain-2 were found to be differentially expressed in the normal but down regulated 
in the diseased. 
RT-PCR was used to assess the expression of 8 genes of interest. Their 
expression was compared with 3 different housekeeping genes. 
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1 Chapter 1 Background Information on Mitral Valve 
Disease 
1.1 Introduction 
Myxomatous Mitral Valve Degeneration (MMVD) is the most common 
cardiac disease in the dog1. It is characterised by myxomatous degeneration of the 
mitral heart valve. The disease is also referred to as Mitral Valve Endocardiosis 
(MVE) or Chronic Valvular Disease. The prevalence and severity of the disease was 
found to be closely age dependent. However, some breeds of dog are more 
predisposed to the disease than others, suggesting a likely inherited component to the 
disease in some breeds. The disease is most widely associated worldwide with the 
Cavalier King Charles spaniel. Pathologically, the disease is recognised by the 
presence of greyish-white nodules and plaque-like nodules, located in the area of 
apposition of the mitral valve leaflets2. Histological studies have shown that the 
disease is manifested by excessive destruction and derangement of the valve stroma 
with loss of the collagen bundle organisation and accumulation of 
glycosaminoglycans in the leaflets. An increase in the severity of valvular damage 
corresponds to a worsening of the clinical disability. MMVD leads to regurgitation 
of blood across the closed mitral valve during ventricular systole. As the disease 
progresses, the lesions are associated with further valvular incompetence, systolic 
murmurs and eventually congestive heart failure. The condition demonstrates close 
similarities to Mitral Valve Prolapse in humans in terms of the pathological change 
and the clinical outcome3. Although in humans, the displacement of mitral valve 
leaflets into the atrium occurs at a lower frequency4, 5. 
Despite major understanding of the diagnosis and pathology of this disease, 
very little information is available on the morphological and cellular phenotypic 
changes. The primary aim of this work is to fill in the gap in the current 




Figure 1.1. Diagram to show the anatomy of the heart and location of the mitral valve.  
1.1.1 Mitral valve anatomy 
The canine mitral valve complex, similar to humans and other species, 
consists of the annulus, two leaflets, chordae tendinea and the papillary muscles 
(Figure 1.1). The mitral valve, separating the atrium and ventricle in the left heart, is 
open during ventricular diastole and closes during systole and has to withstand the 
backward pressure during the full force of ventricular contraction6. This action 
requires all its components, together with the adjacent atrial and ventricular muscle, 
to work in a synchronized fashion in order to direct the blood flow from the left 
atrium to the left ventricle and finally ejecting it into the aorta7, 8.  
1.1.2 Annulus  
The annulus is a complete ring-like fibrous cord that the leaflets are anchored 
to, although it is more D-shaped than circular. The straight border of the ring 
incorporates the fibrous continuity between the leaflets of the aortic and mitral 
valves. The annulus marks the hinge line of the mitral valve leaflets. However, when 
viewed from the ventricular side, the hinge line is not distinct as the fibrous 
continuity is an extensive sheet. The annulus also serves as the border separating the 
atrial and ventricular myocardial muscles. However, the atrial myocardium usually 
extrudes some distance into the leaflets beyond the level of the annulus. 
The flexible nature of the annulus provides a firm origin for the leaflets and 
acts as a dynamic component during valve motion. Passive contraction of the 
annulus ensures that at ventricular systole the leaflets co-apt more effectively. 
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1.1.3 Leaflets 
The mitral valve has two leaflets, which are distinctively different in shape 
and circumferential length. Each leaflet has an atrial and a ventricular surface. The 
septal leaflet, also known as the anterior or aortic leaflet, can be seen as the fibrous 
continuity of the aortic valve. It has a semi-circular shape that occupies a third of the 
annular circumference. The septal leaflet can be divided into two areas. The rough 
zone, which is slightly thick because of the chordae tendineae attached into it, 
includes the closure edge and a membranous zone, which is thinner and devoid of 
chordae tendineae. 
The mural leaflet, also known as the posterior ventricular leaflet, is separated 
from the septal leaflet by two commissures. The mural leaflet is generally scalloped, 
with a larger central scallop and two smaller lateral scallops described as medial, 
middle and lateral. A rough zone and a membranous zone can also be identified, but 
this leaflet also has a basal zone, where the basal chordae tendineae arising, from the 
left ventricular myocardium end.  
The two leaflets meet to form an arc shaped closure line, or zone of 
apposition. Even though the septal leaflet appears to form the major part of the atrial 
floor space, it is approximately equal in area to the mural leaflet. The commissures at 
each end do not reach all the way to the annulus. Strictly speaking there is not a clear 
commissural line to partition the two leaflets. The mural leaflet also forms slits that 
allow snug closure of the valve. An argument concerning the number of leaflets 
within the skirt of the left atrioventricular annulus has been raised; some authors 
suggesting the mitral valve has more than two leaflets7, 8.  
A single layer of endothelial cells continuous with atrial and ventricular 
endothelium covers the surfaces of the mitral valve leaflets. At the mid-point of a 
typical leaflet, there are four cross-sectional layers, namely atrialis, spongiosa, 
fibrosa and ventricularis. From the atrial side, the atrialis layer is rich in elastin, 
mixed with scattered collagen fibres and fibroblasts. Smooth muscle cells can also be 
seen in the atrialis. Underneath the atrialis lies the spongiosa, a loose connective 
tissue layer composed of loose collagen fibres, scattered collagen bundles and thin 
elastin fibres embedded in mucopolysaccharide rich ground substance. Within the 
loosely arranged collagen are scattered fibroblasts and Anitschkov cells (enlarged 
macrophages). Immediately adjacent to the spongiosa is a dense, well-organised 
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fibrosa layer, which consists of well-defined collagen bundles with scattered 
entrapped fibroblasts. The fibrosa is continuous with the annulus fibrosus and branch 
off to form the core of the chordae tendineae. The ventricularis has collagen fibres 
and scattered elastin, which the chordaes are attached to1, 6. Towards the free edge, 
the junction between spongiosa and fibrosa becomes indistinct, with apparent 
merging of loose collagen bundles and ground substance of both layers. At the true 
free edge, this distinction is lost and the free edge appears as almost entirely 
consisting of spongiosa. Although the designation of the mitral valve leaflet cross-
sections into layers is described, nevertheless the leaflet tissue is a continuum of 
structures from one surface to the other. The designation of segmentation into layers 
was merely to assist the observer to identify the prevalent segmental variability 
across the leaflet; the system being somewhat arbitrarily defined.  
Based on the electronmicroscopic studies of healthy dogs of various ages, 
Fenoglio has subdivided the length of the septal leaflet into three zones on the basis 
of the extent of muscle9. The extruding muscle from the atria appears to be 
sandwiched between the atrialis and fibrosa. The proximal third closest to the 
annulus contains valvular muscle and appears to be a direct extension from the 
muscle of the left atrium. At the ultrastructural level, this proximal muscle is 
identical to atrial myocardium with atrial specific granules. Small nerves and 
vascular channels are scattered between the muscle fibres. In the middle third of the 
leaflet, the muscle tissue is progressively thinned leaving individual fibres. The 
individual muscle cells are surrounded by collagen bundles, fibroblasts and scattered 
elastic fibres. These loosely arranged constituents are distinctly separated fibrosa and 
lead to spongiosa. None of the valvular muscle is present in the distal third. In the 
mural leaflet, the muscle is in similar locations as in the septal leaflet. However, the 
muscle ends abruptly in the midportion of the leaflet and is immediately replaced by 
spongiosa and for that reason, Fenoglio divided the mural leaflet into two zones. 
Small nerves and vascular channels are also present in this leaflet.  
1.1.4 Tendinous chords 
The chordae tendineae are thin string-like structures that connect the papillary 
muscles to the mitral valve leaflets. The tendinous chords are attached to two groups 
of papillary muscles in the ventricular wall. The chordae arise from the apices of the 
papillary muscles, branch off in a fan-shaped fashion and attach to adjacent ends of 
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both leaflets. The tendinous chords play a crucial role in determining the geometry 
and hence the performance of the valve. Chordal rupture will result in valve prolapse 
and regurgitation. The chordea have classically been described as first-, second- and 
third order chordae. This classification is according to the site of attachment to the 
leaflets. The first order chords are those attached to the free edge. They are numerous 
and often form networks near the edge. The second order chordae insert into the 
ventricular side of the leaflets beyond the free edge, forming the rough zones. Third 
order chorda attach only to the mural leaflet since they arise from the ventricular 
wall. They are attached to the basal portion of the mural leaflet. However, third order 
chordae are seldom found in dogs.  
Other authors prefer to divide them into commissural, strut, cleft and basal 
chordae10, 11. The commissural chordae are those inserting into the commissures, and 
there are normally two. The rough chordae insert into the rough area of the leaflet, 
and each chordae divides into three before insertion. The strut chordae consist of two 
rough chordae which can be identified because of their increased thickness and 
length, and because they insert into the septal leaflet near its free edge. The basal 
chordae insert into the basal area of the mural mitral leaflet; they tend to be more 
numerous in the middle or larger scallop. Finally, the cleft chordae are those that 
insert into the clefts of the mural mitral leaflet, dividing into several small chordae 
before doing so. The interchordal spaces serve as important pathways for blood flow.  
At the ultrastructural level, the cross section of chordae tendineae consists of 
three distinct layers9. An outer layer of flattened endothelial cells is separated by the 
basal lamina from an area of loosely meshed collagen, elastic fibres and scattered 
bundles of dense collagen. This is known as the spongiosa layer. Nerves are 
occasional found in this region. The central core is made up of dense, wavy, tightly 
packed collagen bundles running in parallel to the axis of the chorda. Scattered 
fibroblasts are found entrapped in the collagen, but no vessels have been identified12. 
At the point of insertion to the ventricular aspect of the leaflet, the endothelial cells 
and spongiosa of chordae are continuous with those of the leaflet, but the collagen 
core divides. The bulk of the collagen is continuous with the fibrosa and courses 
toward the annulus.  
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1.1.5 Papillary muscles 
The two left ventricular papillary muscles are located in an ideal mechanical 
position beneath the ends of the zone of apposition or under the commissures 
between the leaflets; occupying the anterolateral and posteromedial positions in the 
ventricle. Normally, the papillary muscles arise from the apical and middle third of 
the left ventricular wall7. The anterolateral papillary muscle is generally single, and it 
receives its blood from the left anterior descending artery. The posteromedial 
papillary muscle generally consists of two bellies, and receives blood from the right 
coronary artery. Each muscle gives rise to tendinous chords, which in turn run to 
support both leaflets of the valve. Microscopic observations reveal the collagen in 
chordae branching into finger like processes and penetrating between cardiac muscle 
bundles at the tip of the papillary muscles. At the junction between chordae and 
papillary muscle, the spongiosa of the chordae expands to form a cushion of loose 
collagen, together with scattered elastic fibres and large lipid droplets.  As the 
collagen fibres penetrate deeper into the papillary muscle, they divide into smaller 
and smaller units, eventually forming a network anchoring system much like the 
roots of a tree. Within the small, wavy collagen bundles, there are numerous small 
capillaries and nerve fascicles. The collagen fibres appear to terminate in the basal 
lamina of the muscle cells9. 
1.1.6 Pathology of myxomatous mitral valve disease 
The normal healthy mitral valve leaflets are thin, pliable, translucent and soft. 
Mitral valve MMVD involves a complex connective tissue degenerative process with 
little or no inflammatory reaction. The pathology is recognized by the presence of 
greyish-white, smooth, glistening nodules or plaque-like elevations, often situated in 
the area of apposition on the atrialis surface of the leaflets. The diseased valve 
leaflets become opaque and thickened; they are more extensible and less stiff than 
normal leaflets. This compromises the dynamic mechanical properties of the mitral 
valve13. The lesions of MMVD represent a gradual process and may cause no 
detectable signs during early stage of structural change. However, as the disease 
progresses it will lead to insufficient co-aptation of the leaflets, increasing 
regurgitation of blood back into the atria, and in the late stage of the disease dilation 
of the left ventricle and mitral annulus occurs, and in some cases jet lesions and 
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ruptured chordae. As a consequence, these lesions will lead to mitral systolic 
murmurs, and in severe cases, congestive heart failure.  
Older literature has referred to this disease as a process of ‘valvular 
fibrosis’14. However, this concept has been challenged by the observation that the 
disease process involves thickening of spongiosa and destruction of fibrosa.  
1.1.7 Epidemiology 
Various papers have reported the occurrence of MMVD in dogs, ranging 
from 21% to 89% in dogs1, 15-17. This huge divergence in these findings might be 
attributed to the disparate clinical sample selection of the groups of dogs. Apart from 
the sample pool size, other criteria such as age and breed could influence the reports 
markedly and these factors should also be take into consideration.  
Similar lesions can also appear in tricuspid and aortic valves18, concomitant 
with mitral valve lesions, although the incidence of lesions in tricuspid (30%) and 
aortic valves (3%) occur at much lower frequency. A necropsy survey carried out on 
230 dogs with valvular disease at University of Pennsylvania Veterinary Hospital 
showed the relative incidence of mitral valve lesions involved in 227 dogs at 98.7%. 
Among the 227 dogs, 143 had lesions affecting the valve alone, the rest had lesions 
affecting aortic and tricuspid valves as well1, 2. 
1.1.8 Lesion grades 
Due to considerable variation in the size of the normal heart valve in different 
breeds of dogs, direct measurement of the valve lesions offers limited assistance as a 
gauge of the degree of valve damage. A visual scoring method developed by 
Whitney2, is widely used to classify the diseased valve lesions into one of four 
grades. This scoring method has proved most useful in practice and is robust. A 
similar classification system is not available for human mitral valve disease. The 
principal criteria for the classification system are as follows: 
Type 1 lesion   
A few small oedematous nodules are seen in the area of apposition. There are 
areas of diffuse opacity in the basal regions of the leaflets. The chordae tendineae 
themselves are unchanged. There is no sign of valvular incompetence. 
Type 2 lesion 
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Multiple nodules have a tendency to coalesce with their neighbours to form 
larger nodules in the area of apposition. Some nodules are greyish-white in colour. 
Areas of diffuse opacity can be observed. The chordae tendineae are unaffected and 
there is no evidence of valvular incompetence 
Type 3 lesion 
The nodules are increased in size and some coalesce to form irregular plaque-
like deformities in the area of apposition. The chordae tendineae are thickened at the 
junction with the leaflets. The basal zones of the leaflets have defined areas of 
opacity. There is evidence that the lesions are associated with valvular incompetence. 
Type 4 lesion 
The leaflets are grossly distorted with large, greyish-white nodules and 
plaque-like elevations, predominantly situated in the area of apposition. Along the 
closure line, the free border may have a rolled edge and ‘ballooning’ overgrowth. 
The chordae tendineae are thickened. These chordae may be stretched and ruptured 
in some cases. There is evidence of valvular incompetence in the majority of these 
cases2, 4. 
The grading system is easy to apply and can provide useful information on 
the pathogenesis of the disease as each grade represents a stage in the development 
of the disease process. However, this grading system requires a familiarization with 
all the manifestations of the disease and may become subjective from person to 
person.  
Whitney found the prevalence and severity of mitral valve lesions correlated 
with increase in age, based on a post mortem study of 200 dogs subjected to the 
grading system. When combining all four grades, he found lesions in 37% at 0-4 
years of age, 80% at 5-8 years of age, 93% at 9-12 years of age and a staggering 
100% at 13-16 years of age.  Type 1 lesions (15%) were found predominantly in 
dogs under 5 years old. Type 2 and 3 lesions (49%) were common in dogs 9-12 years 
old, while type 3 and 4 lesions (88%) were predominately confined to dogs 13 years 
and over. The more advanced Types 3 and 4 lesions were found in 24% of the dogs 
under 9 years old in comparison to 58% in dogs over 9 years old; where the majority 
showed evidence of congestive heart failure2.  
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A modification of the classic Whitney’s grading of lesions was proposed by 
Kogure; instead of 4 types of lesion, Kogure categorised the mitral lesions into 3 
groups. Group I corresponded to Whitney’s types 1 and 2, whereas Group II is 
similar to Whitney’s type 3 and Group III resembled Whitney’s type 4. Among the 
64 dogs with mitral valve lesion studied by Kogure, 30 (47%) dogs with a median 
age of 2 year old were classified into Group I; 22 (34%) dogs with a median age of 4 
were in Group II and 12 (19%) dogs with a median age of 10 were in Group III. The 
result was parallel to Whitney’s finding that the severity of lesion increased with 
age17. The term grade 1-4, corresponding to Whitney’s Type I-IV are widely used in 
the veterinary cardiology community and will be adopted as the terms used in this 
thesis. 
1.1.9 Diagnosis 
Auscultation examination for cardiac murmur is the common diagnostic 
method19. The systolic murmur is always associated with mitral regurgitation (MR), 
a complication of MMVD20. The murmur sound can be measured in one of the six 
grades. However, hearing a murmur in a dog with MR is not only dependent on the 
disease severity, but also on other factors such as the experience of the auscultatory 
examiner and how difficult the dog is to auscultate20. Over the recent years, 
echocardiography has proven to be the most reliable non-invasive method for the 
diagnosis of MR21. The four-chamber view in echocardiography made visualisation 
of mitral valve in its nature state is especially useful for diagnosis of MMVD22. 
1.1.10 Valvular interstitial cells (VIC) 
Valvular interstitial cells (VIC) are responsible for the maintaining the 
structural integrity of the valve. The extracellular matrix (ECM) depends on a 
dynamic balance of synthesis and degradation, which is governed by VIC 
metabolism. The extracellular matrix (ECM) comprises primarily collagen, elastin 
and glycosoaminoglycans23. VICs also express ECM degradation enzymes such as 
matrix metalloproteases (MMPs). Fibroblasts of mesenchymal origin are believed to 
be the most prevalent VIC. Recent studies have suggested a phenotypic change of the 
valvular interstitial cell from a predominantly fibroblast-like phenotype to a more 
mixed myofibroblast and/or smooth muscle cell-like phenotype in diseased states23-
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26. This phenotypic switching in the disease process is accompanied by dramatic 
increase in cell numbers and excess secretion of catabolic enzymes27. 
1.1.11 Valvular endothelial cells (VEC) 
Denudation of VEC in the mitral valve leaflet in of dogs with myxomatous 
degeneration was found similar to endothelium damage in human mitral valve 
prolapse28-30. Damage to VEC could influence the synthesis and release of vasoactive 
substances that in turn interact with matrix tissue. Increased endothelin receptor and 
NADPH-diphorase activities have been found in canine myxomatous mitral valve 
leaflets31, 32. Therefore, the VEC was suggested to play a role in the pathogenesis of 
MMVD in dog. Furthermore, the endothelium morphology in diseased mitral valves 
resemble a response to injury process, a repeat impact model was hypothesed33.  
1.1.12 Extracellular matrix (ECM) 
Although the ECM composition in canine mitral valve is not well 
characterized, its composition is similar to the well-studied human mitral valve. The 
mitral valve is a complex connective tissue structure, the ECM contains structural 
proteins like collagen and elastin for mechanical function and proteoglycans and 
GAG for compliance34. It is known that loss of collagen density and changes in fibril 
alignment accompany canine MMVD35.  
1.1.13 Matrix metalloproteinases (MMP) 
Increases in MMP have been linked to MMVD progression in dogs. MMP 
induced mitral valve regurgitation has been demonstrated in dogs36, 37. MMP are a 
family of Zn2+ dependent endopeptidases that participate in tissue remodelling in 
several physiological and pathological states38, 39. At present, 20 MMPs are known, 
the members of the family share structural homology and each cleaves at least one 
component of the ECM39. The MMPs are secreted as latent zymogens and require 
catalytic activation by plasmin or other MMPs through conformational change of the 
active site in the molecule40, and are inhibited by their specific tissue inhibitors 
(TIMPs)38, 40, 41.  
1.1.14 Main objectives of this thesis 
Much is know about the clinical features of MMVD, its diagnosis and 
management, but little is know about the aetiopathogenesis. The hypothesis is the 
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alteration in the valvular interstitial cell function that precipitates the myxomatous 
degeneration characteristic of the disease. The aim of this thesis is to 1) identify the 
morphological changes associated with MMVD; 2) map out the cellular phenotypic 
changes and investigate their relationships to ECM during the disease process and 3) 
identify the proteins associated with MMVD. 
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2 Chapter 2 Morpholgical Assessment of the 
Changes in Myxomatous Mitral Valve Disease 
2.1 Introduction 
Morphological changes are the criteria for the assessment of myxomatous 
mitral valve disease pathology2, 42. While the alteration in cellular phenotypes has 
been implicated as the determinant of the disease29, 43, 44, there is little information on 
morphological change in the valve particularly at the ultrastructural level. Most 
reports to date have been limited and descriptive. 
The aim of this chapter is to give a detailed account of morphological and 
cellular changes in this disease using a combination of qualitative and quantitative 
analyses. Microscopic modalities of light microscopy and electron microscopy, in 
both transmission and scanning mode, were used to assess changes. The light 
microscopy was applied to histological stained sections using novel parameters, 
rendering comparisons between samples or even between breeds justifiable. The 
electron microscopy approach provided insight into detailed ultrastructure that would 
achieve high resolution and generate meaningful data. Incorporating digital imaging 
and computer analysis changes that can now be assessed quantitatively makes the 
analysis of pathological events at a focused level possible. This permits the study of 
these processes on a measurable basis, not only in cellular phenotypical changes but 
also in relation to other tissue constituents at microscopic level. ImageJ is a public 
domain, Java-based image analysis program developed at the National Institutes of 
Health. ImageJ was designed with an open architecture that provides extensibility via 
Java plugins and recordable macros. Image analysis allows pictorial information to 
be improved for qualitative human interpretation and offers the possibility of 
extracting valuable quantitative data as well.   
In this chapter, the results of ad-hoc methods using efficient image processing 
techniques to analyse morphological changes in myxomatous mitral valve disease 






2.2 Materials and Methods 
2.2.1 Mitral valve procurement 
Hearts were collected from 30 dogs (various pure and mixed breeds, 22 male, 
8 female, age range between 1 to 15 year) presented to the Hospital for Small 
Animals, Easter Bush Veterinary Centre, University of Edinburgh for euthanasia. 
The background of each dog regarding to age, breed, sex and medical history were 
carefully scrutinized; these data were entered into a custom designed FileMaker Pro 
6 (FileMaker Inc., CA, USA) data bank.  
Prior to euthanasia each dog was examined by an experienced veterinary 
cardiologist. Detectable murmurs were graded on a scale of 1-619. Euthanasia was 
carried out by intravenous injection of pentobarbital sodium (Merial Animal Health 
Ltd., Essex, UK) and tissue was collected with full owner consent. 
2.2.2 Tissue dissection 
The hearts were surgically removed within a few minutes of death and gently 
flushed with 0.01 M phosphate buffered saline (PBS, Sigma, Dorset, UK) to remove 
blood. The left ventricle was then filled with PBS to observe the coaptation state of 
the leaflets and photographed digitally. The left ventricle was opened by carefully 
cutting between the septal and mural leaflets. The anatomy of the mitral complex 
was examined. The extent of valvular lesions was assessed by two experienced 
veterinary cardiologists and a gross pathological grade assigned according to the 
criteria set out by Whitney (Grade 1-4)2.   
The mitral valves were removed by cutting the annulus base from the 
myocardium wall. Thin stripes of tissues were excised from the middle of the leaflets 
(both septal and mural) running from the free edge to the annulus base avoiding 
major chordae. Following dissection, tissue was preserved in 4% paraformaldehyde 
(Sigma, Dorset, UK) buffered in 0.01M PBS before embedding in paraffin wax. 
Serial sections (5µm) of leaflets in transverse position were collected on slides using 
a rotary microtome.  
2.2.3 Histology 
Sections were stained with hematoxylin and eosin for general morphological 
analysis. For the study of connective tissue structures, Masson’s trichrome stains 
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were used to stain for elastin, Wiegert’s van Gieson stains to stain for collagen and 
Alcian Blue stain to stain for GAGs. 
2.2.4 Microscopy and photography 
Microphotographs of low magnification (1.6× objective lens) were acquired 
using a Leica light microscope linked to a Nurolucida system (Micro Bright Field 
Inc. VT, USA). Microphotographs of higher magnification (4×, 10×, 20× and 40×) 
were captured on a Leitz Laborlux microscope (Leica, Germany) fitted with a CCD 
digital camera (Sony, Japan). To eliminate uneven Kohler illumination across a field, 
a digitized image of a blank field was taken at exactly the same lighting conditions, 
then this blank was used to correct other image on a pixel-by-pixel basis by 
subtracting the background image on Adobe Photoshop CS (Adobe Systems 
Incorporated, CA, USA). 
2.2.5 Image analysis 
The morphological analysis was performed on a Macintosh PowerBook G4 
(Apple Computer, Cork, Ireland) using the public domain ImageJ software (National 
Institutes of Health, USA).  
2.2.6 Leaflet length  
The Hematoxylin and Eosin cross-section slices representing the entire 
transverse area from annulus to tip of the leaflets were used. Due to the considerable 
variation in the size of the mitral valve between different breeds of dogs, direct 
interpretation of the actual sizes offers no meaningful results in helping 
understanding of the disease process. Therefore, relationships were expressed in 
terms of ratios to overcome this disparity in breed size. The central axes of the 
leaflets were best fitted using the segmented line selections (Figure 2.1). The entire 
length of the leaflet running from the annulus to the tip was measured. The leaflet 




Figure 2.1. A schematic diagram shows how the central axis is plotted for leaflet length measurement. 
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2.2.7 Leaflet thickness 
A thickness index was measured and defined as the ratio of the distal third of 
the leaflet to the average of two thickness measurements; one taken at the neck of the 
distal in the junction between middle third and distal third, and one taken at the mid 
point of the leaflet (Figure 2.2).  
 
 
Figure 2.2. A schematic diagram shows the positions of the three cross-sectional thickness are taken 
for leaflet thickness measurement. 
 
2.2.8 Cell density  
From Hematoxylin and Eosin slides, images of the spongiosa layer in the 
distal third of the leaflet were taken at 100× magnifications. Areas of myxomatous 
valve were identified and measured using the outline function. Cells were selected 
based on the density threshold and subjected to watershed segmentation using 
ImageJ.  
2.2.9 Cell circularity 
Of the 17,561 cells that were identified in the cell density study, their 
circularities were measured with the circularity function of ImageJ software. The 
circularity is defined by the equation 4π(area/perimeter2), such that the perfect circle 
has a value of 1 and any value deviating from 1 towards zero indicating alteration in 
shape from a perfect circle, which can include elongation. The total number of cells 
and the average circularity were recorded in Excel data sheets.  
2.2.10 Connective tissue 
From Masson’s Trichrome stained slides, images of the distal third of the 
leaflet were taken at 100× magnifications. Areas of interest, myxomatous in disease 
and loose connective tissue spongiosa in normal valves, were selected using the 
outline function of ImageJ. A threshold was applied to pick up the connective tissue 
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in binary (black and white) density. The amount of connective tissue was measured 
and expressed as a fraction of total selected area. 
2.2.11 Glycosaminoglycan (GAG) 
From red-green-blue (RGB) microphotographs of Alcian blue (Periodic Acid 
Shiff pH 2.5) stained slides, the entire cross-sectional area of the mitral valve leaflet 
was selected and the amount of GAG, represented by the extent of blue stain, was 
determined using four different methods; k-means Clustering, RGB Split, Threshold 
Colour and Colour Deconvolution. Each method utilised a separate ImageJ plug-in to 
perform the task and details are listed as follows. 
1. k-means Clustering method: performed pixel-based segmentation of an RGB 
image. Each cluster was defined by its centroid in colour space. Pixels were 
grouped by their proximity to a cluster’s centroid and the cluster of ‘blue’ 
analysed.  
2. RBG split method: the image was separated into three 8-bit greyscale images 
containing the red, green and blue components of the original and the blue 
channel was analyzed.  
3. Threshold Colour method: converted RGB to HSB (hue, saturation and 
brightness). The hue value from 140 to 200, deemed to cover the complete range 
of the blue spectrum was used. Selected pixels were put into a binary format and 
analyzed. 
4. Colour Deconvolution method: implemented a stain separation protocol using 
stain vector. To avoid co-localisation of colours, the previously defined colour 
values for Alcian Blue and Hematoxylin were used45, 46. The detected Alcian 
Blue stains were also changed to binary and the analyzed.  
Finally, the blue pixel of the Alcian Blue stain measured from the above 
mentioned methods were computed with the Analyze Particles function of ImageJ 
and the results were expressed as a percentage of the entire cross-sectional mitral 
valve leaflet area. 
From the entire outlined area of the leaflet, the mean, median, modal, 
integrated density and the forth moment kurtosis values from the blue channel of the 
RGB image was measured using the Measure RGB plug-in. These values were 
standardised against their own weighted RGB reference value 
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(0.299Red+0.587Green+0.114Blue). Furthermore, the means of the green and blue 
colours in the same area of the RGB image were also calculated. The means of the 
RGB colours were ranked in a descending order.  
2.2.12 Statistical analysis 
Data are expressed as means ± standard error of the means. Inferential 
statistical analysis involved one-way analysis of variance ANOVA testing, a p-value 
less than 0.05 was considered as being statistically significant. Means comparisons 
between groups were subjected to each pair Student’s t-test. Due to the number of 
samples in this study, the non-parametric Wilcoxon ranked score was applied to 
validate the significance level and Chi2 were reported along side the p-value.  
Explanation of the graphical display used for demonstrating statistical 
difference in the image analysis study.  
1. Chart displaying means diamonds may be interpreted as follows: A means 
diamond illustrates a sample mean and its 95% confidence interval, as shown by 
the schematic (Figure 2.3). The centre line across each diamond represents the 
group mean. The vertical span of each diamond represents the 95% confidence 
interval for each group. Horizontal overlap marks are drawn above and below the 
group mean. The width of the diamond is proportional to the sample size of each 
level of the x variable. It follows that the narrower diamonds are usually the taller 
ones because fewer data points yield a less precise estimate of the group mean. 
The grey line across the entire chart is the grand mean. The p-value shown with 
charts represents the overall analysis of variance significance level47 (JMP 
version 5.0.1, SAS, NC, USA). The confidence interval computation assumes 
that variances are equal across observations. Therefore, the height of the 
confidence interval diamond is proportional to the reciprocal of the square root of 
the number of observations in the group. 
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Figure 2.3. Features of the means diamonds display used in charts 
 
2. The plot displays a circle for each group, with the centres lined up vertically. The 
centre of each circle is aligned with its corresponding group mean. The radius of 
a circle is the 95% confidence interval for its group mean, comparable to the 
means diamond. Comparison circles are a graphical technique that allows visual 
observation of significant separation among means in terms of how circles 
intersect. The non-overlapping confidence interval shown by the diamonds for 
groups that are significantly different correspond directly to the case of non-
intersecting comparison circles. When the circles intersect, the angle of 
intersection is the key to determine if the means are significantly different. If the 
angle of intersection is exactly a right angle at 90°, then the means are on the 
borderline of being significantly different. If the circles are further apart than the 
right angle case, then the outside angle is more acute and the means are 
significantly different. If the circles are closer together, the angle is larger than a 
right angle; then the means are not significantly different as shown by the 
schematic (Figure 2.4). 
 
Figure 2.4. Diagram of how to interpret the significant difference in comparison cycles. 
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3. In the case that ANOVA of group means yields no statistical difference, that is 
when p>0.05, then the least significant number was calculated to test the sample 
pool size. The least significant number or LSN is defined as the number of 
observations needed to drive down the variance of the estimates enough to 
achieve a significant result with the given values of alpha, sigma, and delta (the 
significance level, the standard deviation of the error, and the effect size, 
respectively). 
4. Means Comparisons table, which shows all means comparisons with letters 
denoted for each level are also presented. The groups are listed with the differences 
sorted in descending order. Levels not connected by same letter are significantly 
different.  Conversely, the levels that share a letter are not significantly different 
from each other.  
5. Analysis of nominal based categorical data is presented in contingency table 
mosaic plot. A mosaic chart has side-by-side divided bars for each level of its X 
variable. The bars are divided into segments proportional to each discrete level of 
the Y variable. The width of each bar is proportional to the sample size. When 
the lines dividing the bars align horizontally, the response proportions are the 
same. When the lines are far apart, the response rates of the samples might be 
statistically different. The hypothesis of marginal homogeneity was tested for 
independence; the p-values of Chi-square tests from likelihood-ratio and Pearson 
are reported. 
 
2.2.13 Transmission electron microscopy (TEM) 
TEM was employed to study the phenotypic changes at ultrastructural level. 
Mitral valves from six dogs were used in this study, three from clinical normal Grade 
0 dogs and three from dogs diagnosed with severe MMVD Grade 3 or above. 
Normal valves were from dogs of aged six year old or younger, whilst MMVD 
affected valves were all from dogs aged eight years or over. Diseased group dogs all 
had left apical systolic heart murmur, clinical and radiographic signs of congestive 






Table 2.1. Background information about the dogs that samples were obtained from. 
Mitral Valve Breed Sex Age 
Normal Mixed Breed Male 3yrs 
Normal Labrador X Male 2yrs 
Normal Staffie X Male 6yrs 
Diseased Cavalier King Charles Male 13yrs 
Diseased Jack Russell Terrier X Male 16yrs 
Diseased German Shepherd Female 8yrs 
 
Specimens from valve tissue were taken from the middle strip of the leaflets. 
The tissues were immediately fixed in 2.5% electron microscope grade 
glutaraldehyde (Agar Scientific Ltd., Essex, UK) in 0.1M sodium cacodylate (Agar 
Scientific Ltd., Essex, UK) buffer overnight. The specimens were rinsed excess 
glutaraldehyde with 0.1M sodium cacodylate buffer (three times for 30 min each) 
followed by distilled water (three times 2 min each). The specimens were post fixed 
in 1% osmium tetraoxide OsO4  (Electron Microscopy Science, Ft. Washington, PA) 
for 1.5 hours. After removal of excess osmium with distilled water (three times at 2 
min each), the specimens were dehydrated in a series of ascending concentrations of 
ethanol (Fisher Scientific, UK) (50% for 15 min, 70% for 15 min, 90% for 15 min 
and 100% for 30 min) and eventually twice for 30 min in pure acetone (Fisher 
Scientific, UK). The specimens were incubated in Spurr™ resin (Agar Scientific 
Ltd., Essex, UK) and acetone mixture in a 1:2 ratio for an hour followed by Spurr™ 
resin and acetone in a 1:1 ratio for an hour at room temperature. The specimens were 
clearly labelled and then cured in a silicone mould with Spurr™ resin at 70°C 
overnight. The embedded specimen blocks were subsequently trimmed and sections 
cut using glass knives on a Leica Ultracut™ UCT microtome (Reichert, Vienna, 
Austria), initially at 1 µm semi-thin, and stained with Toludine Blue. The semi-thin 
sections were viewed under a Leitz Laborlux light microscope (Leica, Germany) and 
areas of interest were selected for ultra-thin sectioning. The ultrathin sections of 
60nm, with gold inference colour, were collected on Formvar coated single hole 
copper grids (Agar Scientific Ltd., Essex, UK) and stained with 2% uranyl-acetate 
(Merck, Darmstadt) for 45 min followed by lead citrate (Electron Microscopy 
Science, Ft. Washington, PA) for 6 min. The ultra-thin sections were then examined 
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in a Philips CM12 transmission electron microscope (Philips, Netherland) at 75kV 
beam acceleration voltage and electron micrographs (Kodak Electron Microscope 
Film 4489, Eastman Kodak, New York) were taken. Ultrastructural identifications 
were based on cross-reference to published literatures9, 48, 49. 
2.2.14 Quantitative stereology 
From each of the six blocks, three ultra-thin sections were cut at assigned 
points along the length of the septal leaflet, the first one at the tip, the next section 
was taken 50 µm from the first one towards the base, and the third section was taken 
a further 50 µm towards the base. Ten images were taken from each of the 18 
sections, at random points along the length of the endothelial edge, giving a total of 
180 images. 
A 1 cm and 1 mm grid were prepared using Macromedia Freehand program 
(San Francisco, CA USA) and printed on to clear acetate. Electron micrographs were 
scanned into digital format and viewed using Window Picture and Fax Viewer. 
Using the 1 cm grid, the number of times collagen lay under a grid intersection was 
counted. This process was repeated for extracellular matrix. The 1 mm grid was used 
to count the grid intersections overlying endothelium and interstitial cells. For 
normalization, the values for collagen and extracellular matrix were multiplied by a 
factor of 10.  
2.2.15 Circularity of endothelium and valvular interstitial cell  
From the 180 transmission electron micrographs, non-interrupted 
endothelium (EH) and valvular interstitial cells (VIC) were identified. The outline of 
each cell along cell membrane was traced and the circularity was calculated using 
ImageJ.  
2.2.16 Scanning electron microscopy (SEM) 
To investigate the connective tissue more closely at ultrastructural level, a 
modification of the NaOH cell-maceration technique reported by Rossi was used50. 
The value of this technique is that it can dissolve the cellular elements and leave 
behind the connective tissue matrix intact, allowing for better three-dimensional 
viewing. Thin strips of tissues were excised in the middle of the septal leaflets 
running from the free edge to the annulus from one normal and one from each grade 
of the diseased mitral valves, Following dissection, the tissues were preserved in 4% 
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paraformaldehyde (Sigma, Dorset, UK). After rinsing in distilled water, the 
specimens were immersed in 10% NaOH (Sigma, Dorset, UK) solution for 4 days at 
room temperature. The specimens were rinsed the excessive NaOH until they 
became transparent, then they were immersed in 1% tannic acid (gift from Scottish 
Forest Research) for 4 hours at room temperature. Subsequently, the specimens were 
thoroughly rinsed in distilled water overnight before post fixation in 1% osmium 
tetroxide OsO4  (Electron Microscopy Science, Ft. Washington, PA) for 2 hours. 
After removal of excess of osmium with distilled water (three times for 2 min each), 
the specimens were dehydrated in a series of ascending concentrations of ethanol 
(Fisher Scientific, UK) (50% for 15 min, 70% for 15 min, 90% for 15 min and 100% 
for 30 min) and eventually twice for 30 min in pure acetone (Fisher Scientific, UK). 
The edges of the specimens were trimmed in the transverse direction with two sharp 
clean blades in a scissors action under a dissection microscope (Leica, Wetzlar, 
Germany). Dehydrated specimens were then critical point dried (Polaron, Quorum 
Technologies, East Sussex, UK), mounted on aluminium stubs (Agar Scientific, 
Essex, UK), sputter coated with gold palladium (EmScope, Quorum Technologies, 
East Sussex, UK), and viewed in a Philips SEM 505 (Philips, Netherland). Structural 
changes were manifested in the mid zone and the distal zone of the leaflets during 
the degenerative disease process. Areas of interest were photographed on black and 
white negative film (Kodak Electron Microscope Film 4489, Eastman Kodak, New 
York). The negatives were scanned on a flat bed film scanner at 300 dpi (Hewlett-
Packard, Berkshire, UK). 
2.2.17 Image analysis of cell-macerated connective tissue using SEM 
imagery 
One assumption has to made before applying microstructure analysis. That 
was to distinguish tissue structure and hole or void spaces. SEM imagery of cell-
macerated mitral valve connective tissue was analysed using an ImageJ plug-in 
“SEM microstructure descriptors software”51. The images were de-noised by 
applying a 3×3 median filter to produce accurate results. This software utilizes two 
commands, namely BinariseSEM and Compustats. BinariseSEM, segments the input 
grey scale image into pores and structure, where a pore is defined as a patch of 
contiguous pixels with similar intensity values. Any discontinuity in the pixel 
intensity is regarded as a discontinuity in the structure of the material. The possible 
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illumination gradient effect due to the acquisition system was taken into account by 
selecting the Bandpass Filter option; a filter was used to correct the intensity 
gradient. A threshold value was automatically computed, after visual inspection 
where any adjustment necessary, the threshold value was used for automatic 
binarisation. CompuStats performs various statistical analysis on the holes extracted, 
using the BinariseSEM and the results were presented in histograms and rose plots. 
The magnification factor in microns of the images was taken into consideration 
during computation. Examples of feature shape descriptor are shown in Table 2.2. 
 
Table 2.2: Shape quantitative descriptors. Meanings of the parameters. A: net area; Aconvex 
: area of the convex hull; Af ill area of the filled polygon; p: perimeter; pconvex : perimeter of 
the convex hull; Dmax , Dmin : maximum and minimum dimension; dinscr and dcircum: 
diameters of the inscribed and circumscribed circle; l: length of the feature along the farthest 
points in the convex hull; lF , wF : fiber length and fiber width (measured from the skeleton of 
the feature). 






























































The breed distribution of the 30 dogs used in this study is shown in Table 2.3. 
Table 2.3. Breed distribution of dogs. 
Breed Number 
Beagle 4 
Beardie Collie 1 
Border Collie 2 
Cavalier King Charles Spaniel 2 
Collie 1 
Collie Cross  4 
Collie Terrier 1 
German Shepherd Dog 5 
Jack Russell Terrier 3 
Kerry Blue 1 
Labrado 1 
Mixed Breed 1 
Spaniel 1 
Staffie 2 
Yorkshire Terrier 1 
Total 30  
 
2.3.2 Age 
The disease is known to follow an age dependent process and the results of 
this study demonstrated the expected progressive nature of this disease. There was a 
positive correlation between the age and the grade of lesion, as the age increased so 
did the disease severity before it reached a plateau (p<0.0001). The mean ages were 
as follow, normal Grade 0=2.40, Grade 1=6.83, Grade 2=10.75, Grade 3=12.25 and 
Grade 4=11.75. Between group comparisons showed that the Grade 0 normal was 
significantly different to all four Grades of the diseased, the Grade 1 was 
significantly different to Grade 0 normal as well as to Grade 2, 3 and 4. This is 
illustrated by the mean age in year plotted against the lesion grade incorporating with 






















Grade    Mean 
3 A     12.250000 
4 A     11.750000 
2 A     10.750000 
1   B   6.833333 
0     C 2.400000 
p<0.0001 
ChiSq=0.0037 
Figure 2.5. Comparison of dog age to mitral valve lesion grade. The results from ANOVA, t-test, and 
Wilcoxon ranked test are presented. The age is increased during the progression of the disease. 
 
None of the Grade 0 normal dogs were older than 5 years. The distribution of 
dog age according to the lesion type is shown in Figure 2.6. The dashed blue line 
joining the means of each group demonstrates the age dependent nature of this 
disease. With the exception of one dog, no other dogs younger than 9 years had 
progressed beyond Grade 3. On the other hand, with the exception of one dog, no 
dogs under the age of 9 had lesion grade 3 or higher. The best linear fit analysis of 
variance (red line) intercepted with age on the y-axis at 4.08 years and this 
extrapolated the age of onset. The mean of response is 9.16 year of age at lesion 
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Figure 2.6. The distribution of dog age according to the lesion grade. The best line fit intercepts with the 
age on the y-axis at 4.08 year of age. 
2.3.3 Murmur 
For the 28 dogs where auscultation were obtained, the systolic cardiac 
murmur as assessed by auscultation grade 1-6 was plotted against the lesion grade 
and is shown in the bivariate scatter plots in Figure 2.7. The intensity of the murmur 
correlated to the severity of the MMVD (p<0.0001). The linear fit intercepted with 
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Figure 2.7. Comparison of murmur to mitral valve lesion grade. The best line fit intercepts with the 
lesion grade x-axis at 0.9. 
2.3.4 Gross pathology 
The normal healthy mitral valves leaflets were very thin and almost 
translucent. Valves with grade 1 lesions lost the translucent appearance and became 
opaque, small nodules budding out from the atrialis surface of the leaflets, notably 
near the free edges. The nodules seem to fuse with their neighbours to form larger 
nodules near the area of apposition in the valves with grade 2 lesions. Some nodules 
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were greyish-white in colour. Areas of diffuse opacity could also be observed. In 
valves with grade 3 lesions, plaque-like thickening were found in the area of valve 
leaflet apposition. The chordae tendineae were thickened at the junction with the 
leaflets. In the valves with grade 4 lesions, the leaflet structures were grossly 
distorted. ‘Ballooning’ or ‘hooding’ types of over growth were found along the 










Figure 2.8. Photographs of mitral valves at necropsy showing lesion grades 1-4. 
2.3.5 Light Microscopy Study 
Representative Hemotoxylin and Eosin stained sections of mitral valve septal 
leaflets in normal and different diseased states are shown below (Figure 2.9). 
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Figure 2.9. Representative of Hemotoxylin and Eosin stained cross-sectional mitral valve leaflet 
tissues. Bar = 1mm. 
 
In general, in the normal valve the septal leaflet is longer than the mural 
leaflet. On the atrialis surface, there are many microscopic crimps in the proximal 
half of the leaflets. Those crimps can stretch out during valve opening, thus increase 




Figure 2.10. H&E stained section of a normal 
mitral valve leaflet shown crimps on the atrialis 
surface. Bar = 50µm. 
 
Figure 2.11. H&E stained section of a normal 
mitral valve leaflet shown the muscle at the base. 
Bar = 50µm. 
 
Beneath the crimps, the atrialis is rich in elastin. The wavy elastin bands 
gradually thin out towards the tip of the leaflets. Cardiac muscle extending from the 
heart wall is sandwiched between the atrialis and spongiosa layers at the base. The 
mural leaflets have higher muscle content than septal leaflets. The cardiomyocytes in 
the inner core were rounded in shape and wrapped by the elongated cells, suggesting 
the muscle is oriented in a circumferential direction and longitudinal direction at the 
base (Figure 2.11). Cardiomyocytes, along with vessels, and sometimes sparse 
numbers of fat cells are seen (Figure 2.12). Occasionally, the fat cells form a defined 
fat tissue layer underneath the atrialis and continue along the axis of the leaflet 
(Figure 2.13).  The spongiosa is composed of a high proportion of ground substance 
with loose connective tissue and cells. The fibrosa consists of tightly packed collagen 
fibre bundles scattered with flattened cells. In the diseased valves, areas of 
metaplasia are identified. Cartilage-like cells are also seen in the fibrosa and/or 
spongiosa layer. Occasionally, macrophages and monocytes can be observed. The 





Figure 2.12. H&E stained section of a diseased 
mitral valve leaflet shown the vessel in the leaflet. 
Bar = 20 µm. 
 
Figure 2.13. H&E stained section of a diseased 
mitral valve leaflet shown the fat cell layer. Bar = 
100 µm. 
 
Towards the free edge, the typical findings are expansion of the spongiosa 
layer and the destruction of the fibrosa layer in the diseased valve. Histologically, 
fibro-elastic proliferation in the spongiosa is concomitant with the degeneration of 
collagen bundles in the fibrosa layer, resulting in areas of myxomatous regions. The 
junction between spongiosa and fibrosa can be indistinguishable, with apparent 
accumulation of loose collagen bundles and ground substance in both layers. 
Together this results in thickening of the leaflets near the free edges. 
2.3.6 Leaflet length 
The septal/mural length ratio was greater than 1 in all dogs, in both normal 
and affected, indicating that the septal leaflet was always longer than the mural 
leaflet within the same valve. The mean length ratio for each grade was as follows; 
Grade 0=1.812, Grade 1=1.745, Grade 2=1.606, Grade 3=1.484 and Grade 4=1.525. 
There was a decrease in length ratio as the disease progressed, being most apparent 
in the more severe forms of the disease (Figure 2.14). However, no significant 
difference was achieved using ANOVA (p=0.4627) or the t-test. The LSN was 
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Figure 2.14. The comparison of septal/mural ratio between mitral valve lesion grade. The results from 
ANOVA, t-test, and Wilcoxon ranked test are presented.  
2.3.7 Leaflet thickness ratio 
Septal and mural leaflets were treated as separate entities as the differences in 
length between the two leaflets were established in length ratios studies. The results 
of the leaflet thickness ratio are shown in Figure 2.15 and Figure 2.16. The thickness 
ratio revealed that there is a trend to progressive thickening at the distal end of 
leaflets according to the severity of the disease, and this applied to both septal and 
mural leaflets. In severe Grade 4 stage of the disease, the distal ends of the leaflets 
were about three times thicker than the Grade 0 valve leaflets. Significant differences 
were found in both septal leaflets (p<0.0001) and mural leaflets (p=0.0041) between 
grades using ANOVA. The mural leaflets consistently had a slightly higher thickness 
ratio than the septal leaflets at all stages of the disease. Between group comparisons 
found that septal leaflet Grade 0 normal was significantly different to disease Grade 
2, 3 and 4; the Grade 1 was different to grade 3 and 4; and the Grade 4 was 
significantly different to all others (Figure 2.15). In the mural leaflets, the Grade 0 
normal was significantly different to Grade 3 and 4, while the Grade 4 was 



































Grade     Mean 
4 A       3.3650000 
3   B     2.2621667 
2   B C   1.9563750 
1     C D 1.4791667 
0       D 0.9185000  
p<0.0001 
ChiSq=0.0029 
Figure 2.15. Comparison of septal leaflet thickness ratio between mitral valve lesion grade. The results 


































Grade    Mean 
4 A     3.2713333 
3   B   2.3598333 
2   B C 1.9927500 
1   B C 1.6471667 




Figure 2.16. Comparison of mural leaflet thickness ratio between mitral valve lesion grade. The results 
from ANOVA, t-test, and Wilcoxon ranked test are presented. 
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2.3.8 Cell density 
In diseased valves, the myxomatous areas were localised to the distal zone of 
the leaflets. The myxomatous areas were readily identifiable. The “initiation” site 
was visible in the spongiosa layer, but as the disease progresses the myxomatous area 
expands to the collagen rich fibrosa layer and to a lesser extent the connective tissue 
in the atrialis layer. The cells in the myxomatous area often appeared in a whorl like 
arrangement, but while cell distribution appeared to be relatively uniform across the 
myxomatous area, cell numbers in the areas adjacent to the myxomatous area varied. 
Variations in cells numbers were observed in the fibrosa layers in the distal zone. 
Areas of increased cell numbers were found adjacent to the myxomatous changes 
near the tip of the leaflets, and there was distinct localisation of cells towards the free 
edge coinciding with likely leaflet contact points (Figure 2.17).  
 
Figure 2.17. An H&E histological section of a myxomatous mitral valve tissue shows the variation in cell 
density. The area periphery (P) to myxomatous area (M) contains higher cell density. Bar = 50 µm. 
 
Because of this distinct localisation, only in the myxomatous area was 
cellularity assessed and compared with cell numbers in the corresponding distal zone 
of the spongiosa layer of the normal valve. A total of 17,561 cells were identified 
and measured using ImageJ in the 30 valves. Cell density in the myxomatous areas 
(as a % of area) in the distal zone of the diseased valves was lower than the 
corresponding spongiosa in normal valve, indicating a decreased cell density 
associated with disease progression. The mean cell density in myxomatous areas 
were as follows; Grade 1: septal = 8.54±1.10 cells/0.01mm2, mural = 8.03±1.10; 
Grade 2: septal = 7.04±1.02, mural = 7.76±1.02; Grade 3: septal = 7.21±0.96, mural 
= 5.66±0.95; Grade 4: septal = 7.20±1.56, mural = 5.94±1.55, cells per 0.01mm2 
(Figure 2.18 and Figure 2.19). Comparable corresponding loose spongiosa areas in 
normal leaflets were found to have higher cell density; septal = 15.04±1.21, mural = 
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15.42±1.20, cells per 0.01mm2. Statistically significant reductions in cell density 
were found comparing the normal and the diseased grades 1 to 4 for both septal 
(p=0.0002) and mural (p<0.0001) leaflets, but within the four diseased grades no 
significant difference was found for either septal or mural leaflets. In general, the cell 
numbers in the spongiosa of the normal valve were two fold higher in comparison to 
































Grade   Mean 
0 A   15.042000 
1   B 8.543333 
3   B 7.206250 
4   B 7.196667 
2   B 7.038571  
p=0.0002 
ChiSq=0.0238 
Figure 2.18. Comparison of cell density in septal leaflet myxomatous area between mitral valve lesion 



































Grade   Mean 
0 A   15.416000 
1   B 8.028333 
2   B 7.764286 
4   B 5.936667 
3   B 5.668750  
p<0.0001 
ChiSq=0.0054 
Figure 2.19. Comparison of cell density in mural leaflet myxomatous area between mitral valve lesion 
grade. The results from ANOVA, t-test, and Wilcoxon ranked test are presented. 
 
2.3.9 Circularity 
The circularity score of cells were calculated in the myxomatous area of the 
diseased and corresponding distal spongiosa area in normal leaflets and are shown in 
Figure 2.20. No significant differences were found in both septal (p=0.1432, 
ChiSq=0.2117) and mural (p=0.5276, ChiSq=0.3912) leaflets between grades. The 
mean circularity values for the septal and mural leaflets within each grade were 
closely matched as shown in the chart (Figure 2.20). The values of circularity were 
restricted to a narrow range (between 0.68 to 0.77) indicating cells are spindle 






































































0 1 2 3 4
Lesion Grade  
Septal leaflet Mural leaflet 
Grade  n  Mean  Grade  n  Mean  
0 5 0.683072 0 5 0.687085 
1 6 0.720720 1 6 0.731160 
2 8 0.770210 2 8 0.749940 
3 8 0.695754 3 8 0.697158 
4 3 0.732988 4 3 0.711650  
Figure 2.20. Comparison of circularity in septal and mural leaflets myxomatous area between mitral 
valve lesion grade. The circularity means are presented. 
On closer inspection, the impression was that cells in the higher grade of 
disease (older dogs) were marginally more elongated, whereas the cells in the normal 
younger dogs displayed a more polygonal shape in the corresponding spongiosa 
regions. In contrast, in areas surrounding the myxomatous region some cells tended 
to be more rounded. This aspect will be discussed in detail in the chapter covering 
immunohistochemistry. Occasionally, twin or multi-nucleated cells were observed 
neighbouring the myxomatous region. In other areas, determining the circularity of 
cells were not possible, due to the range of different cell types. 
2.3.10 Connective tissue 
As previously stated, MMVD is most pronounced in the distal zone of the 
spongiosa layer. During disease progression, myxomatous areas can be initiated from 
more than one site, there is a gradual disarrangement of connective tissue. By 
analogy it can be best described as tearing a knitted fabric and unravelling of the 
twisted yarn to expose the fluffy fibres. Furthermore, loss of connective tissue is 
recognized to be concomitant with accumulation of glycosaminoglycans (GAGs) in 
the myxomatous areas. However, there are localized areas of high connective tissue 
density peripheral to the myxomatous areas with intense collagen, elastin and 
 38 
fibronectin staining. However, these locations are patchy and sometimes sandwiched 
between two neighbouring disease sites (Figure 2.21). This feature will be covered in 
more detail with in later chapters.  
 
 
Figure 2.21. Masson’s trichrome staining of a diseased mitral valve leaflet. Myxomatous area shows 
destruction of collagen (green) and elastin (dark blue). Bar = 100 µm. 
 
Using image analysis of stained histological sections, the extent of connective 
tissue as a fraction of loose spongiosa area in the Grade 0 normal and myxomatous 
area in the diseased Grade 1 to 4 valves were plotted for septal (Figure 2.22) and 
mural (Figure 2.23) leaflets. There was a gradual destruction of connective tissue as 
the disease progressed in both leaflets, with a distinct linear relationship between the 
decrease in connective tissue and progression of the disease. Significant differences 
were found in both the septal (p<0.0001, ChiSq=0.0011) and mural (p<0.0001, 
ChiSq=0.0009) leaflets between grades. In the septal, the normal Grade 0 and Grade 
1 were significantly different from Grade 2, 3 and 4. In the mural, the normal Grade 
0 is significantly different from Grade 2, 3 and 4, whereas the Grade 1 was 








































Grade   Mean 
0 A   0.77352000 
1 A   0.67213333 
2   B 0.54148750 
4   B 0.46570000 
3   B 0.46040000  
p<0.0001 
ChiSq=0.0011 
Figure 2.22. Comparison of connective tissue in septal leaflet myxomatous area between mitral valve 







































Grade     Mean 
0 A       0.73258000 
1 A B     0.67540000 
2   B     0.59261429 
3     C   0.50537500 
4       D 0.36723333  
p<0.0001 
ChiSq=0.0009 
Figure 2.23. Comparison of connective tissue in mural leaflet myxomatous area between mitral valve 




The intensity and extent of GAG-specific Alcian blue staining was readily 
appreciated in the normal and affected valves. In the normal mitral valves, staining 
had a light shade of blue, was evenly distributed throughout the entire leaflet and had 
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a slightly greater intensity in the spongiosa layer towards the distal end of the leaflet 
(Figure 2.24).  
 
Figure 2.24. Alcian blue GAG staining of a Grade 0 normal mitral valve septal leaflet. 
 
In the diseased leaflets conspicuous areas of intense blue colour, indicative of 
GAG accumulation was noted in the spongiosa of the distal part of the leaflet, and 




Figure 2.25. Alcian blue GAG staining of a Grade 4 diseased mitral valve septal leaflet. 
 
k-means clustering 
From k-means Clustering, although ANOVA found no significant differences 
existed in both septal (0.2559) and mural (p=0.1294) leaflets, between groups 
comparison the t-test revealed that in the septal leaflets the blue pixels area in normal 
Grade 0 (44.40%) valves was more than twice as in Grade 4 (20.56%) and this 
difference was significant. Nonetheless, the large mean error bar in Grade 0 due to 
sample placements outside the diamond confidence zone was observed. In mural 
leaflets, a different trend was seen; the Grade 1 (40.0%) was different to Grade 0 
(26.83%) and Grade 3 (25.8%). The LSN was 53.99 for septal and 36.11 for mural 




































































Grade   Mean 
0 A   44.400000 
3 A B 31.825000 
1 A B 31.000000 
2 A B 30.262500 




Grade   Mean 
1 A   40.000000 
4 A B 31.666667 
2 A B 31.414286 
0   B 26.820000 




Figure 2.26. Comparison of the percentage of blue area of GAG in leaflet between mitral valve lesion 
grade using k-means clustering method. Septal leaflet is on the left and the mural leaflet is on the right. 
 
RGB split 
From RGB split, all the group means were similar and fell into a limited 
range, from 30.62% to 37.05% within less 7% margin in septal leaflets and from 
34.55% to 43.36%, within less than 9% margin in mural leaflets. As a result, the 
ANOVA of means detected no significant differences in both septal (p=0.8145) and 
mural (p=0.4561) leaflets. Furthermore, no statistical differences were found in 
between group comparison using Student’s t-test in both septal and mural leaflets. 











































































Grade  Mean 
4 A 37.050000 
2 A 34.750000 
0 A 34.180000 
3 A 32.000000 




Grade  Mean 
0 A 43.360000 
2 A 38.162500 
1 A 38.120000 
4 A 37.025000 




Figure 2.27. Comparison of the percentage of blue area of GAG in leaflet between mitral valve lesion 
grade using RGB split method. Septal leaflet is on the left and the mural leaflet is on the right. 
Deconvolution 
The Alcian Blue hematoxylin colour deconvolution method separated the two 
chromogens while taking the co-localization of colours into consideration. In septal 
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leaflets, the blue stain group means all fell into a narrow range, covered 26.67% to 
32.22% within a margin of less than 6% of the total leaflet area, and so one-way 
analysis shown no statistical significance was achieved. Between groups comparison 
found no difference between pairs. In the mural leaflets, one-way analysis of group 
means revealed the p-value was 0.085, and Student’s t-test showed Grade 2 (41.65%) 
was different to Grade 0 of (27.84%) and Grade 4 (25.08%). The LSN was 314.11 













































































Grade  Mean 
1 A 32.216667 
0 A 31.040000 
2 A 28.900000 
3 A 28.650000 





Grade   Mean 
2 A   41.650000 
3 A B 36.750000 
1 A B 33.560000 
0   B 27.840000 




Figure 2.28. Comparison of the percentage of blue area of GAG in leaflet between mitral valve lesion 
grade using deconvolution method. Septal leaflet is on the left and the mural leaflet is on the right. 
 
Threshold colour 
From Threshold HSB method, ANOVA of means found no significant 
differences in both septal (p=0.7064) and mural (p=0.1542) leaflets. Again, the group 
means in septal leaflets were fell into a narrow range from 28.28% to 36.14% within 
a margin of less than 8%, and no differences were found between groups using the 
Student’s t-test. However, in the mural leaflets, the grade 2 (40.81%) was found to be 
different to normal Grade 0 (26.54%) and Grade 1 (24.8%). The LSN was 135.16 for 





















































































Grade  Mean 
0 A 36.140000 
4 A 34.266667 
2 A 31.762500 
1 A 28.650000 




Grade   Mean 
2 A   40.814286 
3 A B 32.757143 
4 A B 27.766667 
0   B 26.540000 




Figure 2.29. Comparison of the percentage of blue area of GAG in leaflet between mitral valve lesion 
grade using threshold colour method. Septal leaflet is on the left and the mural leaflet is on the right. 
 
Comparing the results calculated by the four different colour measuring 
techniques, all the group means including both septal and mural leaflets lie between 
20% to 44% of total area, with no more than 24% margin of difference in area. The 
results computed from Decovolution and Threshold Colour HSB methods were 
noticeably similar. When presented in bar charts side by side, the close resemblance 
in patterns was obvious (Figure 2.30). This could be interpreted that regardless of the 
severity of MMVD there are no significant differences in GAG expression, that the 
GAG occupy between 20% to 44% of the cross-sectional area of a mitral valve 
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0 1 2 3 4
Lesion Grade  
 
Figure 2.30. Comparison of the percentage of blue area of GAG in leaflet between mitral valve lesion 
grade show in mean error bar with (clockwise from top left) blue cluster of k-mean clustering, blue 
channel of RGB split, blue deconvolution and threshold of HSB 140-200. The blue area of GAG are all 
between the range of 20-44%. 
 
Mean blue 
From standardised mean blue values, ANOVA of group means found no 
significant difference in the septal leaflets (p=0.5364). However, in the mural 
leaflets, the p-value of 0.0959 is closer to the borderline of significance. Between 
groups t-test showed there was no difference in the septal leaflets, even though a 
slightly higher blue value found in grade 1 normal and grade 4 diseased. In mural 
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leaflets, the mean blue in grade 2 was different to grade 1. The LSN for septal was 


































































Grade  Mean 
0 A 1.0964645 
4 A 1.0874295 
1 A 1.0627591 
2 A 1.0620499 




Level   Mean 
2 A   1.1070690 
3 A B 1.0814645 
0 A B 1.0805401 
4 A B 1.0557790 




Figure 2.31. Comparison of the standardised mean blue value in leaflet between mitral valve lesion 
grade. The septal leaflet is on the left and the mural leaflet is on the right. 
 
Mean blue ranking 
The ranking orders of the mean values for each of the three RGB colours 
were expressed as frequency counts, each type of ranking order was represented in a 
different colour in the contingency table (Figure 2.32). In the septal leaflets, the 
general trend was that the B>G>R type (pink) never surpassed B>R>G (lime) in 
probability, provided that the B>R>G (lime) was always equal to or higher than the 
others in probability. The R>B>G type (blue) contained the least probability and it 
did not exceed more than 25% in any situations. The grade 4 stood out as the odd 
one, it was similar to grade 3 with B>G>R (pink) at 25% and B>R>G (lime) at 50%, 
but instead of R>B>G (blue) as in grade 3, the grade 4 contained the unique R>G>B 
type (orange) at probability of 25%. As a whole, the blue colour in the septal leaflets 
consistently achieved the highest mean value in ranking at no less than 75% in 
probability. However, likelihood and Pearson tests found no statistical differences.  
In the mural leaflets, both the Grade 0 normal and Grade 1 were at the same 
level of B>G>R (pink) at 20% probability, but compared with the 60% B>R>G 
(lime) as in Grade 0, there was only 20% probability in Grade 1, the lowest B>R>G 
(lime) counts in all groups, whereas the R>B>G in Grade 1 was at 60% probability, 
the highest in all groups. The Grade 2 and the Grade 3 both achieved a same  
B>G>R (pink) probability at 50%, but instead of 12.5% R>B>G (blue) as found in 
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Grade 3, there was no R>B>G (blue) in Grade 2. The Grade 4 composed of 70% 
B>R>G (lime) and 30% R>B>G (blue) was distinctly different to others, as no 
B>G>R (pink) was found. Overall, in the mural leaflets with the exception of the 
Grade 2, the mean values of the blue colour achieved the highest rank at 75% or 
















































Likelihood Ratio p=0.8884 
Pearson p=0.7534  
Test ChiSq 
Likelihood Ratio p=0.1325 
Pearson p=0.2087  
Figure 2.32. Contingency tables show the comparison of mean blue ranking between mitral valve 
lesion grade. Septal leaflet is on the left and the mural leaflet is on the right. 
 
Median blue 
From standardised median blue values, ANOVA found no significant 
differences in both septal (p=0.2003) and mural (p=0.1993) leaflets. Between groups 
t-test shown the normal Grade 0 was different to Grade 2 in the septals and the Grade 
2 was different to Grade 4 in the murals. The LSN for septal leaflets and mural 

































































Grade   Mean 
0 A   1.1073757 
4 A B 1.0796149 
1 A B 1.0634958 
3 A B 1.0631357 




Grade   Mean 
2 A   1.1065784 
0 A B 1.0943961 
3 A B 1.0800046 
1 A B 1.0463567 




Figure 2.33. Comparison of standardised median blue value between mitral valve lesion grade. The 
septal leaflet is on the left and the mural leaflet is on the right. 
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Modal blue 
The standardised modal blue represents the most frequently occurring blue 
value. The group means of modal appeared to conform to a certain pattern when 
comparing the septal leaflets and mural leaflets, with the Grade 0 normal taken the 
highest level and the severely diseased grade 4 at the lowest level. Nevertheless, no 
significant differences were detected in ANOVA in both septal and mural leaflets. 
Between group comparison showed no difference in septals, but in the murals the 


































































Grade  Mean 
0 A 1.1875711 
3 A 1.1332640 
2 A 1.0704085 
4 A 1.0586940 




Grade   Mean 
0 A   1.2443046 
1 A B 1.1403321 
3 A B 1.1387645 
2 A B 1.1091423 




Figure 2.34. Comparison of standardised modal blue value between mitral valve lesion grade. The 
septal leaflet is on the left and the mural leaflet is on the right. 
 
Integrated blue intensity 
From the standardised integrated intensity, even though no statistical 
differences were found in ANOVA in both septal (p=0.5363) and mural (p=0.0959) 
leaflets, the p-value for mural leaflets was relatively low. Between groups t-test 







































































Grade  Mean 
0 A 1.0964633 
4 A 1.0874305 
1 A 1.0627582 
2 A 1.0620494 




Grade   Mean 
2 A   1.1070698 
3 A B 1.0814662 
0 A B 1.0805401 
4 A B 1.0557796 




Figure 2.35. Comparison of integrated blue intensity between mitral valve lesion grade. The septal 
leaflet is on the left and the mural leaflet is on the right. 
 
2.3.12 Transmission electron microscopy (TEM) 
2.3.12.1 Endothelium: normal samples  
In the normal samples, the endothelium was found to cover the tissue forming 
a continuous single-cell thick outer layer. The cells were flat and joined tightly 
together. The apical side of the cell membrane was quite smooth, forming an even 
surface. The basal side of the cell was attached to the basement membrane of the 
tissue. The basement membrane can be seen as an unbroken grey line underneath the 
endothelium marking the border with ECM (Figure 2.36). In between cells, 
desmosomal type cell junctions were observed. The nucleus was the most prominent 
organelle in the endothelial cells, occupied the majority of the cytosolic space and 
often appeared as flattened rod-like in shape. The granulated nuclear chromatin was 
particularly apparent, but unlike the typical nuclear morphology of actively 
expressed genes with light euchromatin in the centre and the dormant genes of the 
dark heterochromatin located near the periphery, the dense heterochromatin of the 
endothelial cell with their tightly bound histones appeared as black speckles in 
juxtaposition with the lighter granulated euchromatin throughout the nuclear space. 
The cell nucleoli were not readily visible. Other organelles like mitochondrion and 
vacuoles could be seen in small numbers, often sparsely located in the two polar ends 
of the perinuclear area in the cytoplasm. Occasionally, tiny round vesicles were 
recognized near the sub-surface in the apical side, indicating endocytosis and/or 
exocytosis activity. However, the endothelial cells in the normal valve lacked the 
well-defined endoplasmic reticulum and Golgi apparatus.  
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Figure 2.36. Transmission electron micrograph of an endothelial cell (E) from normal mitral valve. 
Basement membrane (BM), Collagen (Co), extracellular matrix (ECM), desmosome junction (D). Bar = 
2 µm. 
 
In some areas, apoptotic and cycling processes of endothelium were 
observed, where healthy normal looking endothelial cells were found lying below 
another endothelial cell undergoing apoptosis. Apoptotic cells demonstrated a 
nucleus that was swollen and caused the cell to bulge outwards towards the apical 
side. The nuclear contents were flocculated with no distinguishable chromatic 
structures visible. Degradation in the cytoplasm produced large vacuoles and many 
small vesicles, while the granular electron dense cytoplasmic contents disappeared 
(Figure 2.37). Often the cell membrane was no longer intact and cytoplasmic matter 




Figure 2.37. Transmission electron micrograph shows an endothelial cell (E2) undergoing apoptosis 
near the surface and is with bulge nucleus (Nu) and large vacuole (Va). A healthy endothelial cell (E1) 
is underneath it. The sub-endothelial tissue is filled with collagen (Co). Bar = 4µm. 
 
2.3.12.2 Sub-endothelial layer: normal samples 
Immediately beneath the basement membrane, there was a narrow band of 
extracellular matrix separating the endothelium and the underlying collagen rich 
connective tissue. This band consisted of isolated individual collagen fibres together 
with proteoglycan ground substance. Valvular interstitial cells were occasionally 
found in this zone, some in close proximity to the endothelium and others in direct 
contact with the endothelial cells through extended cytoplasmic processes or 
pseudopodia (Figure 2.38). Different types of cells were recognized in this zone just 
beneath the endothelium, including multi-nucleated neutrophils, lysosome-carrying 
macrophages, polymorphic fibroblasts and collagen associated smooth muscle cells. 
Deeper into the tissue, organised collagen bundles running in different directions 
were observed. Typical banding pattern of the collagen was visible at high power. In 
some areas, collagen extended out towards the surface endothelium and was in close 




Figure 2.38. Transmission electron micrograph shows a multi-nucleated interstitial cell (IC) situated 
very close to an endothelial cell (E). Small cytoplasmic processes are seen on the interstitial cell. The 
sub-endothelial space is filled with ground substance and collagen bundles (Co). Bar = 4µm. 
 
2.3.12.3 Abnormality in clinical normal valve 
Throughout one of the samples classified as clinically normal, there was 
some evidence of sub-clinical disease. Abnormalities were evident in the 
endothelium, basement membrane and sub-endothelial tissues. Although the 
endothelium had areas that were normal, with features as those described above, 
other areas were denuded of endothelium, with just fragments of cells left. These cell 
fragments had a variable shapes. In some areas the endothelium was still present, the 
cells were frequently degenerating or dying. Many vacuoles and small vesicles were 
observed in these cells. The nuclei were swollen, and the cytoplasmic contents rose 
above the endothelium lining towards the apical side cause the cell to appear dome-
shaped. Some of these cells had lost their attachment to the tissue (Figure 2.39). 
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Figure 2.39. Transmission electron micrograph showing an endothelial cell with a large flocculated 
nucleus (Nu) has started to detach from the tissue. The cytoplasmic material has been degraded, but 
the mitochondria (M) are visible. The neighbouring endothelial cells (E) lay flat on the surface. Bar = 4 
µm. 
 
Changes to the basement were also seen. In some areas where the endothelial 
cells were degenerating, breaks in the basement membrane were observed at high 
power. In other areas the basement membrane was thickened, but also included gaps. 
Where there were interruptions to the basement membrane, the junctional spaces 
between the cells were increased, and were joined together only by the desmosomal 
attachments (Figure 2.40).  
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Figure 2.40. Transmission electron micrograph shows two endothelial cells side by side at the surface 
of the tissue, their nuclei (Nu) labelled. The attachment between them is breaking down; there are now 
large intercellular spaces (IS) and the cells are joined only by desmosomes (D). The lower cell has also 
lost its attachment to its other neighbour, leaving a gap (G) in the endothelial surface. Beneath the cells 
is an expanded extracellular matrix (ECM) and a few sparse collagen bundles (Co) in between. Bar = 3 
µm. 
 
The tissue underneath the disrupted basement membrane was also marked by 
change.  At high magnification, amorphous ECM material was seen leaking out 




Figure 2.41. Transmission electron micrograph shows the discontinuation of endothelium (E), a large 
gap is seen. The basement membrane (BM) has broken down, allowing extracellular matrix (ECM) 
material to escape through the gap. Bar = 1 µm. 
 
2.3.12.4 Endothelium: MMVD diseased samples 
In the diseased samples, the denudation of endothelium was much more 
extensive. Although isolated cells were often present on the surface, the continuity of 
the endothelium was lost. The remaining cells underwent transformations from a 
flattened profile with an even outer surface to cells with a protuberant dome shaped 
out growth and ragged outer surface. The ragged and often crenated outer surface 
revealed micro-appendages or short cytoplasmic processes (Figure 2.42).  
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Figure 2.42. Transmission electron micrograph shows an endothelial cell (E) undergoing degenerative 
process in a diseased valve. Many cytoplasmic buds (CB) created a ragged apical surface. The 
nucleus (Nu) and vesicles (Ve) can be seen within the cell. Underneath, an interstitial cell  (IC) is in 
close proximity to the endothelium. The interstitial cell has cytoplasmic processes that extend towards 
the endothelium. Bar = 3µm. 
 
Similar to the apoptotic cells in the normal samples described earlier, cells in 
the diseased valve also had swollen nuclei with increasing numbers of small 
vacuoles, some appeared as dense storage vacuoles. However, unlike the typical cell 
going through the apoptotic process, it seemed these cells were actively detaching 
from the basement membrane and migrating towards void space on the apical side. 
The definition between euchromatin and heterochromatin structures in the nuclei 
became apparent. As the cell protruded the shape changed from a dome to 
mushroom-like (Figure 2.43). Finally, the cells totally detached themselves and 
separated from the basement membrane (Figure 2.44). 
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Figure 2.43. Transmission electron micrograph shows an endothelial cell (E) is detaching itself from the 
basement membrane (BM). A gap (G) between the cell membrane and basement membrane can be 
seen. The extracellular matrix (ECM) contains abundant ground substance and sparse collagen 
bundles (Co). Bar = 3 µm. 
 
Figure 2.44. Transmission electron micrograph shows an endothelial cell (E) in a diseased valve is 




2.3.12.5 Sub-endothelial layer: MMVD diseased samples 
The damage to the basement membrane was present at different degrees of 
severity. In some areas, where endothelial cells were still present, the basement 
membrane was disrupted with small gaps in it exposing the underlying ECM. As 
with “sub-clinically” affected areas in normal valves, the basement membrane 
became thickened and in other areas a definite two-layered membrane structure was 
observed (Figure 2.45). There were areas where the basement membrane appeared 
intact despite desquamation of overlying endothelial cells. Remnants of cells under 
advanced flocculation were found nearby. However, at higher magnification small 
gaps were discovered on the membrane. In severe changes, there was obliteration of 
the basement membrane, exposing the underlying ECM. The degraded ECM often 
appeared as an amorphous mixture of grey and translucent matter, and some small 
matrix vesicles.   
 
Figure 2.45. Transmission electron micrograph shows basement membrane (BM) has become double 
layered. There is a gap (G) between the endothelial cell (E) and the basement membrane. The 
extracellular matrix (ECM) contains collagen bundles (Co). Bar = 1µm. 
Interstitial cells were seen congregated towards the damaged endothelial cells 
in the diseased valves. More interstitial cells were found in the zone just beneath the 
basement membrane compared to normals. Whether the interstitial cells play a direct 
role in the transformation or degeneration of the endothelial cells is hard to elucidate 
in this study, but there was strong evidence to demonstrate that some interstitial cells 
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were in contact with endothelial cells through their micro-appendages. Another 
interesting observation was that interstitial cells could squeeze between two 
endothelial cells and escape from the ECM (Figure 2.46).  
 
Figure 2.46. Transmission electron micrograph shows an interstitial cell (IC) is squeezing between two 
endothelial cells (E). The extracellular matrix (ECM) contains sparse collagen. Bar = 2 µm. 
 
In the sub-endothelial level, the collagen fibre bundles appeared in disarray. 
The disorganized collagen bundles were sparsely arranged in the abundant ground 
substance. The typical banding patterns of densely packed collagen fibre were no 
longer readily visible. Some collagen bundles showed signs that they had been 
splintered. Close inspection revealed that some individual collagen fibrils were bent 
at various angles rather than being straight. There was an increase in inter-collagen 
fibril space. At higher magnification, some collagen fibres were associated with 









Figure 2.47. Transmission electron micrograph shows the collagen (Co) in the diseased valve are bent. 
The collagen are associated with filamentous proteoglycans (F). Bar = 0.5 µm. 
 
The interstitial cells presented in the tissue were truly pleomorphic. Cells of 
disparate morphology were co-localised side by side in the tissue. More than one 
phenotype was observed at any one time. The fibroblast-like cells were usually 
elongated in shape. These cells contained numerous vacuoles and vesicles. Some of 
the vacuoles were filled with lipid. Twin nucleated cells were commonly seen 
(Figure 2.48). They were initially thought to be cells of high proliferation undergoing 
cell division, but there was no evidence of spindle formation, a characteristic feature 
of cell division. In spite of their abnormal morphology, these cells were seen to be 
involved with the ECM. The majority of the fibroblast-like cells were actively 
engaged in secreting. Matrix vesicles of various sizes could be seen next to cells. 
These cells contained nuclei that consisted of central light granulated euchromatin 
surrounded by dark heterochromatin, typical of mature viable cells. 
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Figure 2.48. Transmission electron micrograph shows a twin nucleated (Nu) interstitial cell with an 
elongated shape secreting vesicles. Bar = 2 µm. 
 
Other cells identified were more rounded and had a more smooth muscle like 
phenotype. The cytoplasm was more granular, indicative of a more rigid 
cytoskeleton. The cells were viewed regularly in association with collagen, and 




Figure 2.49. Transmission electron micrograph shows a round shaped interstitial cell is in close contact 
with collagen (Co). The cytoplasmic vesicles contain pro-collagen. Bar = 2 µm. 
 
2.3.13 Quantitative Stereology  
The data obtained from stereology grid count was analysed using ANOVA. 
The four data sets included endothelium, interstitial cells, collagen and extracellular 
matrix. The features of the data sets are presented (Table 2.4).  
Table 2.4. Medians, means and quartile values for the quantitative stereology of endothelium, 
interstitial cells, collagen and extracellular matrix data sets. 
 Endothelium Interstitial cells Collagen Extracellular matrix 
 Normal Diseased Normal Diseased Normal Diseased Normal Diseased 
75% Q 3796.0 2551.2 2696.8 4006.0 16425.0 9525.0 14050.0 17425.0 
Median 2439.5 1667.0 1775.5 2146.0 12700.0 5650.0 9500.0 14600.0 
25% Q 1339.0 263.8 696.2 1159.0 8200.0 3375.0 5575.0 10250.0 
Mean 2669.7 1639.2 2018.8 2862.9 12404.4 6876.7 9808.9 13958.2 
 
Dramatic differences in medians and means in each data pair between normal 






Results from the sterology study shown there was less endothelium in the 
diseased valves. The median and both the upper and lower quartile values were lower 
in the diseased valves in comparison with their counterparts in normal valves. There 
was a slight skew in the distribution of data in the diseased, where more data had 
values at the lower end of the range. This was due to the lower frequency of 
endothelium presented in the diseased. ANOVA showed the difference in 






























Group   Mean 
Normal A   2669.6889 
Diseased   B 1639.2444  
p<0.0001 
Figure 2.50. Comparison of endothelilum as assessed by quantitative stereology between normal and 
diseased mitral valve. 
 
2.3.13.2 Valvular interstitial cells 
The data sets for interstitial cells in both normal and diseased valves showed 
deviation from the standard normal distribution. The distributions were similar to an 
exponential distribution that skewed to one side. The lower tails were shallow but 
dense. Nonetheless, results showed more interstitial cells in the diseased state (Figure 




































Group   Mean 
Diseased A   2862.9000 
Normal   B 2018.7778  
p=0.0084 
Figure 2.51. Comparison of valvular interstitial cell as assessed by quantitative stereology between 
normal and diseased mitral valve. 
 
2.3.13.3 Collagen 
The data sets for collagen for both normal and diseased resembled the 
standard normal distribution of a unimodal data set. There was a dramatic decrease in 
collagen quantity in the diseased valves that almost two fold less than the normal 




















Group   Mean 
Normal A   12404.444 
Diseased   B 6876.667  
p<0.0001 
Figure 2.52. Comparison of collagen as assessed by quantitative stereology between normal and 




2.3.13.4 Extracellular matrix  
Both the data sets for normal and diseased valves showed the classic standard 
normal distribution with unimodal peaks. There was a marked increase in the amount 
extracellular matrix in the diseased valves (Figure 2.53). ANOVA revealed this 































Group   Mean 
Diseased A   13958.222 
Normal   B 9808.889  
p<0.0001 
Figure 2.53. Comparison of extracellular matrix as assessed by quantitative stereology between normal 
and diseased mitral valve. 
  
2.3.13.5 Circularity 
All the data sets obtained for circularity analysis exhibited the normal 





Table 2.5). By comparing the number of cells in each category between 
normal and diseased, the data confirmed the observations made under TEM and 
confirmed the change in cell numbers previously reported. Out of the 180 
micrographs analysed there was a decrease in the number of endothelial cells, but an 
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Table 2.5. Medians, means and quartile values for the circularity of endothelium and interstitial cell. 
 Endothelium Interstitial cell 
 Normal Diseased Normal Diseased 
n 52 44 37 42 
75% Q 0.34500 0.51375 0.74050 0.81725 
Median 0.28100 0.42700 0.64100 0.67400 
25% Q 0.21675 0.36900 0.51800 0.53375 
Mean 0.309096 0.443795 0.62354 0.656547 
 
2.3.13.5.1 Endothelium vs. interstitial cells: Normal valve 
In the normal valves, the mean circularity value for endothelial cells was low 
typical of their flattened and elongated shape. In contrast, the interstitial cells were 
much circular and had a higher mean circularity; more than two fold higher than the 
endothelium. This difference was highly significant (p<0.0001). There were a few 
outliers in circularity score in the endothelium at the top tail end, due to cells 
undergoing apoptosis and becoming plumper. The sample distribution covered a 
wide range in the interstitial cells as a result of the multi type of polymorphic 
interstitial cells. The outliers at the lower tail end in the interstitial cells were 
probably due to the development of irregular micro-appendage in certain cells 



























Group   Mean 
Interstitial A   0.62354054 
Endothelium   B 0.30909615  
p<0.0001 
Figure 2.54. Comparison of cicularity between endothelium and interstitial cell in normal mitral valve. 
 
 
2.3.13.5.2 Endothelium vs. interstitial cells: Diseased valve 
In the diseased valves, although the degree of difference in circularity 
between endothelial and interstitial cells was smaller, owing to the presence the 
endothelial protuberances. The mean circularity score of the interstitial cells was 
higher than the endothelial cells. The difference was highly statistically significant 
(p<0.0001). Again, the samples distribution covered a wide range due to the 




























Level   Mean 
Interstitial A   0.65654762 
Endothelium   B 0.44379545  
p<0.0001 
Figure 2.55. Comparison of cicularity between endothelium and interstitial cell in diseased mitral valve. 
 
 
2.3.13.5.3 Endothelial cells: normal vs. diseased 
The mean circularity of endothelial cells was higher in the diseased valve as a 
consequence of pathological transformation in which the endothelial cells bulged out 
compared to the normal flattened state. A highly significant difference in circularity 
of the endothelial cells between normal and diseased was formed. Any outliers at the 



























Group   Mean 
Diseased A   0.44379545 
p<0.0001 
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Normal   B 0.30909615  
Figure 2.56. Comparison of endothelium cicularity between normal and diseased mitral valve. 
 
2.3.13.5.4 Interstitial cells: normal vs diseased 
In both normal and diseased the circularity values for interstitial cells 
exhibited more variation than for endothelial cells. This attribute was due to the 
polymorphic nature of the interstitial cells. Cells of different phenotypes often 
coexisted in close proximity. The data distribution patterns were at similar levels in 
both normal and diseased. Even though a slight increase in circularity in the disease 
was noticed, this difference did not reach statistical significance. The postulated LSN 
was calculated at 443. The circularity values for the interstitial cells showed no 
statistical difference between normal and diseased valve and were not much different 
from the circularity values calculated in myxomatous regions using ImageJ light 

























Group  Mean 
Diseased A 0.65654762 
Normal A 0.62354054  
p=0.4056 
LSN=443.38 
Figure 2.57. Comparison of valvular interstitial cell cicularity between normal and diseased mitral valve. 
 
2.3.14 Scanning electron microscopy of cell macerated samples 
2.3.14.1 Normal  
At the mid zone of the leaflet, the layered structure of the connective tissue 
skeleton structure was distinctly visible. The atrialis layer consisted of interwoven 
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fibres forming a fine mesh network. The middle spongiosa layer was loosely 
constructed. Its organisation had a honeycomb appearance with many matrix empty 
voids. On close examination, collagen struts could be seen to make up the framework 
structure. The fibrosa layer was compacted with dense collagen and formed a 
continuous band.  There were numerous tiny gaps evenly spaced in the band of 
collagen. The void gaps had a spindle shape which closely resembled the outlines of 
interstitial cells. To delineate the ventricularis layer used by other researchers was 
slightly tricky. Surprisingly there was no clear line distinguishing the ventricularis 
from the fibrosa. The ventricularis could be arbitrarily identified as a very thin dense 
layer on the outer rim of the fibrosa (Figure 2.58).  
 
Figure 2.58. Scanning electron micrograph of a normal mitral valve septal leaflet at the mid zone. The 
three layers atrialis (A), spongiosa (S) and fibrosa (F) are distinguishable. Bar = 0.1 mm. 
 
At the distal end, the leaflet showed a sponge or cork-like connective tissue 
architecture. The cross section views exhibited a craquelure like texture made of 
lignified connective tissue juxtaposed with tiny gaps. The layered structure was 
vaguely distinguishable, although the spongiosa in the middle appeared loosely 




Figure 2.59. Scanning electron micrograph of a normal mitral valve septal leaflet at the distal zone. 
Atrialis surface (A) and ventricularis surface (V). Bar = 0.1 mm. 
 
At higher magnification, the spongiosa in the distal zone appeared trabecular 
in organisation. The collagen fibres inter-twined to form an extensive network. Some 
collagen fibres twisted together to form thicker collagen bundles. Lateral struts were 
found connecting between bundles for support (Figure 2.60).  
 
 
Figure 2.60. Scanning electron micrograph of a normal mitral valve septal leaflet at the distal zone in 
close up. The collagen fibril (Co), lateral struts (*) and proteoglycan network (PG) are visible. Bar = 10 
µm. 
 
At the free edge, the surface was made of an interweaving network of 
collagen fibres. There were slightly thicker main fibres aligned in the same direction 
as the axis of the leaflet. The main fibres were joined together by the aborisation of 




Figure 2.61. Scanning electron micrograph of a normal mitral valve septal leaflet at the free edge 
surface. Bar = 5 µm. 
 
2.3.14.2 Diseased Grade 1 to 4 
In the diseased samples, disruption of the connective tissue structure was 
evident at the mid zone, notably in the collagen rich fibrosa layer. The degree of the 
destruction was proportional to the severity of the disease. In the Grade 1 diseased, 
the honeycomb pocket structure in the spongiosa layer was collapsed. The normal 
collagen struts supporting the framework could not be seen, leaving a distorted 
structure with large void spaces. However, the fibrosa in Grade 1 was intact and 
comparable to that seen in the normal. In the Grade 2 diseased, distortion of the 
pocket structure in spongiosa was observed as well as small cracks in the fibrosa 
layer. In the Grade 3 disease, disintegration could be seen in all three layers. The 
atrialis was frayed looking, a departure from its normal wavy structure. The 
compartmental arrangement in spongiosa architecture was barely recognisable. 
Instead the spongiosa was filled with large void gaps. There were numerous 
crevasses and cracks in the fibrosa layer, a sign of major collagen disintegration. In 
the Grade 4 disease, there was a marked destruction of the connective tissue structure 
of the valve stroma. The tissue skeleton seemed as been torn apart. There were only 
remnants of the trabecular structure still visible in the spongiosa and collagen in the 







Grade 3  
 
Grade 4  
Figure 2.62. Scanning electron micrographs of diseased mitral valve septal leaflets at the mid zone. 
Disruption of the connective structure during the disease progression is evident. The three layers 
atrialis (A), spongiosa (S) and fibrosa (F) are labelled. Bar = 0.1 mm. 
 
At the distal end, increase in thickness of the leaflet during disease 
progression was apparent and the overall structure had a bizarre looking appearance. 
There were deep groove lines dividing the areas into “lobe-like” structures. Some 
lobes had vein like crack lines. Others had crinkled lines and resembled brain gyri 
and sulci (Figure 2.63).  
 
 
Figure 2.63. Scanning electron micrographs of diseased mitral valve septal leaflets at the distal zone. 
There were deep groove lines dividing the areas into “lobe-like” structures. Some lobes had vein like 
crack lines, atrial side (A) and ventricular side (V). Bar = 1 mm. 
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At high magnification the distal end spongiosa layer, the major site of 
myxomatous changes, showed much thicker fibres separate from each other. Each 
thick fibre was made of very thin thread-like fibre, and many fibres exhibited frayed 




Figure 2.64. Scanning electron micrographs of diseased mitral valve septal leaflets at the distal zone in 
close up. The collagen fibres are thicken, and some with frayed ends. Bar = 10 µm. 
 
At some discrete locations in the distal zone, thin collagen fibres in a highly 
compacted arrangement were found. These collagen fibres did not seem to be part of 
any recognizable structure arrangement or network (Figure 2.65).  
 
 
Figure 2.65. Scanning electron micrographs of a disease mitral valve septal leaflet shows amassed 
collagen fibres in distal zone. Bar = 5 µm. 
 
At the atrialis surface near the free edge, some of the thin collagen fibres 
were tangled into lumps. The mesh-like appearance of collagen fibres was not evenly 




Figure 2.66. Scanning electron micrographs shows a diseased mitral valve septal leaflet at the free 
edge surface. The mesh-like appearance of collagen fibres was not evenly spaced, with voids of in 
different sizes visible. Bar = 0.5 µm. 
 
2.3.15 Quantitative connective tissue micro-structural analysis 
The BinariseSEM method was found capable of dealing with this problem. 
The software was fully automated after the initial stage of calibration and image 
segmentation and was capable of calculating a large data set and generating 
numerous different structural distribution profile data charts. To overcome the 
problem of data overload, the determination of the difference between normal and 
diseased only used micrographs taken at the distal zone spongiosa layer in Grade 0 
normal valve and Grade 3 diseased valve. The micrographs were captured at the 
same magnification of ×1690, the same viewing angle and the same orientation 
relative to the surface. The different quantitative shape descriptors were applied as 
parameters to determine the difference in connective tissue structure between normal 
and diseased mitral valves. 
Pore Area 
Pore area is a measure of pore size. The computed results shown the mean 
pore area in the diseased valve was 0.301 µ2, and was more the twice as large as the 
pore area in normal valve at 0.127 µ2. Furthermore, the maximum pore area in the 
diseased valve was 6.190 µ2 compared to 0.777 µ2 in the normal valve. Many smaller 
pores clustered at the left hand side of the x-axis on the distribution chart were seen 
in both normal and diseased, even though their respective x-axes were at vastly 
different scales (Figure 2.67).  
Pore form factor 
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Pore form factor is a shape descriptor. The distribution patterns of pore form 
factor were markedly different between the two samples. However, the mean pore 
form factors were similar; 1.064 in the normal and 0.928 in the diseased. Moreover, 
the min, max and mode values of the two samples were also similar. 
Pore roundness 
Pore roundness is a measure of pore circularity. The pore roundness 
distribution in the normal valve showed some resemblance of a normal distribution 
curve with unimodal peak in the middle. The counts in the normal sample occurred 
at regular intervals, but only up to 0.003, whereas the roundness distribution in the 
diseased was scattered across a wider range up to 0.007. The pore roundness 
distribution in the diseased valve exhibited a twin peak distribution curve deviation 
from the normal distribution. Furthermore, the mean and maximum roundness values 
were also higher respectively in the diseased valve. 
Pore aspect ratio 
Pore aspect ratio is a ratio of the maximum to minimum dimensions. There 
were certain common features in the pore aspect ratio distribution patterns in both 
normal and diseased valve. Both distribution patterns resembled a normal 
distribution despite of counts weighted slightly more on the left hand side of the 
charts. Additionally, the means were almost the same plus the minimun, maximum 
and mode values were also similar. 
Pore perimeter 
Pore perimeter is a measure of the pore boundary. Increase in crevasses in the 
diseased had resulted in numerous pore counts with large perimeters. Although the 
means between the two samples (normal=1.018, diseased=1.484) were very close, 
the maximum value in the diseased valve was 14, more than four times bigger than 
the 3.434 in normal valve. The two distribution charts consequently had varying in 
scale on the x-axis, but if the chart for normal is resized to match the diseased, the 
two distribution patterns would match each other quite well, the majority of pore 
perimeters were on the smaller side of the scale in both samples. 
Pore max diameter 
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The pore max diameter is a measure of the longest line that can fit into a 
pore. The mean pore max diameter at 9.836 µ in normal was actually bigger than the 
diseased at 7.830 µ. The lower end values of the two samples were the same at 
1.1414 µ, but the upper end value range extended to 75.432 µ in the diseased valve, 
more than twice as large as the 34.132 µ in the normal valve. If the distribution 
charts were standardised, the distribution patterns of pore max diameter in normal 
valve was quite similar to the pore max diameter in diseased valve.  
Pore min diameter 
The pore min diameter is a measure of the shortest line that can fit into a 
pore. This was similar to the distributions in the pore max diameters. The lower end 
minimum diameters were the same again at 1.414 µ in both samples. The two means 
were close, but the top minimum diameter in diseased valve was up to 27.019 µ and 
up to 17.088 µ in the normal valve. The distribution pattern profiles were similar 
between the two samples. The trend was an exponential increase in counts when 
moving towards the lower end on the left. 
Pore directionality 
Pore directionality is a measure of the gradient direction. The pore 
directionality distribution profiles in both samples were similar. However, the normal 
valve had more freedoms of choice in directionality than the diseased. One striking 
feature was the gaps seen in the middle of distribution charts in both. It could be 
interpreted, that there was a limited range of pore directionality in both normal and 
diseased valves.  
Pore directionality angle 
The pore directionality angle diagrams corresponded to the patterns in pore 
directionality distribution charts. In the normal, there were more degrees of freedoms 
found in the directionality angle, although there were a few preferred directions 
found. The orientations of the pores in the diseased valve were restricted to certain 
angles. The remaining directionality angles in the disease valve were similar to the 
directionality found in normal. 
Overall, there was an increase in pore area and pore perimeter as the disease 
progressed, but there was no change in pore aspect ratio. The change found in pore 
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form factor was so small it could be considered as negligible. There was an alteration 
in pore roundness and the diseased covered a wider range than the normal. Both the 
pore maximum and minimum values increased and the range extended in the 
diseased valve while their mean values remained comparable to the normal. The pore 
directionality was more restricted in the diseased but the preferred directionality was 
similar to the normal. 
 
Grade 0 Normal binarised Grade 3 diseased binarised  
  
 
Grade 0 Pore Area (µ2) 
 
Grade 3 Pore Area (µ2) 
 
Grade 0 Pore Form Factor 
 
Grade 3 Pore Form Factor 
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Grade 0 Pore Roundness 
 
Grade 3 Pore Roundness 
 
Grade 0 Pore Aspect Ratio 
 
Grade 3 Pore Aspect Ratio 
 
Grade 0 Pore Perimeter (µ) 
 
Grade 3 Pore Perimeter (µ) 
 
Grade 0 Pore Max Diameter (µ) 
 
Grade 3 Pore Max Diameter (µ) 
 79 
 
Grade 0 Pore Min Diameter (µ) 
 
Grade 3 Pore Min Diameter (µ) 
 
Grade 0 Pore Directionality 
 
Grade 3 Pore Directionality 
 
Grade 0 Pore Directionality Angle 
 
Grade 3 Pore Directionality Angle 
Figure 2.67. Quantitative connective tissue micro-structural analysis distribution charts. From top, 
binarised images, pore area, pore form factor, pore roundness, pore aspect ratio, pore perimeter, pore 




The mitral valve complex is a complicated anatomical structure whose 
function requires all its components to work in a precise synchronised fashion to 
allow adequate left ventricular filling and emptying6, 7. Alteration in tissue structure 
will result in deformation and compromised performance of the valve. In this study 
image analysis methods were applied to investigate different aspects of the 
morphological and cellular changes that occur with myxomatous mitral valve disease 
in the dog. Qualitative visual evaluations as well as quantitative analyses were 
conducted at macro-structural and ultra-structural levels. Using a novel set of 
parameters, this study has shown that with disease progression there are quantifiable 
changes in leaflet length, leaflet edge thickness, connective tissue content and cell 
numbers in the valve leaflet. A subjective change in GAG expression was found but 
could not be quantified using different colour measuring techniques. In the 
myxomatous area, there was no change in cell shape associated with disease and 
cells were typically spindle-shaped, consistent with an interstitial cell phenotype. 
However, the morphological changes in endothelial cells noted with disease were 
found to be significant. The study also showed the public domain image analysis 
software ImageJ can be used to assess morphogenesis, but should be used with 
caution when applied to measure changes in colour intensity. 
The age dependent nature of MMVD52 was highlighted once again in this 
study. The age distributions of the dogs according to lesion grades are in line with 
previously published data1, 2, 22, 53, 54. All the normal dogs were five years or younger 
and all dogs over the age of nine were affected by this disease. At the extreme end of 
the scale, it seemed the Grade 4 disease has reached the upper limit set by age. This 
observation was likely due to mortality kicked in as an antagonist to survival. 
Although there is no comparable grading system in human medicine the dog age 
distribution is comparable with human patients. Most reported human patients 
requiring mitral valve repair surgery or replacement tend to be middle-aged. It is 
likely such intervention occurs before the more severe form of the disease seen in 
aged dogs becomes apparent55-57. The exact prevalence of MVP in the human 
population is still a matter of debate. Compiling the data from 17 population-based 
studies, the prevalence commonly ranges from 2 to 10 percent, but up to 35 percent 
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in studies56, 58. The prevalence of MVP is low in young children, but increases from 
childhood to adolescence, and this change is concomitant with the growth spurt of 
adolescence59. The conflicting data from human medicine is clearly shown by two 
separate papers published by Framingham heart study where the prevalence of MVP 
and MR were determined using echocardiography. The prevalence of MVP was 
found at to be as low as 2.4%, whereas the MR normally regarded as a complication 
of MVP, was found in a surprising 19.0% of patients60, 61. The sample selection, the 
diagnostic tool used and the criteria of selection used could all have influenced the 
outcome of these studies, and the issue of a standardised method of diagnosis and 
measurement criteria has been raised62.  
Using the data from the current study, the onset of the disease in the dog can 
be extrapolated to be just shortly after the age of four years. However, this onset 
could only be applied to a heterogeneous group of mixed breed dogs, as in this 
instance, and it is well documented that certain highly predisposed breeds like the 
Cavalier King Charles spaniel (CKCS) shown signs of MMVD at very early age53, 54. 
Because of this breed association it has long been thought the disease is inherited. 
The parent to offspring inheritable relationship was established in an 
echocardiographic study of MR in CKCS and Dachshounds32. The disease, in 
affected breeds, is believed to be an autosomal dominant complex polygenic trait 
with variable penetrance63. Increase in plasma platelets response and fibrinogen have 
already been put forward as useful biomarkers in CKCS64-66. An inherited form of 
the disease is seen in human Marfan syndrome patients who develop myxomatous 
mitral degeneration at an early age. However, Marfan Synfrome is caused by the 
mutation a single gene encoding for the extracellular structural protein fibrillin67-69.  
There may be a gender predisposition to MMVD. Although the gender issue 
was beyond the scope of this study, there were more male dogs in the sample group. 
However, a proportion of the samples available were from male dogs with a history 
of behavioural problems (reason for euthanasia). A higher incidence in male dogs 
has been found in some studies, which might point to a possible hormonal factor1, 70. 
In human MVP, higher prevalence among lean young women in some cases raised 
the question about life style choice58. 
The auscultatory findings for the dogs in this study were highly dependent on 
the progression of the disease. The extrapolated data has shown the earliest murmur 
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detected intercepted with Grade at 0.9, thus auscultation was only sensitive for 
detection of murmur from Grade 1. Pedersen has pointed out the auscultation finding 
was related to stage of the disease, the early stage mild systolic murmur has low 
intensity therefore very hard to detect even for experienced cardiologist71.  
In normal valve closure, the two leaflets meet each other snugly with the free 
edges in apposition but at an angle to the smooth zone of the leaflet7. The leaflet 
itself is a multilayer structure covered by a single cell thick endothelial lining along 
each surface. On cross section the mitral valve leaflet can be seen to consist of an 
elastic atrialis layer, a loose spongiosa layer, a dense connective tissue fibrosa layer and 
a ventricularis layer to which the chordae tendinae attach. Nevertheless, the leaflet is a 
continuous structure with each constituent element performing specialized functions. 
Although the designation of mitral valve leaflet cross-sections into layers was somehow 
arbitrarily defined in the distal zone of diseased valves, the layering across the leaflet 
was otherwise distinct. The structural changes due to myxomatous degeneration in the 
leaflets are not always uniformly distributed, but have long been identified as the most 
important factors contributing to mitral valve dysfunction in dogs1, 2, 17, 43, 72. The 
rough zone of the leaflet on the ventricle side where the tedinous chords attach is 
particularly prone to myxomatous degeneration. The chordal insertion areas were 
usually the most severely affected73. At later stages of this disease, gross distortion of 
the apposition line of the leaflets was caused by the development of interchordal 
hoodings7, 71. The middle section of the leaflet is less susceptible to myxomatous 
degeneration and at the same time withstands the strongest pressure loading during 
the cardiac cycle74. In mitral valve prolapse in people, the mid section of the leaflets 
is involved, especially the middle scallop of the mural leaflet with changes seen in 
88% of patients55, 75. Considering the changes noted in dogs, the current study 
focused on the tissue in the central line from free edge to annulus.  
The mean diamonds incorporating comparison circles method was chosen to 
graphically represent the final statistical analysis. This allows a view of the large 
amount of information embedded in the chart graph, and appreciation of the spread 
of variance, the sample group size, the distribution of sample, the confidence level, 
the standard error and the distance in significance between each group. 
Various techniques have been used over the years to investigate 
morphological and structural changes in human and canine MMVD. These 
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techniques have concentrated mainly on biochemical methods to assess ECM 
expression76-78. Gross, histological and ultrastructural descriptions have also been 
reported17, 29, 43. The current study is the first to use image analysis for this purpose in 
the dog. A similar methodology has been used in normal human valves, but not in 
human diseased leaflets79. In that study age-related reduction in valve area, increase 
in GAGs and elastin and a decrease in collagen, all as a function of total valve area, 
were reported. Using Movat’s pentachrome staining and Image Pro Plus the “area” 
of GAGs was measured and not the intensity of staining. Bearing in mind canine 
MMVD is an age-related condition, it is possible that in that study by McDonald and 
co-workers (2002)79 their aged “normal” subjects would be classified as abnormal in 
a veterinary context and that the changes noted matched those found in dogs with 
MMVD. Indeed, the authors refer to thickening of the leaflets with age, a feature 
common in canine MMVD, and the potential problem this would cause with 
echocardiograph assessment of mitral valves in aged human subjects. It could be 
argued that the valve thickening and ECM changes noted is in fact evidence of 
disease and the report by Murata (1981) that GAG content decreases with age in 
humans would support that view76. 
Myxomatous degeneration is associated with valve interstitial cell (VIC) 
phenotypic alteration, and this has been demonstrated in both dogs and humans, and 
there is a degree of reasonable assumption that this change in VIC from a quiescent 
fibroblast (vimentin-positive) to an activated myofibroblast (α-smooth muscle actin-
positive (α-SMA) phenotype contributes to the pathology of the disease27, 43, 80-82. 
What is not clear is whether or not this process involves changes in cell numbers in 
diseased areas. Studies in human mitral valve disease have documented an increase, 
in one study of 3.5 times, in activated myofibroblasts in myxomatous areas, and that 
many of these cells are also CD-34 positive27, 83. However, in the dog α-SMA 
positive cells congregated toward the valve edge have been demonstrated, while 
there is a concurrent reduction in vimentin positive cells in myxomatous areas80. 
Furthermore, it can be seen in myxomatous lesions there are concentrations of cells 
at the edge of such lesions towards the tip of the leaflet, and it is likely that counting 
those cells alone would suggest an apparent increase in cell numbers.  Using a 
computerised imaging tool it could now in this study be shown that, compared to 
normal spongiosa, there is a reduction in cell density in myxomatous areas in all 
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grades of disease in the dog. While this contrasts with previous reports for human 
valves the present data is more robust since as many of the cells if not all the cells in 
definite diseased areas were counted using a computerised imaging tool26, 27, 83. 
However, there is no difference in the cell density when comparing myxomatous 
areas between different grades of disease, suggesting no cell recruitment or cell 
proliferation. The increased numbers of CD-34 positive cells reported in 
myxomatous areas of human mitral valves might be due to cell recruitment from the 
blood pool83. Immunohistochemistry studies have failed to shown a marked increase 
in CD34+ cells, suggesting such recruitment of CD-34 cells does not occur in the 
dog.  
The exact phenotype of cells in the myxomatous areas of leaflets is likely to 
be complex, and there is a reasonable presumption that they are predominantly 
mesenchymal interstitial cells. There is evidence from immunohistochemical and 
ultrastructural morphology studies in dogs and humans that this is the case, and the 
majority of cells are either quiescent vimentin-positive fibroblasts or activated α-
smooth muscle actin-positive myofibroblasts26, 43, 82-84.  Since fibroblast-like cells 
have an elongated spindle shape, it was interesting to see if analysis of cell shape 
would support this view. A measurement of cell circularity indeed demonstrates a 
tendency towards an elongated spindle shape in myxomatous areas leaflets. 
However, some cells in myxomatous areas that are vimentin and α-SMA negative, 
that tend be more rounded in shape were reported, but their exact phenotype has not 
yet been fully identified80.  
Scanning Electron Microscopy has previously documented denudation of the 
endothelium in some areas of the diseased valves of dogs with regional 
pleomorphism in adjacent intact endothelial areas. The significance of these 
observations was not known29. The TEM data from the current study clearly shows 
the denudation of endothelium is linked to the MMVD. Furthermore, the denudation 
of endothelium was concomitant with destruction of collagen and build up of 
extracellular ground substance in the presence of congregation of VIC near the distal 
surface. One consideration is that since the Whitney’s grading is a gross 
classification only, and was used to classify the dogs into different grades, and that 
only a small area of the relatively large valve is observed with TEM, it is problematic 
to accurately correlate changes seen with disease severity. In the study by Corcoran 
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et al (2004) abnormally diseased and normal endothelium were found adjacent to 
each other. An additional confounding factor is that the orientation of the TEM 
sections were not discerned after the point of ultrathin section collection, However, 
images were taken at random intervals along the length of the endothelium on each 
sample in an attempt to get better association with disease severity. The labour 
intensive nature of TEM sample preparation did not allow cross-sectional surface-to-
surface examination of samples. Since the main use of TEM is to study a very small 
area at high magnification, the TEM study was focused on the endothelium and its 
immediate microenvironment. The observation area did not extend deep into the 
stroma where myxomatous areas are mainly located. 
A favoured hypothesis at present is that the MMVD is a response to repeated 
impact of the leaflet edges71. Myxomatous deformation alters the valve motion 
resulting in abnormal closure and further damage and the changing in hemodynamic 
force due to regurgitation may cause endothelial damage30. The location and the 
histology of the thickened foci on leaflet edges supports this hypothesis, but the 
sequence of events and the time course is unknown4. Damage to valve endothelial 
cells (VEC) could influence the synthesis and release of vasoactive mediators that in 
turn interact with subendothelial matrix tissue. Endothelin is a potent vasoconstrictor, 
but also has the potential of stimulating proliferation of fibroblasts and increasing 
collagen production, and is a possible candidate.  An increase in endothelin receptor 
density has been found in the distal end of canine mitral leaflet with myxomatous 
changes31. However, the actual level of the endothelin was not measured; so direct 
involvement of endothelin could not be substantiated. Alternatively, endothelium 
derived nitric oxide might be important and nitric oxide synthase (NOS) has been 
shown to be increased in the presence of collagen degradation32. The clear-cut 
alteration in the sub-endothelial space shown by TEM favours the idea of 
involvement of mechanisms of endothelial derived vasoactive substances. However, 
damage and denudation to endothelial is not restricted to the valve free edge; but can 
be seen in other areas of the leaflet including the chordae tendineae 29, 85. Even the 
endothelium in the normal valve leaflet exhibited a pleomorphic surface feature 
under SEM86. This suggests repeated impact from opening and closing of the valve 
might not account for the injury to the endothelium alone. The altered turbulence and 
shear stress during MMVD could also be assumed to exert a detrimental effect on the 
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endothelium. In vitro porcine aortic valve endothelial cells (PAVEC) respond to 
steady shear stress by aligning perpendicular to flow87. Steady shear stress also 
induced alteration in transcriptional profile of PAVEC on collagen I in culture by up 
regulating genes associated with chondrogenesis88. Co-culture models have also 
shown that endothelial cells hinder VIC proliferation with hemodynamic shear 
stress89 and VIC have been shown to migrate to and proliferate at the site of 
endothelial denudation and damage in a mitral valve explant organ culture system84. 
Evidence from in vitro experiments suggests that VECs respond dynamically to 
environmental stimuli and at the same time modulate the VIC activities. Ex-vivo 
studies have demonstrated that wound healing in the mitral valve is a slow process 
and involves VEC migration and incorporation into damaged endothelium. Only the 
VECs at the margin of an injury appear to participate in the regenerative response. At 
eight weeks post denudation injury round shaped VEC covered the cut edge and the 
VEC became more flattened only after 12 weeks. This healing process is also 
associated with phenotypic modulation of interstitial cells from fibroblast to 
myofibroblast90. In the current study, the phenotype of the VICs seen on TEM could 
not ascertained by their morphology, but there was distinctive VIC polymorphism.  
It can be presumed the morphological changes in the VEC and VIC 
populations are part of the mitral valve response to injury and it is reasonable to 
speculate it is the response of the mitral valve to injury that determines the clinical 
and pathological features of MMVD. Using the valve injury model, a reasonable 
hypothesis is that up-regulation of fibroblast growth factor 2 (FGF-2) contributes by 
promoting mitral VIC migration and proliferation in response to injury91. The 
mitogenic effect of FGF-2 in conjunction with TGF-β1 induces fibroblast to 
myofibroblast transformation this can be elegantly demonstrated by TEM92-94. The 
fibroblast-like VICs express matrix metalloproteinases that degrade extracellular 
matrix and so facilitating migration towards damaged endothelium and transform 
into myofibroblasts to participate in valve repair and remodelling82. Lastly, another 
consideration is that the damaged endothelium would no longer form a barrier on the 
surface and the underlying valvular tissue will be exposed to blood borne factors. 
However, these mechanisms, while useful in explaining changes at the valve surface, 
are less able explain the processes observed in the overtly myxomatous areas of the 
inner spongiosa layer. The current study has clearly identified destruction of 
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structural connective tissue in these areas concomitant with accumulation of GAGs 
but without cellular phenotypic change in numbers or shapes. Much of the current 
knowledge of the biochemical mechanism in MMVD is derived from experimental 
work in cell culture. The intricate spatial and temporal relationship in native mitral 
valve could not be demonstrated in vitro. The possibility of another pathobiological 
mechanism being involved in the ectopic myxomatous degeneration needs to be 
considered. Currently there is no feasible mechanical pathway that could adequately 
be applied to explain the changes in the myxomatous areas, but an understanding of 
valve development and embryogenesis might be useful. During the early stage of 
valve development, the GAG rich cardiac cushion is the site that initiates ECM 
remodeling that transforms later into valve leaflets. However, the cells responsible 
are believed to be VECs delaminated from endothelium that migrate into the cardiac 
cushion through a process referred to as endothelial-mesenchymal transformation 
(EMT)95-97. The mechanisms governing the EMT are complex, with many pathways 
implicated, including VEGF, TGF-β, Notch and Wnt/β-catenin96. Some of the 
mature aortic VECs retain their ability to trans-differentiate in vitro to a 
mesenchymal phenotype98. The question is, is it possible the endothelial cells are 
also responsible for maintaining the VIC in the mature valve? The hypothesis would 
be that once the VEC is damaged, signals from the endothelium are diminished and 
the VICs in the spongiosa, the most remote part of the valve revert to their foetal 
form and express GAGs for ECM remodeling. A useful model of this effect is seen 
in the interactions between endothelial and pericyte (smooth muscle cells) in 
vascular biology. Failure of the interaction between these two cell-types results in 
severe cardiovascular defects in genetic mouse models99. Unfortunately, present 
knowledge in this field derived from experimental studies on angiogenesis has no 
parallel implication in MMVD research, but close association between VEC and VIC 
in both normal and diseased mitral valves is evident, and the functional interaction 
between these two cells populations needs further examination.  
It has generally been presumed that while necessary to maintain normal 
physiological valve structure and function, the normal valve VECs and VICs are 
relatively quiescent. In diseased valve, cellular signals promote cell activation100. 
Nuclear bulges and micro-appendages on endothelial cells have been reported in the 
diseased dog mitral valve on SEM28. It is assumed these changes reflect cell 
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derangement or activation but what causes this change or what the functional 
consequences might be are unknown. Nuclear bulging might be a response to surface 
tension changes due to myocardial stretching, and surface micro-appendages might 
participate in phagocytotic sampling the blood pool. Circulating endothelium derived 
micro particles have been shown to inhibit mitral VEC function; possibly by 
negatively regulating VEC migration and proliferation101. In the diseased dog valve 
one of the most striking findings was the range of VEC and VIC shapes, 
demonstrating their plasticity and motility capabilities. Motility of VECs is essential 
in the normal repairing process, and in this role decorin has an important function in 
promoting VEC adhesion and migration on collagen I through integrin102. 
Considering the wide range of ECM components in the VEC microenvironment and 
the various mechanisms that are necessary to fine tune the synthesis and remodeling 
of ECM, it is apparent there is a complex relationship between the ECM and many 
aspects of VEC migration and survival103, 104. In the cell-macerated connective tissue 
skeletons from diseased valves, the surface mesh-like collagen fibril network, typical 
of normal valves was lacking and this will hamper the motility of VECs. It is not 
known precisely how the VECs desquamate from the surface. All the evidence from 
TEM suggested it was not necessary for VEC to defend its post resolutely until 
became obliterated by the hemodynamic force. Unlike the VEC under went apoptosis 
procedure in the normal repair process. Swollen but viable EC could simply detach 
itself from the surface and escape into the space. It was assumed the basement 
membrane was also damaged as many were seen either thickened or in double layers 
with gaps in between them. The fate of these escaping VEC from the endothelium 
remained a mystery. A few VIC were spotted squeezing through the basement 
membrane towards the surface. It is conceivable they were also part of the repair 
process, but to what extent still needs to be elucidated. Cell macerated connective 
tissue skeleton of diseased revealed void holes on the surface that could well 
facilitate VIC migration. It is now believed that there is a reservoir of stem cells in 
mitral valve that could participate in repair. Stem cell trans-differentiate into EC and 
improve heart function was demonstrated in canine ischemic model105. The 
biochemical changes in VEC and VIC merit further investigation.  
This study investigated gross morphological changes in canine valves. The 
challenge posed in studying the dog is the considerable variation in the size of the 
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mitral valve between different breeds of dogs making comparison of the actual 
dimensions difficult. This problem has been identified by other investigators106. 
Therefore, in the present study relationships were expressed in terms of ratios to 
overcome the disparity in breed sizes106. This also allowed comparison between 
individual samples. By expressing the leaflet length as septal/mural ratio, the leaflets 
themselves acted as their own standard control. What was found was that there was a 
gradual decrease in anterior/posterior leaflet length ratio from normal to severe grade 
3, but no further change at grade 4. The difference was not found to be a statistically 
significant. However, whether elongation or shrinkage in one or both leaflets plays a 
detrimental role in mitral valve redundancy is unproven. Previous reports have 
described the leaflets of MMVD dogs as contracted with a rolled edge border, but 
also point out the possible contribution of stretching of the mitral valve annulus 
associated with left ventricular dilation and stretching of the chordae tendinae to 
distortion of valve geometry1, 2, 4. Increasing in mitral leaflet area has been reported 
in human patients with a floppy valve in combination with MR56, 107-109. 
Previous studies of normal human mitral valves have reported valve leaflet 
lengths that gave anterior/posterior length ratios of 1.71-1.78 for men and 1.75-1.81 
for women11, 110. These ratios are comparable to the ratio of 1.81 noted for normal 
dogs in present study. A review of the literature on this subject is shown in (Table 
2.6).  
Table 2.6. Previous studies investigated the mitral valve leaflets length and their calculated 
septal/mural ratio. 
 Normal mitral valve Diseased mitral valve 
Investigators Year Species Septal Mural Septal/Mural Septal Mural Septal/Mural 





1.75 - - - 





1.83 - - - 







1.67 - - - 
Grande-
Allen111 
2005 Human (37) 2.51 1.64 1.53 3.22 2.31 1.39 
Timek112 2006 Sheep  2.11 1.14 1.85 2.43 1.33 1.83 
 
In human patients with congestive heart failure, Grande-Allen and co-
workers reported much longer valve leaflets (ratio 1.39) than normal controls (ratio 
1.53), and suggested myxomatous degeneration as the best explanation for this 
difference111. This change in ratio is comparable to our findings in the dog. However, 
it is not possible to compare absolute length changes because of the marked disparity 
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in size between different breeds of dogs used in this study. Judging by the 
extrapolated spetal/mural leaflet ratios from two recent studies, seemingly the 
decrease in septal/mural length ratio appeared to correlated with increasing in leaflet 
length. Coupled with the change in connective tissue elements in diseased valves, it 
can be seen how such length changes could contribute to poor leaflet co-aptation and 
mitral regurgitation during ventricular systole. Furthermore, increased leaflet 
extensibility and reduced stiffness has been demonstrated in human myxomatous 
leaflets13, and this has been in conjunction with a change in length ratio and a 
progressive thickening of the leaflet, most noticeable towards the leaflet edge. In 
normal mitral valves the leaflet tapers towards the free edge34. The thickening of the 
leaflets near the free edge apposition is conspicuous in MMVD and MVP and it is 
suspected that repeated trauma at time of closure might be implicated. The 
progressive nature of the disease is manifested in the gradual expansion of the 
spongiosa at distal zone. The thickening noticed in disease is likely to be due to the 
expansion of the loose connective tissue component of the leaflet and increased GAG 
production. Such changes will undoubtedly have profound effects on the mechanical 
competence of the leaflet34. Similar to human mitral valve prolase, the mural leaflet 
in the dogs was found to be more severely affected than the septal, suggesting the 
mural leaflet in dogs would appear to degenerate at a more accelerated rate than 
septal leaflet. Interestingly, current mitral valve surgical repair techniques are 
targeted at the middle scallop of mural leaflets113. Despite obvious changes the 
thickened mitral valve is rarely discussed in the literature107, 111. This is despite the 
principle of Whitney’s classification being based largely on mitral valve thickness2. 
With the advancement of echocardiographic technology, the thickening of leaflets 
has been identified as a ‘classic’ feature in mitral valve prolapse61. The Whitney 
system provides an easy and reliable grading system and when applied to valves 
from different breeds of dog the system remains robust as demonstrated in this study. 
In humans a similar grading system does not exist, and a mixture of clinical terms 
such as mitral prolapse, mitral incompetence, billowing valve are indiscriminately 
intermingled with pathological terms such as mitral redundency and mitral 
fibroelastic deficiency which are used to describe a common pathological 
pathway114.  
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The mechanical properties of the mitral valve leaflets are intrinsically linked 
to the amount of connective tissue, its organisation and orientation. In this study, a 
reduction in connective tissue (collagen mainly being assessed) quantity and density 
was demonstrated. Furthermore, this reduction in connective tissue showed a close 
relationship with disease progression. Previously, x-ray diffraction studies have 
shown loss of collagen in visibly diseased area of canine valves, changes in fibril 
alignment and total tissue volume35. Importantly, in the visibly normal areas of 
diseased leaflets, which often co-exist in close proximity to diseased areas, such 
changes are not identified.  
While using x-ray diffraction has not yet investigated the changes in 
connective tissue across all grades of disease, the current study has shown that this 
does indeed occur. There are conflicting reports on changes in collagen content in 
human MMVD. Using image analysis of histological stained sections, collagen 
content decreases with age in normal humans with a concomitant increase in GAGs, 
but biochemical analysis has also shown an increase, no change and a decrease 
(chordal collagen)77-79, 115, 116. The difficulty in interpreting these data includes the 
problem of disease identity (many patients had rheumatic heart disease), the co-
existence of areas of fibrosis, which is seen in discreet areas in canine MMVD, and 
the measurement of collagen in the entire valve as opposed to distinctly diseased 
areas. The cell macerated connective tissue skeleton technique used in the current 
study has shown discreet areas of compressed collagen fibrils near the myxomatous 
area. X-ray diffraction has previously demonstrated the patchy distribution of 
collagen loss in canine MMVD and it is likely that the same loss can be seen using 
image analysis of histologically stained canine and human (age-related) mitral 
valves79. The reported increase collagen in human valves may represent the 
consequence of reactive fibrosis or increased collagen production in the valve mid 
and basal zones in response to the mechanical failure of the valve. It would have 
been interesting to quantify changes in elastin content, but this was not possible 
using image analysis as elastin staining was diffused. There was an impression in 
some diseased valves of an increase in elastin, but this change was variable and 
inconsistent. While elastin makes up a small component of the total connective tissue 
content of the valve leaflets, its mechanical strength and deformability may give it a 
role in valve mechanics disproportionate to the quantity in a leaflet. An increase in 
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elastic fibres has been reported in human myxomatous mitral valves, but the fibres 
are thinner than normal, arranged into more distinct bundles, and the bundles are 
more widely separated than in normal leaflets117. 
The destruction and fragmentation of collagen as seen in the connective 
tissue as the disease progresses was particularly striking. The crevasses and cracks 
observed in collagen rich fibrosa were probably a consequence of the harsh 
treatments during SEM sample preparations. The tissues were macerated in a strong 
10% w/v NaOH, solution, the equivalent of 2.5M NaOH for a considerable period of 
time. Afterwards, the tissue went through a thorough a dehydration process of 
ascending concentrations of ethanol and then acetone. Nevertheless, the appearance 
of crevasses and cracks can be regarded as a sign of weakening of the structural 
protein collagen. It was known from the TEM studies that the collagen fibres in 
diseased valves are loosely packed and disorganised, and hence it can be presumed 
tensile strength was compromised. It was also observed at high power TEM that the 
collagen was associated with proteoglycans in abundance in the diseased valves. 
Myxomatous leaflets have been shown to have more water content and higher GAG 
concentration than normal118. Proteoglycans are complex macromolecules, which 
consist of specialized polysaccharide chains called glycosaminoglycans linked to a 
core protein via a covalent linkage.  Proteoglycan is extremely hydrophilic and has 
strong tendency to bind to water. With associated water molecules, these components 
of the extracellular matrix tend to occupy large volumes called domains119. This in 
part explains the increase in distance of the collagen inter-fibril space observed in 
diseased valves. Once water was extracted from the tissue, the spaces once occupied 
by water turned into voids and crack formation occurs along weak points of the 
tissue. The lobe-like configurations of the masses observed in the distal zone of 
diseased under SEM resemble the myxomatous areas viewed under light microscope. 
The vein like crack patterns in the lobes match the whirl arrangement of cells in the 
myxomatous area.   
Collagen and elastin are the most important structural connective tissue 
proteins in the mitral valve. During synthesis and subsequent assembly, collagen and 
elastin are acted upon by lysyl oxidase, an enzyme that converts the amine side chain 
of lysine and hydroxylysine residues into an aldehyde for subsequent self cross-
linking. In collagen, the telopeptide regions are the established sites of aldehyde 
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formation for self cross-linking. The chemistry of this type of self-cross-linking is 
complex and not fully understood although it is known that lysyl oxidase catalyses 
the formation of hydroxy-pyridinium cross-links in collagen and desmosine and 
isodesmosine in elastin120, 121. Mutation in genes coding for collagen I, III and V was 
not associated with human MVP in segregation analysis122. The loose collage 
arrangement together with disappearance of the trabeculated connective tissue 
network thus might point to a down stream deficiency in collagen assembly.  
Mitral valve disease has serious cardiovascular consequences. The current 
treatment regimes in human medicine involve surgical repair or at the severe case 
valve replacement. Unfortunately, even the latest generation of bioprosthetic valves 
has a major drawback. The bioprosthetic valve tissue undergoes structural 
degeneration after implantation in the human heart due to calcification process. The 
cells in bioprosthetic valve tissue are rendered non-viable by chemical fixation are 
unable to promote growth and tissue modeling123. Advancement in tissue engineering 
has presented new hope in valve therapy. The cell-macerated connective tissue 
skeleton provided an incredibly useful insight into the architecture of mitral valve, 
the complicated splendor of the structure projected a blueprint for the frontier in 
bioengineered valve that will be bioactive to promote cell growth and tissue 
modeling. 
Reduction in connective tissue density in myxomatous mitral valve disease is 
known to coincide with increased expression of GAGs77, 116-118. The relative 
proportions of the different GAGs also changes with age in normal human subjects25, 
79. This was subjectively and clearly apparent using Alcian blue staining in the dog, 
but image analysis was not able to confirm or quantify this finding. The outcome of 
the results using the four different colour measuring methods to detect the blue 
staining of GAG was surprising, none of the colour measuring techniques applied 
was able to detect a significant difference in blue staining comparing normal and 
different grade of the diseased valves. This finding was not anticipated. This 
represents a shortcoming of image analysis in colour measurement. The images 
underwent analysis as 8-bit per channel RGB images such that in any picture the blue 
component consisted of 28=256 possible shades of blue. In any of the colour 
measuring techniques used, the colour thresholds covered a wide range of the blue 
spectrum and all pixels considered blue were taken into account and contributed, 
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irrespective of their corresponding greyscale values, to the total estimation of GAG 
content. This means that even the light shade of blue throughout the normal valve 
leaflet occupies more or less the same percentage area as the diseased valves making 
differences between valves indistinguishable. One other possible explanation is that 
different dyes were used in Alcian Blue staining. Histological stains behave as 
"subtractive" colours and it was very likely that they colocalised in some places. 
Although different structures were visualized as having different colours, they might 
actually have complex overlapping absorption spectra. When perceived colour was 
to be separated, the quantification of each stain component could not be determined 
at any single wavelength because the optical density at such wavelength was 
determined by the combination of different stains. 
GAGs are an important component of the ECM and while their role in the 
ECM appears complex it is also not completely understood. In human MVP there is 
an alteration in the respective concentrations of the different GAGs, but the normal 
age-associated change is a confounding factor in interpreting this change76, 79. GAGs 
are necessary for the proper assembly of the ECM and collagen II shows a greater 
level of interaction with GAGs than collagen I in human leaflets124. GAGs also 
interact with other important structural proteins such as fibronectin and laminin and 
may have a role to play in the interaction between VICs and the ECM. They also 
have a role in elastin fibrogenesis.37 Hyaluronic acid is the most abundant GAG in 
mitral valves, but other proteoglycans, particularly the small leucine-rich 
proteoglycans (SLRP), may have an equally important role in maintaining a healthy 
ECM125. There is increased expression of the SLRP decorin in human myxomatous 
leaflets.  The accumulation of GAGs in MMVD and MVP is a major contributor to 
valve thickening and undoubtedly contributes to the mechanical failure of the 
valve117. 
In conclusion, this study has quantified morphological changes in canine 
myxomatous mitral valve disease and recognised changes in leaflets associated with 
disease progression. Since disease grade in the dog roughly approximates to the 
duration of disease, it can be readily appreciated that connective tissue changes are 
progressive over time. For cell density, there is a reduction in myxomatous diseased 
areas compared to analogous loose connective tissue areas of normal valves, but 
cellularity then remains constant throughout the time course of the disease. 
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Denudation of endothelium in concomitant with destruction of collagen and 
increasing ECM in the presence of congregation of VICs near the surface is 
associated with MMVD.  
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3 Chapter 3 Immunohistochemistry and 
immunophenotyping of myxomatous mitral valve 
disease in the dog 
 
3.1 Introduction 
Myxomatous mitral valve disease is the single most common acquired 
cardiovascular disease of dogs and is a major cause of morbidity and early death in 
this species53, 81. The disease is of substantial veterinary importance but is also of 
comparative interest as bears close similarity to mitral valve prolapse in humans4, 71. 
The underlying cause of this degenerative process is unknown but appears to be 
associated with phenotypic alteration in the valvular interstitial cell population26, 27, 
43.  Previous studies suggested that this phenotypic alteration is crucial to the 
development of myxomatous degeneration, accompanied by alteration to the valve 
endocardial endothelium29, 32. With respect to the valvular interstitial cell population, 
transformation from an inactive fibroblast phenotype to a more active myofibroblast 
has been documented for dogs43 and human27. This is suspected to result in a 
derangement of dynamic valve matrix remodeling, which may be the result of over 
expression of a range of matrix metalloproteinases (MMPs) and other catabolic 
enzymes27, 82.  
To date, the only data illustrating valvular interstitial cell phenotypic 
alteration in dogs with MMVD have been at the ultrastructural level and this has 
been found only in small localized, obviously diseased areas of affected valve 
leaflets43. This is also the case in humans with MMVD, where no data exist on 
regional development of pathologic changes. The purpose of this study was to map 
the cellular distribution and phenotypic alteration of the predominant cell population 
throughout the entire valve length of dogs with MMVD. In addition, the role of 
MMPs in matrix remodeling during the disease process was explored. These were 
achieved by use of histological and immunohistochemical techniques to identify 
phenotype on the basis of expression of standard cell and protein markers. 
Furthermore, the relationship between disease severity, cell distribution and cell 
immuno-phenotype was also investigated.  
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3.2 Materials and Methods  
3.2.1 Mitral valve procurement 
As described in Chapter 2.2.1. 
3.2.2 Tissue dissection 
As described in Chapter 2.2.2. 
3.2.3 Immunohistochemistry 
In order to distinguish valvular interstitial cells phenotypes and extracellular 
structure changes, the following primary antibodies were used (Table 3.1. Antibodies 
were used at the manufacturer’s recommended concentration, or at concentrations 
previously published.  
Table 3.1. Details of antibodies used. 
Antibody Clone Cat. No. Specie Raised Manufacturer 
Vimentin V9 V 6630 Monoclonal Mouse Euro/DPC, Llanberis, UK 
α-Smooth muscle actin 1A4 A 2547 Monoclonal Mouse Sigma, Missouri, USA 
Smooth muscle myosin HSM-V M 7786 Monoclonal Mouse Sigma, Missouri, USA 
Desmin DE-U-10 D 1033 Monoclonal Mouse Sigma, Missouri, USA 
Fibrillin 11C1.3 MAB1919 Monoclonal Mouse Chemicon, Watford, UK 
CD34126 1H6 MCA2411 Monoclonal Mouse AbD Serotec, Oxford, UK 
Von Willebrand Factor  A0082 Polyclonal Rabbit DakoCytomation, Denmark 
MMP-2127 8B4 IM83T Monoclonal Mouse Calbiochem/Merck, USA 
MMP-9128 56-2A4 IM37T Monoclonal Mouse Calbiochem/Merck, USA 
MMP-13 VIIIA2 IM78T Monoclonal Mouse Calbiochem/Merck, USA 
Fibronectin IST-3 F 0791 Monoclonal Mouse Sigma, Missouri, USA 
Myeloid/Histocyte129 MAC387 M0747 Monoclonal Mouse DakoCytomation, Denmark 
IgG1κ  M 9269 Monoclonal Mouse Sigma, Missouri, USA 
IgG2a,κ  M 9144 Monoclonal Mouse Sigma, Missouri, USA 
 
Tissue sections were dewaxed in xylene and rehydrated through descending 
concentrations of ethanol. Antigen retrieval was carried out where necessary either 
by heating in 0.01M citric acid pH 6.0 (Fisher Scientific, UK) or 10mM Tris buffer 
(Sigma, Dorset, UK) with 1mM EDTA (Sigma, Dorset, UK) pH 9.0 by 
microwave130-132. Sections were treated with 1% hydrogen peroxide (Sigma, Dorset, 
UK) in PBS for 10 min to inhibit endogenous peroxidase activity.  Antibody 
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detection procedures were performed in a Sequenza immunostaining centre (Thermo 
Shandon, Runcorn, UK). Tissue sections were first incubated with primary 
antibodies diluted in PBS contained 0.5% Tween 80 (Fisher, Leicestershire, UK) and 
10% species appropriate normal sera (Sigma, Dorset, UK); this was followed by 
incubation with biotinylated secondary antibodies (Vector Laboratories, USA) 
against mouse IgG. An avidin biotin peroxidase system was used according to 
manufacturer’s recommendation (ABC kit, Vector Laboratories, Peterborough, UK). 
Diaminobenzidine (DAB kit, Vector Laboratories, Peterborough, UK) were added as 
colour identification substrates for the peroxidase. In some cases, nickel chloride 
enhancement was employed in the diaminobenzidine step. Finally, sections were 
lightly counter stained with Mayer’s hematoxylin (Sigma, Dorset, UK), dehydrated 
through ascending concentrations of ethanol, cleared in xylene and mounted on 
slides in DPX (Fisher, Leicestershire, UK). Histological section from canine lung 
tissue served as positive control for the identification of fibroblasts, smooth muscle 
cells, macrophages and MMPs. Bone marrow was used as positive control for 
CD34+. Immunoglobulin isomers IgG1κ and IgG2a,κ were substituted for primary 
antibody and applied as negative controls. For the identification of mast cells, 
sections were stained with acidic toluidine blue and counter stained with eosin 
orange.  
The slides were viewed under an Olympus BH-2 light microscope (Olympus 
Optical Co., London, UK). Positive cell identifications were based on cross-reference 
to corresponding negative control (IgG1κ and IgG2a,κ) slides and positive control 
slides. For morphological analysis of immunohistochemistry slides, a semi-
quantitative scoring system was developed to assess the degree of antigen-antibody 
reaction. Score were defined as 0 absent, 1=weak (less than 33% of cells), 
2=moderate (between 33% to 67% of cells) and 3=strong (greater than 67% of cells). 
A score was given in best estimation to each of the atrialis, spongiosa and fibrosa 
layers at base, middle and distal third of the leaflets (Figure 3.1). In addition, the 
prominent distribution patterns of the positive cells were described in each layer of 
the three zones. The scores and distribution patterns were entered into a custom 
designed FileMaker Pro 6 (FileMaker Inc., CA, USA) data bank. Similarly, a semi-
quantitative scoring scheme was applied to antigens staining for extracellular matrix 
proteins, 0=absent, 1=weak, 2=moderate and 3=strong. Since each zone and each 
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layer could have a maximal score of 3, the combined score for a layer or zone could 
have a maximal score of 9. A scoring system was also applied to assess the number 
of fat cells in each zone of a leaflet using of a lens graticule. The number of fat cells 
as compared with the surface-to-surface thickness of the leaflet, where 0=absent, 
1=mild (up to 15% thickness), 2=moderate (15%-30% thickness) and 3=strong (over 
30% thickness). Only a small number of cells stained positive for CD34, MAC387 
and toluidine blue, consequently the total number of cells could be counted 
accurately employing an eyepiece reticle and a manual cell counter. For all of the 
above, comparisons of total number of positive cells were made between grades.  
 
Figure 3.1. A schematic diagram shows a mitral valve leaflet divided into three zones basal, mid and 
distal and three layers atrialis, spongiosa and fibrosa for immunohistochemistry scoring. 
The distribution patterns and morphologies of the positive cells were 
recorded in a table of hierarchical order. 
The descriptors adapted to depict the distribution pattern were:   
Pattern Definition 
Sparse cells to cells distance were uniform and cells were evenly distributed 
Cluster conglomerates of cells with minimum cells to cell distances 
Whorl cells forming concentric circles 
Layered cells aligning to each other 
 
The common morphological features of von Willebrand factor positive 
endothelial cell shapes and the endothelial cell lining were described thereof: 
 




Endothelial cell lining 
Attaching endothelial cell lining is fasten on the valve surface. 
Detaching small intermitted gaps between endothelial cell lining and valve 
surface. 
Lifting a defined void space between endothelial cell lining and valve 
surface. 
Separating endothelial cell lining is totally disconnected from valve surface, 
often the endothelial cell lining is broken up. 
  
3.2.4 Statistical analysis 





In mitral valves of clinically normal dogs, the immunostaining for vimentin 
was extensive. The vimentin positive cells were visible in all layers, being distributed 
evenly throughout both septal and mural leaflets. The cardiomyocytes at the basal 
zone spongiosa layer did not show any reactivity, but a few positive cells were found 
between muscle bundles. The fat cells in the spongiosa layer were weakly positive. 
Although the greatest density of vimentin positive cells was in the mid zone of septal 
leaflet (score 7 out of 9) and distal zone of mural leaflet (7.5 out of 9) (Figure 3.2), 
fewer positive cells were seen in the fibrosa layer. Vimentin positive cells were in 
close alignment with the direction of the collagen bundles in the fibrosa layer and 
were elongated and spindle shaped, whereas vimentin negative cells were more 
rounded. In the septal leaflet, the density of positive cells in the fibrosa layer 
increased from mid to distal zone, whereas the proportion of positive cells in the 
atrialis layer remained the same. On the other hand, densities of vimentin positive 
cells in distal zone were higher than the mid zone in all three layers. The most 
commonly observed vimentin positive cells were oval or spindle shaped and 
distributed throughout the tissue. 
 
Figure 3.2. Vimentin staining in normal valve 
distal zone. The vimentin positive cells are more 
elongated in shape. Bar = 10 µm. 
 
Figure 3.3. Veimentin positive cells are  
associated with connective tissue and vimentin 
negative cells are associated with myxomatous 
tissue. Bar = 10 µm. 
 
In mitral valve leaflets of dogs with MMVD, immunostaining for vimentin 
was still substantial, but a recognizable decrease in vimentin positive cell density 
was found with increasing disease severity (Figure 3.3). This reduction was gradual 
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and proportional in all layers in all zones, but somewhat more so in the atrialis and 
spongiosa layers. The densities of vimentin positive cells were closely matched 
between septal and mural leaflet in each grade of disease. The rate of reduction in 
vimentin positive cells was similar between septal and mural leaflets, with a 
approximately10~15% reduction in vimentin positive cells in each zone from one to 
the next lesion grade (Figure 3.4 and Figure 3.5). The distribution pattern of positive 
cells was a predominantly sparse arrangement. As the disease progressed a more 
clustered and layered pattern emerged in the mid and distal zones and whorl like 
distribution appearing in the distal zone (Table 3.2 and Table 3.3). 
Within the connective tissue in the atrialis and ventricularis layers, some 
vimentin positive cells were slightly flattened. However, in the myxomatous regions 
of the valve, elongated spindle shaped vimentin positive cells predominated. Yet, 
oval or more rounded shaped positive cells could also be seen adjacent to the 
myxomatous area in the distal zone of the diseased valves. In the severe form of the 
disease, little evidence of vimentin positive cells was observed in myxomatous areas 
















Figure 3.4. Vimentin scores in septal leaflets. Three different columns represent the three zones and 
three different colours represent the three layers. Each zone and each layer could have a maximal 








Figure 3.5. Vimentin scores in mural leaflets. Three different columns represent the three zones and 
three different colours represent the three layers. Each zone and each layer could have a maximal 
score of 3, the combined score for a layer or zone could have a maximal score of 9. 
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Table 3.2. Vimentin positive cell distribution patterns in septal leaflets. They are presented in a 
hierarchal order. The most frequently occurring distribution pattern is at the top of each block. 
Grade 0 Septal Basal Mid Distal 





















Fibrosa Sparse Sparse Cluster=Sparse 
 














































Spongiosa Cluster=Sparse Layered=Sparse Whorl 
Sparse 













Table 3.3. Vimentin positive cell distribution patterns in mural leaflets. They are presented in a 
hierarchal order. The most frequently occurring distribution pattern is at the top of each block. 










































































Grade 4 Mural Basal Mid Distal 
Atrialis Sparse Sparse Sparse 
Layered 















Table 3.4. Vimentin positive cell morphologies in septal leaflets. They are presented in a hierarchal 
order. The most frequently occurring cell shape is at the top of each block. 



















































































Grade 4 Septal Basal Mid Distal 


















Table 3.5. Vimentin positive cell morpholgies in mural leaflets. They are presented in a hierarchal 
order. The most frequently occurring cell shape is at the top of each block. 
Grade 0 Mural Basal Mid Distal 




Spongiosa Oval Spindle 
Oval 
Spindle=Stellate 










































































Grade 4 Mural Basal Mid Distal 















Regardless the lesion grade, the adipocytes in mitral valve leaflets stained 
moderately positive to vimentin antibody (Figure 3.6). Adipocytes were seen as a 
“signet ring” structure with unilocular of lipid mass in the centre. The cytoplasm was 
pushed to the side forming a thin rim around the lipid. The cytoplasm was the site 
that showed positive staining for vimentin. The nucleus was not always distinct, but 
when visible was flattened and displaced to the edge by the lipid mass.  
 
Figure 3.6. The adipocytes are moderately positive to vimentin. Bar = 10 µm. 
 
There were no major differences in fat content between normal and varying 
grades of the disease, in either septal or mural leaflets. However, the difference in fat 
content between septal and mural leaflets within the same valve was marked (Figure 
3.7). In the septal leaflets, the fat accounted for about a third of the basal zone and 
about a quarter of the leaflet thickness in the mid zone, except the Grade 4 diseased 
which contained less fat. Only half of the fat content was found at corresponding 
zones in the mural leaflets. In both septal and mural leaflets, the adipocyte layer was 
apposed to the muscle at the base and extended towards the spongiosa layer in the 
mid zone, but adipocytes were rarely found in the distal zone. Due to the higher fat 
content in the septal leaflets, the adipocytes conformed into a defined layered 
structure (Table 3.6). The adipocytes were pushed against each other in the fat layer 
and seemed to form a mosaic of polygonal cells instead of the usual round or oval 
shape. In the mural leaflets, the distribution of the adipocytes was sparse by 









Figure 3.7. Fat score in septal and mural leaflets. Three different columns represent the three zones. 
Each zone could have a maximal score of 3,  
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Table 3.6. Adipocyte distribution patterns in septal leaflets. They are presented in a hierarchal order. 
The most frequently occurring distribution pattern is at the top of each block. 
 Basal Mid Distal 




 Basal Mid Distal 







 Basal Mid Distal 







 Basal Mid Distal 







 Basal Mid Distal 




Table 3.7. Adipocyte distribution patterns in mural leaflets. They are presented in a hierarchal order. 
The most frequently occurring distribution pattern is at the top of each block. 
 Basal Mid Distal 
Grade 0 Mural Sparse Cluster=Sparse - 
 
 Basal Mid Distal 






 Basal Mid Distal 






 Basal Mid Distal 







 Basal Mid Distal 
Grade 4 Mural Cluster=Sparse Cluster=Sparse Cluster 
 
3.3.3 α-Smooth muscle actin (α-SMA) 
Immunostaining for α-SMA was sparse in mitral valve leaflets from 
clinically normal dogs. In both septal and mural leaflets, among the α-SMA positive 
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cells, larger numbers were located in the atrialis layer just beneath the endothelium, 
and to a lesser extent in the basal zone of the fibrosa side. α-SMA was differentially 
expressed in cardiomyocytes at the base of leaflets and displayed a filamentous 
appearance. Some small arterioles with or without patent intima were α-SMA 
positive, showing they are vascular smooth muscle cells. Occasionally, a few 
protruding cells from the endothelial lining were found to be α-SMA positive. 
Although positive cells were quite sparsely distributed in all zones and all layers, 
towards the distal ends the pattern became was more clustered or layered in 
appearance (Table 3.8 and Table 3.9). The cells were predominantly oval or spindle 
shaped (Table 3.10 and Table 3.11). 
 
Figure 3.8. α-SMA positive cells in layered 
formation near the endothelium. Bar = 50 µm. 
 
Figure 3.9. A cluster of α-SMA positive cells 
associated with connective tissue. Bar = 10 µm. 
 
In mitral valve leaflets of dogs with MMVD, the number of α-SMA positive 
cells increased with an increase in disease severity. The variations in densities of α-
SMA positive cells were closely matched between septal and mural leaflet in each 
grade. The cardiomyocytes in the base were still differentially positive for α-SMA. 
In Grade 1 diseased valves, α-SMA positive cells were seen under eroded 
endothelium of the atrialis layer. Towards the distal end, α-SMA positive cells were 
in juxtaposition with negative cells in the newly developed areas of metaplasia, often 
in a cluster or layered fashion. Many of the α-SMA positive cells were spindle 
shaped that resembled the morphology of fibroblasts. In Grade 2 diseased valves, 
there was a distinct increase in positive cells along the atrialis layers. Aggregations 
of α-SMA positive cells were found lying underneath the thickened endothelium 
(Figure 3.8). The positive cells were closely associated with dense fibrous connective 
tissue. In Grade 3 diseased, an increase in the density of α-SMA positive cells in the 
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distal zone was more apparent, especially in the fibrosa layer. Clusters of α-SMA 
positive cells were found underneath detached endothelium. However, the cells in 
the overtly myxomatous area were not readily identified to be α-SMA positive. In 
Grade 4 diseased, an increase in α-SMA positive cells was notable in the mid zone, 
with the ventricularis side having a higher concentration of cells (Figure 3.10 and 
Figure 3.11). Positive cells were embedded in the dense fibrosa connective tissue and 
were absent from the distinct myxomatous areas (Figure 3.9). Little change in cell 
morphology comparing normal to the varying grades of diseases was noted and a 


























Figure 3.10. α-Smooth muscle actin scores in septal leaflets. Three different columns represent the 
three zones and three different colours represent the three layers. Each zone and each layer could 







Figure 3.11. α-Smooth muscle actin scores in mural leaflets. Three different columns represent the 
three zones and three different colours represent the three layers. Each zone and each layer could 
have a maximal score of 3, the combined score for a layer or zone could have a maximal score of 9. 
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Table 3.8. α-Smooth muscle actin positive cell distribution patterns in septal leaflets. They are 
presented in a hierarchal order. The most frequently occurring distribution pattern is at the top of each 
block. 
Grade 0 Septal Basal Mid Distal 

























































Grade 4 Septal Basal Mid Distal 

















Table 3.9. α-Smooth muscle actin positive cell distribution patterns in mural leaflets. They are 
presented in a hierarchal order. The most frequently occurring distribution pattern is at the top of each 
block. 
Grade 0 Mural Basal Mid Distal 
Atrialis Sparse Cluster 
Layered 
Cluster 
Spongiosa Muscle Sparse - 
Fibrosa Sparse Sparse Cluster 
 







































































Table 3.10. α-Smooth muscle actin positive cell morpholgies in septal leaflets. They are presented in a 
hierarchal order. The most frequently occurring shape is at the top of each block. 
Grade 0 Septal Basal Mid Distal 






Fibrosa Spindle Oval Oval 
 






























Fibrosa Oval=Round=Spindle Oval Oval 
 











































Table 3.11. α-Smooth muscle actin positive cell morpholgies in mural leaflets. They are presented in a 
hierarchal order. The most frequently occurring cell shape is at the top of each block. 
Grade 0 Mural Basal Mid Distal 




Fibrosa Round=Spindle Oval=Stellate Spindle 
 
Grade 1 Mural Basal Mid Distal 
























Fibrosa Round=Oval=Spindle Round Oval 
Flat=Round 
 







































In mitral valve leaflets from clinically normal dogs, the immunostaining for 
desmin was almost exclusively associated with cardiac myocytes in the basal zone 
(Figure 3.12). The cardiac myocytes differentially expressing desmin had a distinct 
filamentous banding pattern (Table 3.12 and Table 3.13). The spindle shaped 
fibroblast like cells located between the cardiac myocytes were desmin negative 
(Table 3.14 and Table 3.15). In the mid zone, a few desmin positive cells were 
sparsely scattered among fat cells. Occasionally, clusters of spindle shaped desmin 
positive cells were located between atrialis and spongiosa layers in the mural leaflet. 
Positive cells were rare in the distal zone.  
 
Figure 3.12. Desmin positive cardic myocyte 
shows filamentous banding. Bar = 10 µm. 
 
Figure 3.13. Desmin positive chondrocytes in the 
fibrosa layer. Bar = 10 µm. 
 
There was no apparent change in the density of desmin positive cells between 
varying grades of disease and in the diseased valve the desmin positive cells were 
still predominantly associated with cardiac myocytes in the basal zone spongiosa 
layer. Overall, the desmin positive cells were rare in the distal zone of the diseased 
leaflets. A slight but almost negligible increase in positive cells occurred in the 
atrialis layer (Figure 3.14 and Figure 3.15). However, a few clusters of positive cells 
were observed in the possible mid point stress zone on the atrialis layer, the location 
coinciding with α-SMA positive cells in connective tissue. Cells that were 
suggestive of cartilage metaplasia were desmin positive. These cells were 
conspicuous, often arranged in a row with a distinct morphology of intense desmin 
staining in the centre and a diffusely speckled staining towards the periphery of the 








Figure 3.14. Desmin scores in septal leaflets. Three different columns represent the three zones and 
three different colours represent the three layers. Each zone and each layer could have a maximal 







Figure 3.15. Desmin scores in mural leaflets. Three different columns represent the three zones and 
three different colours represent the three layers. Each zone and each layer could have a maximal 
score of 3, the combined score for a layer or zone could have a maximal score of 9. 
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Table 3.12. Desmin positive cell distribution patterns in septal leaflets. They are presented in a 
hierarchal order. The most frequently occurring distribution pattern is at the top of each block.  
Grade 0 Septal Basal Mid Distal 






Fibrosa Sparse -  
 
Grade 1 Septal Basal Mid Distal 









Fibrosa Sparse Sparse Cluster 
 











Fibrosa - Sparse Sparse 
 

















Grade 4 Septal Basal Mid Distal 






















Table 3.13. Desmin positive cell distribution patterns in mural leaflets. They are presented in a 
hierarchal order. The most frequently occurring distribution pattern is at the top of each block. 
Grade 0 Mural Basal Mid Distal 






Fibrosa Sparse - - 
 












Fibrosa Layered Sparse Sparse 
 
Grade 2 Mural Basal Mid Distal 






Fibrosa - - - 
 













Fibrosa Cluster Sparse Sparse 
 
Grade 4 Mural Basal Mid Distal 



















Table 3.14. Desmin positive cell morpholgies in septal leaflets. They are presented in a hierarchal 
order. The most frequently occurring cell shape is at the top of each block.  
Grade 0 Septal Basal Mid Distal 






Fibrosa Spindle - - 
 
Grade 1 Septal Basal Mid Distal 








Fibrosa Oval=Spindle Sparse Round 
 
Grade 2 Septal Basal Mid Distal 








Fibrosa - Sparse Round 
 














Grade 4 Septal Basal Mid Distal 


















Table 3.15. Desmin positive cell morpholgies in mural leaflets. They are presented in a hierarchal 
order. The most frequently occurring cell shape is at the top of each block. 
Grade 0 Mural Basal Mid Distal 






Fibrosa Oval - - 
 














Fibrosa Round Sparse Oval 
 
Grade 2 Mural Basal Mid Distal 




Fibrosa - - - 
 












Fibrosa Spindle Sparse Spindle 
 
Grade 4 Mural Basal Mid Distal 
Atrialis Oval Oval=Round - 
Spongiosa Oval Oval 
Spindle 
- 













3.3.5 Smooth muscle myosin 
Smooth muscle myosin positive cells in mitral valve leaflets from clinically 
normal dogs were rare and the positive cells were exclusively associated with 
arteriole walls in the basal zone spongiosa layer (Figure 3.16). In one rare case, a 
small number of positive cells were located near the atrialis surface in the mid zone 
of a septal leaflet. 
 
Figure 3.16. Microphotograph showing the 
arteriole wall stained positive for smooth muscle 
myosin. Bar = 10 µm. 
 
Figure 3.17. Microphotograph showing a vessel 
wall stained positive for smooth muscle myosin. 
Bar = 10 µm. 
 
There were no apparent changes in the density of smooth muscle myosin 
positive cells between normal and varying grades of diseased. In mitral valve leaflets 
with MMVD, smooth muscle myosin positive cells were closely associated with 
arteriole walls in the spongiosa layer, mostly situated in the basal zone. On rare 
occasions, small clusters of myosin positive cells were found possibly involved in 













Figure 3.18. Smooth muscle myosin score in septal leaflets. Three different columns represent the 
three zones and three different colours represent the three layers. Each zone and each layer could 







Figure 3.19. Smooth muscle myosin score in mural leaflets. Three different columns represent the 
three zones and three different colours represent the three layers. Each zone and each layer could 
have a maximal score of 3, the combined score for a layer or zone could have a maximal score of 9. 
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3.3.6 Fibrillin 
The amount of fibrillin detected in the mitral valve leaflets from clinical 
normal dogs was limited. In both septal and mural leaflets, immunostaining for 
fibrillin was predominantly found under the endothelial lining and trace amounts of 
fribrillin fanning out through the extracellular fibril in the atrialis layer. 
Occasionally, some cells and their immediate periphery were seen to be fibrillin 
positive. The fibrillin score in Grade 1 diseased was comparable to the normal, but as 
the disease progressed, there was a decrease in fibrillin staining (Figure 3.20). In the 
mitral valve leaflets of dogs with MMVD, weak fibrillin staining was found in the 





















Figure 3.20. Fibrillin scores in septal and mural leaflets. Three different columns represent the three 
zones and three different colours represent the three layers. Each zone and each layer could have a 
maximal score of 3, the combined score for a layer or zone could have a maximal score of 9. 
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3.3.7 MMP-2 
No staining for MMP-2 was detected in any of the sample slides. 
3.3.8 MMP-9 
In mitral valve leaflets from Grade 0 clinically normal dogs, trace amount of 
MMP-9 expression was found restricted to the luminal side of arterioles located near 
cardiomyocytes at the basal zone. Due to the small number of arterioles found in the 
valve and the space only occupy in leaflet, the level of MMP-9 staining could be 
regarded as negligible in most cases. As the disease progressed, MMP-9 was 
detected in the mid zone of Grade 1 valves. Slight elevation in MMP-9 expression 
was noted in Grade 2 diseased valves and the staining extended to the distal zone, but 
was predominantly seen in the spongiosa layer. No further elevation of MMP-9 was 
found in Grade 3 diseased valves. In Grade 4 diseased, although the MMP-9 level 
was still low, the expression spread to atrialis and fibrosa layers (Figure 3.23). In the 
diseased valves, MMP-9 expression was seen as a diffused form in the para-lumenal 
of vessels. The endothelial cells expressing MMP-9 in the para-lumen were swollen 
compared to MMP-9 negative cells (Figure 3.21). Occasionally, MMP-9 expression 
was seen in the tight intercellular space of a series fusiform cells lining up in a row 
(Figure 3.22). However, at no time was MMP-9 expression associated with 
myxomatous areas.  
 
Figure 3.21. Endothelial cells lining the vessel and 
the para-lumin space are positive for MMP-9. Bar 
= 10 µm. 
 
Figure 3.22. The intercellular space near the polar 










Figure 3.23. MMP-9 scores in septal and mural leaflets. Three different columns represent the three 
zones and three different colours represent the three layers. Each zone and each layer could have a 
maximal score of 3, the combined score for a layer or zone could have a maximal score of 9. 
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3.3.9 MMP-13 
The immuno reactivity for MMP-13 was limited in mitral valve leaflets from 
clinically normal dogs. In both septal and mural leaflets weak immunostaining was 
confined to certain sub-endothelial space predominantly in the mid zone towards the 
atrialis surface (Figure 3.24). The MMP-13 positive areas appeared focalised.  
 
Figure 3.24. MMP-13 positive in sub-endothelial 
space. Bar = 10 µm. 
 
Figure 3.25. MMP-13 positive area associated 
with a nodule. Bar = 10 µm. 
 
In diseased mitral valve leaflets, MMP-13 reactivity was exclusively 
associated with the damaged endothelium. More intense immunostaining for MMP-
13 was found underneath the endothelial basement membrane (Figure 3.25). As the 
disease progressed, the MMP-13 expression was slightly increased and extended into 
the areas of metaplasia beneath the damaged endothelium in distal zone (Figure 
3.26). Some of the papillary-like nodule outgrowths on the atrialis surface were 
MMP-13 positive and staining seemed closely associated with oval or rounded 












Figure 3.26. MMP-13 scores in septal and mural leaflets. Three different columns represent the three 
zones and three different colours represent the three layers. Each zone and each layer could have a 




Quantifying the amount of fibronectin in leaflets proved difficult, as 
fibronectin appeared as a diffuse background stain. Nickel chloride enhanced 
staining showed the fibronectin as a shade of grey in the background. This meant the 
scoring system could not be applied to measure fibronectin. However, fibronectin 
was seen closely associated with structural connective tissue, but in the overtly 
myxomatous area, there was absence of fibronectin staining. In the areas of 
metaplasia of the diseased valve, intense staining of fibronectin was often observed 
in the presence of α-SMA positive cells. 
3.3.11 Macrophage 
Macrophage (MAC-387 positive cells) numbers in clinically normal dogs 
were low with only a mean of 6 cells/valve and were predominantly found in the 
spongiosa layer at the base. An increase in mean macrophage number of 12 
cells/valve was found in Grade 1 diseased, but the number fell back to 4 cells/valve 
in Grade 2. In the more severe forms of disease, the macrophage numbers were 
markedly increased with a mean of 26 cells/valve in Grade 3 and 27 cells/valve in 
Grade 4. However, the samples showing obvious increased numbers were widely 
distributed within the groups of Grade 3 and 4 diseased valves. The distribution of 
macrophages in later stage disease spread out to the atrialis and fibrosa layers in the 
mid zone. Although no significant difference (p=0.1719) was found on ANOVA, 
Wilcoxon ranked test showed the Chi square was significant at 0.0309. The Student 
t-test also revealed that Grade 2 was statistically different to Grade 3 (Figure 3.29).  
 
Figure 3.27. MAC-387 positive macrophages 
associated with luminal side of a vessel. Bar = 10 
µm. 
 
Figure 3.28. MAC-387 positive macrophages 
associated with tissue. Bar = 10 µm. 
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Macrophages in the mitral valve could be divided into two groups according 
to their locality. Macrophages in the first group were associated with the blood 
vessels, often seen in round shapes sitting in the lumen of the vessels and reacted 
intensively to the MAC-387 antibody (Figure 3.27). The second group of 
macrophages were associated with loose connective tissue. They were more lightly 
stained and more elongated in shape (Figure 3.28). The general impression was that 






























Level   Mean 
3 A   27.125000 
4 A B 25.750000 
1 A B 12.166667 
0 A B 6.100000 




Figure 3.29. Comparison of macrophage number in mitral valve between mitral valve lesion grade. The 
results from ANOVA, Wilcoxon ranked test, Student’s t-test, and LSN are presented. 
Even though the ANOVA analysis of macrophage numbers in septal leaflet 
between grades was not significant (p=0.4104), the Chi square from the Wilcoxon 
ranked test was significant (ChiSq=0.0246). Macrophage numbers were much higher 
in septal leaflets of Grade 3 and 4 valves. There were no significant changes in 






























































Grade  Mean 
4 A 33.250000 
3 A 31.625000 
0 A 6.000000 
1 A 5.333333 




Grade  Mean 
3 A 22.625000 
1 A 19.000000 
4 A 18.250000 
0 A 6.200000 




Figure 3.30. Comparison of macrophage number in septal leaflet (left) and mural leaflet (right) between 
mitral valve lesion grade. The results from ANOVA, Wilcoxon ranked test, Student’s t-test, and LSN are 
presented. 
When the numbers of macrophages in the valves were normalized to leaflet 
area (mm2), the sample distribution within each group was spread out. Outliers in the 
top tail ends were seen in each sample group. Neither ANOVA nor Wilcoxon test 
detected any significant differences, but Grade 4 diseased (2,38 cell/mm2) had the 
highest number of macrophages per area, the mean was different to Grade 2 (0.50 
































Level   Mean 
4 A   2.3840266 
1 A B 1.5766032 
0 A B 1.4445007 
3 A B 1.3566605 




Figure 3.31. Comparison of macrophage number per mm2 area between mitral valve lesion grade. The 
results from ANOVA, Wilcoxon ranked test, Student’s t-test, and LSN are presented. 
In septal leaflets alone, the ANOVA of normalized macrophage numbers to 
area between grades did not achieve a significant statistical difference. The Grade 4 
diseased valves attained the highest value (2.38 cell/mm2) and the mean was 
significantly different to Grade 2 disease (0.27 cell/mm2) using Student t-test. In the 
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mural leaflets the normalized macrophage numbers to area between grades did not 
show a significant difference in either ANOVA or Wilcoxon test. Again, the Grade 4 
attained the highest value (2.38 cell/mm2), but this did not achieve significant 





































































Grade   Mean 
4 A   2.3840878 
3 A B 1.2306042 
1 A B 1.0619045 
0 A B 0.9198065 




Grade  Mean 
4 A 2.3839654 
1 A 2.0913019 
0 A 1.9691949 
3 A 1.4827167 




Figure 3.32. Comparison of macrophage number per area in septal leaflet (left) and mural leaflet (right) 
between mitral valve lesion grade. The results from ANOVA, Wilcoxon ranked test, Student’s t-test, and 
LSN are presented.  
The overall distribution of macrophages was variable and no particular 
pattern was observed. However, the general trend was for a higher distribution in the 
central spongiosa, spreading out towards the atrialis and fibrosa layers as the disease 














Figure 3.33. Distribution of macrophage as a percentage in septal leaflet (left panel) and mural leaflet 
(right panel). Three different columns represent the three zones and three different colours represent 
the three layers. 
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3.3.12 Mast cells 
The mast cell had the appearance of a bright blue colour blob with more 
polygonal outlines. They were often seen sitting alone in the loose connective tissue, 
but occasionally in pairs side by side. Some of the mast cells, as demonstrated by the 
presence of pseudopodia, were in active form. At high magnification, the punctuated 
dense organelles were visible (Figure 3.34). 
 
Figure 3.34. Mast cell with punctuated dense organelles by Toluidine Blue stain. Bar = 10 µm. 
 
The number of mast cells in clinically normal valves was low (4.63 
cell/valve). The mast cell numbers were similar in Grade 1 (4.67 cell/valve) and 
Grade 2 (4.81 cell/valve). An increase in mast cell numbers was found in Grade 3 
(6.60 cell/valve) with a further increase in Grade 4 (8.00 cell/valve). The samples 
were widely distributed in each group of the series. No significant differences were 


























Level  Mean 
4 A 8.0000000 
3 A 6.6000000 
2 A 4.8125000 
1 A 4.6666667 




Figure 3.35. Comparison of mast cell number in mitral valve between mitral valve lesion grade. The 
results from ANOVA, Wilcoxon ranked test, Student’s t-test, and LSN are presented. 
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In the septal leaflets, higher mast cell numbers were found in Grade 3 and 
Grade 4, there was no apparent change in cell number between normal Grade 0 to 
Grade 2, however, the difference was not significant. In the mural leaflets the highest 





















































Level  Mean 
3 A 8.7142857 
4 A 8.0000000 
2 A 5.6250000 
1 A 5.0000000 




Level  Mean 
4 A 8.0000000 
3 A 4.7500000 
1 A 4.3333333 
0 A 4.2500000 




Figure 3.36. Comparison of mast cell number in septal leaflet (left) and mural leaflet (right) between 
mitral valve lesion grade. The results from ANOVA, Wilcoxon ranked test, Student’s t-test, and LSN are 
presented. 
When the number of mast cells was normalized to area, the normal Grade 0 
valve attained the highest cell per area value (1.07 cell/mm2). Although the ANOVA 
showed the difference (p=0.0779) was not significant, on the Student’s t-test, the 
Grade 0 was found to be significantly different to Grade 1 and Grade 2. Still, the 





























Level   Mean 
0 A   1.0721670 
4 A B 0.7099065 
3 A B 0.6656451 
1   B 0.6078668 




Figure 3.37. Comparison of mast cell number per area between mitral valve lesion grade. The results 
from ANOVA, Wilcoxon ranked test, Student’s t-test, and LSN are presented. 
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In the septal leaflets, no significant difference was found in the normalized to 
area mast cell numbers on either ANOVA or Wilcoxon. The Student’s t-test showed 
that the Grade 3 (0.80 cell/mm2) was different to Grade 2 (0.38 cell/mm2). In the 
mural leaflet, again no significant difference was found in ANOVA or Wilcoxon 
when mast cell numbers were normalized to area, but the normal Grade 0 (1.38 
































































Level   Mean 
3 A   0.80283362 
0 A B 0.76135298 
4 A B 0.57547913 
1 A B 0.49896665 




Level   Mean 
0 A   1.3829809 
4 A B 0.8443338 
1 A B 0.7167670 
2   B 0.5785841 




Figure 3.38. Comparison of mast cell number per area in septal leaflet (left) and mural leaflet (right) 
between mitral valve lesion grade. The results from ANOVA, Wilcoxon ranked test, Student’s t-test, and 
LSN are presented. 
In the normal valve, mast cells were predominantly located in the basal zone 
and to a lesser extent in the mid zone. The cells in the basal zone were almost 
entirely associated with the spongiosa layer and this applied to both septal and mural 
leaflets. The general trend during the disease progression was shifting of mast cells 
from base towards the distal zone. However, the majority of the cells were still 










Figure 3.39. Distribution of mast cell as a percentage in septal leaflet (left panel) and mural leaflet (right 
panel). Three different columns represent the three zones and three different colours represent the 
three layers. 
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3.3.13 CD34  
CD34+ cells were found in only 12 of the 31 mitral valves examined. Even in 
valves where CD34+ cells were found they were not necessarily in both septal and 
mural leaflets, and the numbers of positive cells were few. The distribution of 
CD34+ according to lesion grade is shown in Figure 3.40. In both septal and mural 
leaflets of normal Grade 0 valve, only 1 out of 5 were CD34+. The majority of the 
Grade 1 valves were CD34 negative and CD34+ cells were predominately found in 
Grade 2 and Grade 3 valves. No CD34+ cells were observed in any Grade 4 diseased 
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CD34 within Lesion Grade  
Figure 3.40. Number of septal leaflets (left) and mural leaflets (right) found with and without CD34+ 
cells. 
The localisation of CD34+ cells in the valve was uneven. ANOVA of total 
CD34+ cells in the valve comparing between grades showed a significant difference 
(p=0.0240). Grade 3 dogs had the highest number of CD34+ cells and their mean was 
































Level   Mean 
3 A   2.3750000 
0 A B 1.1000000 
2   B 0.5000000 
1   B 0.1666667 




Figure 3.41. Comparison of CD34+ cell number in mitral valve between mitral valve lesion grade. The 
results from ANOVA, Wilcoxon ranked test, Student’s t-test, and LSN are presented. 
In the septal leaflets, ANOVA detected no significant difference between 
grades (p=0.4525) in CD34+ cell numbers, but there was a significant difference in 
mural leaflets (p=0.0034). On the Student’s t-test, the mean of Grade 3 was different 


























































Level  Mean 
3 A 2.5000000 
0 A 2.0000000 
2 A 0.8750000 
1 A 0.3333333 




Level   Mean 
3 A   2.2500000 
0   B 0.2000000 
2   B 0.1250000 
1   B 0.0000000 
4   B 0.0000000  
p=0.0034 
ChiSq=0.0183 
Figure 3.42. Comparison of CD34+ number in septal leaflet (left) and mural leaflet (right) between 
mitral valve lesion grade. The results from ANOVA, Wilcoxon ranked test, Student’s t-test, and LSN are 
presented. 
 
Although the cells were sparse, the CD34+ cells were mainly found in the 
spongiosa layer, notably in the mid zone of the leaflets and to a lesser extent in the 
basal zone. No CD34+ cells were found in the ventricularis layer. Since CD34+ cells 
were not found in all the valves, normalising cell numbers to valve area could not 
yield any useful data.  
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3.3.14 Von Willebrand factor 
The immuno-staining for endothelial specific von Willebrand factor proved 
difficult to assess due to denudation of endothelium. As a result, the semi-
quantitative scoring system used for other immunohistochemical studies was not 
suitable for the complex nature of valve endothelial cell (VEC). The pleomorphic 
features of VEC along the endothelial lining could be clearly seen in all grades of 
mitral valves. Morphological features of VEC and endothelial lining consistently 
observed were listed in Table 3.16. 
Table 3.16. Morphological features of VEC and endothelial lining during the disease progression. 
Lesion Grade Endothelial cell shape Endothelial cell lining 
1 Flat Attaching 
2 Spindle Detaching 
3 Dome Lifting 
4 Round Separating 
 
It appeared the VECs were showing an injury response involving a series of 
transformation steps from a flat to spindle then to dome and finally to round shape. 
However, all the shapes possible for a VEC could be found in one single valve leaflet 
regardless of the lesion grade of the disease. Local variations between different cell 
shapes were evident along the endothelium, but there was a greater propensity for 
round shaped VEC associated with nodules on the atrialis surface of diseased valve. 
The changes in the endothelial lining were linked to the progression of MMVD. 
During the advancement of the disease, the endothelium lining detaching from the 
surface and then lifted, eventually separating from the surface and became free 
floating after losing the VEC.  Two-endothelium damage hotspots were identified, 
located on either side of the distal zone near the free edge. In the severe cases of 
MMVD, the endothelial lining at these points were often obliterated and the area of 
metaplasia could be found underneath. Some of the cells in the dense connective 
tissue area of metaplasia were found to be immuno-reactive to von Willebrand 
Factor. Occasionally, papillary projections tissue out growth at the site of 
endothelium damage was found.  
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3.4 Discussion  
In this study, the cellular profile of the mitral valve in dogs was 
comprehensively mapped, qualitatively illustrated the changes that occur with 
MMVD, and semi-quantitatively determine cellular phenotypic changes. 
Furthermore, this is the first study in which the regional distribution of cell types in 
the mitral valve leaflet of dogs and how it might relate to disease progression has 
been examined. To date, studies in dogs and humans with forms of myxomatous 
degeneration have described cellular changes in localized areas of diseased and have 
not addressed the issue of spatial organization of this change or change with disease 
development. Rabkin et al27 did describe, in a limited fashion, regional distribution 
of cells in myxomatous valve leaflets of humans, with α-SMA positive cells 
localized mainly to the base and mid zones of the atrialis layer. The description of 
the localization of cell types is important in improving understanding of the 
pathological process of this disease, and was strongly emphasized in this study, as 
are changes in cell types, density and distribution with disease progression. In 
addition, this study investigated the roles of certain proteins that have been 
implicated in matrix remodelling in human mitral valve prolapse, but have not yet 
been looked into in any animal models. 
Initial attempts to quantify the immuno staining with computer-assisted 
techniques failed, because top range high-resolution slide scanner was not available 
during the course of this study. The scoring system was developed to assess the 
immuno staining in a semi-quantitative fashion. The immuno score in a particular 
zone or layer did not actually reflect the real number of the positive cells, but a 
relative proportion to the observation area, thus the size variations between samples 
could be eliminated as a variable in this study. In this way the direction of the 
phenotypic changes could be accurately measured. Though the scoring system was 
efficient to assess the immuno staining in most cases, it had limited applications for 
those antigens where staining was sparse and exclusively associated with blood 
vessels. 
The valvular interstitial cell population is recognized as having phenotypic 
plasticity23, 133, in that the cell phenotype can change from a quiescent fibroblast to an 
activated myofibroblast and eventually to a more smooth muscle like cell 
 149 
phenotype26, 43, 133, 134. This cell plasticity seems to be crucial to heart valve 
development, remodelling and repair and in diseased states, the myofibroblast cell 
type predominates27, 134. Vimentin, an intermediate filament constituent of cells from 
mesenchymal origin is widely used for the purpose of immunophenotyping 
interstitial cells135-137, and it is expressed predominantly in mature cells. In mitral 
valves of dogs with MMVD, a mixed population of vimentin positive and vimentin 
negative cells was found, with a gradual reduction in positive cell numbers during 
the disease progression in all zones and layers. This reduction in vimentin positive 
cells agrees with previous reports from the human disease27, but the overall reduction 
in cell density in myxomatous areas does not. The difficulty in comparing this result 
with previous reports is knowing the amount of the valve leaflet that was assessed, 
and either this has not been stated or the amount was small27, 83. In the current study, 
the entire valve length has been assessed for the first time. The nature of MMVD in 
dogs is that the pathologic change is focal in distribution, and varying grades of 
pathologic severity of the disease are described2. A pathologic grading system is 
lacking for the human form of the disease, so it is difficult to interpret what level of 
disease has been described in previous human reports. Nevertheless, the impression 
in dogs is that cellular changes in visibly pathologic areas of mitral valves are 
reasonably consistent irrespective of severity, but a variation in change is found 
across the entire valve length and width. The exact immuno-phenotype of the 
vimentin negative cells in myxomatous areas was not identified. These cells were 
also α-SMA negative, suggesting they are not typical activated myofibroblasts seen 
associated with myxomatous degeneration 27, 138. They do have an elongated spindle 
interstitial cell shape that contrasted with the more rounded vimentin negative cells 
seen in the spongiosa layer of unaffected mitral valves. The overall functional role of 
vimentin in cells has remained elusive. Vimentin-deficient mouse fibroblasts in 
culture display a reduced mechanical stiffness, motility, and contractility, but 
absence of vimentin filament does not impair cellular function needed for growth. 
Therefore, it was proposed that vimentin deficiency impaired all functions depending 
upon mechanical stability139.  
The increase in α-SMA positive cells in this study was expected as this has 
been reported in studies from human patients27. α-SMA is a cytoskeletal 
microfilament and can be used to distinguish smooth muscle cells from fibroblast140, 
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141, but has been mainly used in valve studies to identify activated myofibroblasts 
since no antibody currently available could definitively distinguish myofibroblast 
from smooth muscle cells24. Consequently, the myofibroblast phenotype was verified 
by incorporating the results from smooth muscle myosin immuno reactivity44, as the 
cells associated with the disease presented an α-SMA positive but myosin negative 
phenotype. Findings in an electron microscopy study in dogs with MMVD has 
identified a population of smooth muscle like cells with an increase in these cells in 
the most severe forms of the disease, but the overall cell numbers are likely to be 
low43. What is interesting about α-SMA positive cells in dogs is the localization to 
the edge of the valve, with few cells visible in the overtly myxomatous areas. This 
finding contrasts with reported for human myxomatous degeneration27. The 
consensus is that α-SMA positive cells represent an activated myofibroblast 
population that are involved in extracellular matrix remodelling, but some 
disagreement exists as to whether such a phenotypic expression is associated only 
with disease24, 26, 27, 92. It would be reasonable to presume activated myofibroblasts 
contribute to normal tissue remodelling and also to damage. The data from dogs 
would suggest a more quiescent vimentin positive fibroblast population 
predominates in the mitral valve of clinically normal dogs and only in the disease is 
there an obvious increase in the activated myofibroblast population44. This agrees 
with reports of human disease26 and animal models84, 90, 142 of valve damage repair, 
but it is the distinct localization of the α-SMA positive cells in dogs that is different. 
However, an ex-vivo study of wound healing in mitral valve has shown an increasing 
in α-SMA positive cells near the damaged surface90. The transition from fibroblast to 
myofibroblast would appear to be under the control of angiotensin II stimulated 
transformation growth factor-β (TGF-β) through the MAP kinase-2 pathway93, 143-145, 
and in cell culture systems at least, this results in the development of α-SMA with 
enhanced contractility84, 146. Results from a recent study on genomic expression in 
dogs with MMVD has revealed, among numerous other changes, up regulation of the 
5-hydroxytryptamine 2B receptor gene, and the authors speculated that a serotonin-
transforming growth factor-β mediated activation of myofibroblasts might be 
implicated in disease pathogenesis147. The serotonin signal could come from platelets 
adhering to damaged endothelium148, and endothelial denuding does occur in dogs 
with MMVD. It can be further speculated that the localization of α-SMA positive 
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cells to sub-endothelial layers may be in response to such signaling29, 43. Indeed, it 
has long been recognized that in vitro models of valve injury interstitial cells 
proliferate toward the valve surface, and these cell express α-SMA84, 142. 
Furthermore, in such models, there appears to be a preferential accumulation of α-
SMA positive cells on the ventricularis side of the leaflet142.  The increase in α-SMA 
positive cells seen in the ventricularis side of the distal zone could be explained by 
the development of regurgitation during disease progression. In a regurgitating valve, 
the two leaflets would not coapt properly together and with the distal parts of the 
leaflets protruding towards the atria, the new contact point between the leaflets might 
switch from the atrialis side to the ventricularis side. The regurgitation jets exert 
more force on the ventricular side of the leaflets. The change in distribution of α-
SMA positive cells in this study was consistent and related to disease severity, but it 
was surprising that no increase in α-SMA positive cells were observed in the overtly 
myxomatous areas. The increase in α-SMA positive cells roughly matched the 
decrease in vimentin positive cells observed with increased disease severity but not 
at the same sites. The importance of the initial α-SMA positive cells accumulation 
adjacent to the atrialis might be to provide additional contractility, as the atrialis 
surface stretch out more during the opening and closing of the valve. The clustering 
of cells and their organization close to the valve edge in the distal zone may reflect 
an attempt to compensate for the reduced mechanical integrity of the valve. Walker 
et al92 suggest this augmented contractile myofibroblast response could be a 
precursor to the alteration in valve matrix seen with myxomatous degeneration, but 
data from the current dog study and previous electron microscopy data from dogs 
suggest it might be a later consequence of the disease process43. 
The role of other cell types in the aetiopathogenesis of this disease was 
considered in this study. The identification of desmin positive chondocyte-like cells 
was unexpected and the cartilage morphology was also confirmed by the toluidine 
blue staining. Although their numbers were small in the diseased valves, this might 
pointed to another route by which valve stromal cells could transform to during the 
disease progression. Ossification commonly occurs in human aortic valve stenosis 
but at a low frequency in mitral valves. In the human pathological conditions the 
myofibroblast in the mitral valve could existed as a combination of vimentin and 
desmin phenotypes27. The adult mesenchymal stromal cells have the potential to 
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differentiate into chondrocytes149. The location of ossification corresponded to that 
seen in human mitral valve studies, namely the ventricular side collagen rich fibrosa 
layer150. The cartilage phenotype seen in myxomatous mitral valves in humans has 
recently been investigated. Molecular biological studies have shown an up-regulation 
of low-density lipoprotein receptor related protein 5 (Lrp5) and Sox9, a transcription 
factor for osteoblast differentiation and it has been hypothesized the osteoblastic 
differentiation by Lrp5 mediated signalling causes valve thickening151. 
Coincidentally, the VEGF and TGF-β which are implicated in the fibroblast to 
myofibroblast transformation are also suspected to be involved in fibroblast to 
osteoblast differentiation150, 152.  
The role of adipocytes in mitral valve has not been discussed in the literature. 
Presumably the adipocytes were derived from the multi potent mesenchymal stromal 
cells149, as the cells were immuno-positive to vimentin. Judging by the location of 
the adipocytes almost exclusively in the spongiosa layer of the leaflet they could 
perform an important supporting role by providing resilience to the valve during the 
dynamic structural change in the cardiac cycle. Although no distinct difference in fat 
was found between normal and varying grades of diseased, much higher fat content 
was found in the septal leaflet than the mural leaflet within the same valve. Image 
analysis study from the previous chapter has revealed the septal leaflet is always 
longer than the mural and it is probably resonable to assume a higher fat content is 
related to the mechanical function of the septal leaflet. Adipocytes are soft and 
compressible in comparison to the rigid neighbouring cardiomyocytes and 
connective tissue. By wrapping around the cardio myocytes and separating from the 
connective tissues the fat serves as a cushion to dissipate the mechanical stress 
generated from the valve opening and the impact of leaflet recoil. In the normal 
heart, the adipocytes function as an energy storage by providing lipids as fuel to 
cardiomyocytes for metabolic need153. It is possible the adipocytes in mitral valve 
have a similar energy storage function, judging by their proximaty to the 
cardiomyocytes in the basal zone of the leaflet. While fat as a risk factor to 
cardiovascular disease is well established in medicine, what risk, if any, that valve fat 
has is unknown154. Advancement in the understanding of fat cells in cardiovascular 
system has shown in addition to energy storage they also exert important endocrine 
control and modulate immune function. Adipocytes express pro-inflammatory 
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products that attract macrophages through the release of adipocytokines. In 
pathological conditions the pro-atherogenic adipocytokines enhance inflammatory 
processes and accelerating atherosclerosis155, 156. Atherosclerosis in human 
cardiology has been a major research topic, but the focus is on atherosclerosis in 
arteries. In a study looking at arteriosclerotic changes in dogs, the intramyocardial 
arteriosclerosis was found to be more significantly advanced in dogs with MMVD157. 
However, parallel to human medicine, the fat content in dogs is related to the dietary 
and exercise regimes.  
Although a genome expression study has shown the up-regulation of genes 
for inflammation and immunity in dogs with MMVD147, There is no concrete 
evidence exists that MMVD involves an inflammatory process, and this would 
appear also to be the case in human myxomatous degeneration158. Evidence for a 
possible role of mast cells in the development of MMVD is presented in this study, 
but the cellular response is small and could be argued to be trivial. The number of 
mast cells found in mitral valves of humans is also small150. However, the cardiac 
mast cell numbers are known to increase in response to mitral regurgitation in the 
dog159.  Mast cells in human heart tissue have previously been found in atrial 
appendages160 and calcified valves150. Furthermore, since there is an association 
between mast cells, mast cell chymases, matrix metalloproteinase activity, a role for 
mast cells in extracellular matrix remodelling of the myocardium is recognized159, 161-
164. Mast cells can release pro-inflammatory substances, such as tumour necrosis 
factor-α and prostaglandin D, and the existence of similar mast cell dependent 
mechanisms in MMVD is worth considering, especially taken into account that the 
disease is developed during a number of years165. The finding of mast cells 
accumulation in normal and also in diseased valves of variable pathology grades, 
raises the possibility that local activation of these cell could participate in the disease 
and valve injury in the dog. 
In contrast to the mast cells, no evidence exists of direct involvement of the 
resident macrophage population in the development of MMVD, at least at the sites 
where disease develops, and this agrees with findings in human mitral valve 
disease158, 166. The slight increase in the number of macrophage in the spongiosa 
layer of diseased valves was possibly related to the increased adipocyte numbers. 
The adipocytokines released by the adipocytes are attractants for macrophages156. 
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The damaged endothelium seen with MMVD could facilitate recruitment of 
macrophages into the valve by providing easy passage for circulating macrophages 
entering the valve tissue155. Once the macrophages entered, they could then become 
activated and have the potential to take up LDL158, 167. Lipid deposition in VIC, 
proliferation of lamina material and activation of macrophages were induced by 
hypercholesterolemia in rabbit and hamster168. Whether those macrophages 
subsequently trigger atherosclerosis in mitral valves remain to be proven, but in a co-
culture study of macrophages and vascular smooth muscle cells (SMC), the 
macrophages were found to induce the apoptosis of SMC169. This might explain why 
the macrophages in the valve leaflets were predominantly located in the spongiosa 
layer towards the base in proximity to the adipocytes, whereas the increase in 
numbers of myofibroblasts in the diseased valves was found near the two surfaces 
towards the distal zone.  
In a recent report, the predominant cells in both unaffected and affected 
mitral valves of humans have been identified to be CD34+ fibrocytes. In addition, 
the expression of α-SMA and CD34 in stromal cells was found to be reciprocal to 
each other such that most CD34+ cell were α-SMA negative and vice versa. These 
cells are known to have a functional fibroblast phenotype producing matrix 
metalloproteinase-9 and collagen I and III. It has therefore been proposed that the 
CD34+ fibrocytes might play an important role in the aetiopathogenesis of 
myxomatous mitral valve degeneration83. However, using a canine specific antibody, 
the involvement of CD34+ cells was less obvious in dogs and many samples did not 
show any immunoreactivity to CD34. Among those that did stain positive for CD34, 
the numbers found were substantially lower than those reported in human mitral 
valves. In spite of a slight increase noted in the Grade 3 diseased valves, the disease 
in dogs does not appear to be associated with changing in numbers of CD34+ cells. 
The CD34 antigen is a well recognised marker for multi-potent mesenchymal 
stem cells126, but also stains granulated mast cells. Using sequential sections, Veinot 
et al have found the majority of the CD34+ cells in normal and prolapsed mitral 
valves were toluidine blue positive but CD117-, indicating they were mast cells. 
However, a small proportion of cells did exhibit the stem cell marker pattern of tol-
/CD34+/ CD117+165. This current study is the first to demonstrate the presence of 
CD34+ cells in both normal and myxomatous canine mitral valves. Comparing with 
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the numbers the of normalized toluidine blue positive mast cells, it is possible that a 
small number of these cells are valve stem cells and their numbers increased during 
development of Grade 2 and 3 disease. Their fibroblast-like spindle shaped 
morphology in the spongiosa layer matched the stem cells morphology seen in 
human valves. Research on multi potent CD34+ stem cells has created much 
excitement in the field of regenerative medicine170, and CD34+ stem cells have 
shown some promise in the potential treatment of non-valvular heart diseases105, 171. 
The presence of CD34+ stem cells in the canine mitral valve may open new insight 
into the pathology of this disease and offer new therapeutic options. Whether or not 
these cells are differentially encountered in varying grades of the disease, and can 
migrate or differentiate into other cell phenotypes remains to be determined.  
The mitral valve ECM is a complex network composed of collage, elastin, 
proteoglycans and glycosaminoglycans12, 77. The matrix secures the cells in space 
and provides the cells with environmental signals. The interaction between cells and 
matrix is dynamic and bidirectional. ECM remodelling is mediated by the cells 
resident in the matrix and MMPs are responsible for breaking down the matrix39. 
MMPs have been suggested to play an important role in myocardial extracellular 
matrix remodelling in both normal and pathological conditions172. Two types of 
MMPs, the gelatinases (MMP-2 and MMP-9) and the collagenase (MMP-13) were 
assessed in this study173.  
An altered arrangement of ECM component has been demonstrated in human 
disease12, 27, 67, 77. The expression of MMPs in mitral valves has been the focus in a 
number of studies, but their exact expression pattern remains to be clarified. This is 
probably due to the complexity of MMP regulation at various levels, not least their 
activation from latent forms and their tissue inhibition (TIMPs). Rabkin et al have 
reported increased expression of MMP-2, MMP-9 and MMP-13 in human 
myxomatous mitral valves using immunohistochemistry27. Soini et al have presented 
a slightly different view, where they reported MMP-2 was mainly expressed in 
endocarditis and MMP-9 in inflammed valves, but low levels of expression 
otherwise82. Dreger et al have found no MMP-2 and MMP-9 in any of their normal 
mitral valves174. Togashi et al, using a combination immunohistochemistry and 
zymographs have demonstrated an increase in both activated MMP-2 and MMP-9 in 
myxomatous mitral valves175. In the only and very recent report from dogs, the 
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MMP-2 was found to be decreased in diseased mitral valves176, the authors explained 
this as a consequence of increased TIMP-1, which has been reported in a separate 
genomic expression study147. However, no visible MMP-2 expression was observed 
in any of the samples in the current study, irrespective of the grade of disease.  These 
results suggest there is no involvement of MMP-2 in myxomatous valve 
degeneration177. 
The expression of MMP-9 in the current study was found closely associated 
with vessel walls and a possible slight increase in MMP-9 staining occurred as the 
disease progressed. The preferable substrate for MMP-9 is collagen IV which is a 
constitute of the basement membrane38. It could be postulated the endothelial cells 
lining vessels secrete the MMP-9 and participate in the role of angiogenesis in the 
diseased valves. Macrophages, often observed near the lumen of the vessels, could 
also help to raise the MMP-2 level27, but any other role for MMP-9 in the 
aetiopathogenesis of MMVD could not be identified. 
The MMP-13 (collagenase) cleaves collagen I and collagen III preferentially. 
The finding of the MMP-13 expression near the damaged endothelium is consistent 
with in with the TEM morphological study showing endothelial damage. The sub-
endothelial space of damaged endothelium is the site of fibroblast migration and 
transformation from fibroblasts to myofibroblasts. The immediate environment also 
exhibited a decreased in collagen content. MMP-13 expression by the VICs 
facilitates the migration of the fibroblasts and participates in matrix remodelling by 
the newly transformed myofibroblasts in the diseased valves. There is a reasonable 
amount of evidence to suggest that signalling brought about by endothelial damage 
and VIC migration towards the damaged endothelium is important in the 
development of this disease, and the over-expression of MMP-13 would fit this 
paradigm. 
Overall the data presented here are a comprehensive description of the 
cellular changes in mitral valves of dogs with MMVD, and although changes in cell 
populations in affected valves have been found, it is the information on temporal and 
spatial development of these changes that may be most important in the 
understanding of the disease in both dogs and humans. It is likely that the increase in 
activated myofibroblast numbers in MMVD is a reaction to the disease process rather 
than a cause. The variations in the degree of MMP expression in humans with 
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MMVD, which some patients having no expression of MMP, would support that 
view. 
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4 Chapter 4 Proteomics 
4.1 Introduction 
Despite the high prevalence of MMVD among the adult canine populations, 
the aetiology and physiochemical features of the disease have not been characterised. 
Alterations in ECM protein components have been described in human mitral 
prolapse12, 67, 77, but very little is known about the abnormalities at the post-
translational protein level. Previously, the genome expression pattern of mitral valve 
from dogs with MMVD was evaluated at transcriptional level147. However, the 
transcriptional profile cannot directly correlate with protein expression due to 
complex post-transcriptional processing. In order to understand the cellular and 
molecular mechanisms of this disease, it is paramount to study the gene expression at 
the protein level. Proteins are responsible for all cellular mechanisms and are 
functional units within the ECM and their functional activities will be reflected in 
their proteome. The aim of this study was to compare protein expression profiles of 
normal and diseased valves and try to identify differentially expressed proteins 
associated with the diseased valves.  
Characterising and identifying of the proteins associated with MMVD could 
unravel the pathological mechanism at the functional protein level and ultimately 
provide targets for therapeutic treatments in the future. 
In order to investigate alteration in protein expression from dogs with and 
without MMVD, two strategies were employed: 1D gel SDS-PAGE incorporating 
liquid chromatography - tandem mass spectrometry (LC-MS/MS) for the qualitative 
global protein expression profiles, and 2D gel SDS-PAGE combining computer 
image analysis and matrix-assisted laser desorption / ionisation – time of flight 




4.2 Materials and Methods 
4.2.1 Protein Extraction  
Mitral valve leaflet tissues were collected from normal and affected dogs as 
described in Chapter 2. The muscle bases of the mitral valve leaflets were trimmed 
off. The mitral valve tissues were homogenized on dry ice with mortar and pestle. 
The homogenized tissues were collected, weighed and then transferred to rehydration 
buffer 8 M urea (Sigma, Dorset, UK), 2% CHAPS (Bio-Rad, Hertfordshire, UK), 
0.4% dithiothreitol (DTT, Sigma, Dorset, UK), 0.2% Biolytes 3-10 (Bio-Rad, 
Hertfordshire, UK). The concentrations (weight to volume ratios) were standardized 
to 0.20 g tissues per ml of rehydration buffer. To ensure effective solubilization, the 
homogenized tissues were dissolved in rehydration buffer and gently agitated for 1 h 
at 21°C, then centrifuged at 12,000 g at 15°C for 15 min. The supernatants were 
divided into small aliquots and stored in -70°C until required. 
4.2.2 1-D SDS-PAGE 
Protein samples (150 µl) from three normal (Whitney’s type 0)2 and three 
severely diseased valves (Whitney’s type IV)2 were mixed with loading buffer and 
electrophoresed on 10% SDS polyacrylamide separating gels, with a 4% stacking gel 
on top. Molecular weight standard (SDS-PAGE Broad Range, Bio-Rad, Hertfordshire, 
UK) were added as size indicators. The gels were run in Bio-Rad Mini PROTEAN 
cells that contained electrophoresis running buffer 25 mM Tris (Sigma, Dorset, UK); 
0.2 M glycine (Fisher, Leicestershire, UK); 0.1% SDS (Fisher, Leicestershire, UK), 
pH 8.3 at 200 V for about 30 min when the separation distance was 2.5 cm. The 
separated protein bands were detected with Coomassie Blue R-250 Imperial Protein 
Stain (Pierce, Northumberland, UK). 
4.2.3 2-D SDS-PAGE  
Twelve mitral valve protein samples were allocated to three groups according 
to the severity of the disease as follows: normal healthy n=4; mild (corresponding to 
Whitney’s type I and II) n=4; and severe (correspond to Whitney’s2 type III and IV) 
n=4. The protein samples (10 µl) were made up to a final volume of 450 µl with 
rehydration buffer and loaded into separate lanes in the focusing tray. Dry 18 cm 
immobilized pH gradient strips (Readystrip, pH 3-10, Bio-Rad, Hertfordshire, UK) 
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were first rehydrated in the focusing tray at 50 V for 12 h before the isoelectric 
focusing step was carried out at 8000 V for 45000 Vhr in a Bio-Rad Protean IEF cell 
(Bio-Rad, Hertfordshire, UK). After focusing, the strips were equilibrated for 15 min 
in an equilibration buffer 6 M urea (Sigma, Dorset, UK), 2% SDS (Fisher, 
Leicestershire, UK), 0.375 M Tris-HCl pH 8.8 (Sigma, Dorset, UK), 20% glycerol 
(Sigma, Dorset, UK) and 130 mM dithiothreitol (DTT, Sigma, Dorset, UK) to reduce 
the proteins. A second equilibration step was then performed for 15 min in the same 
equilibration buffer, but with the DTT replaced by 135 mM iodoacetamide (IAA, 
Sigma, Dorset, UK) to convert the free cysteine to carboxyamidomethyl cysteine. 
The strips were placed onto pre-cast 16 × 20 cm 10% SDS polyacylamide gels and 
sealed with 1% agrose (Ambion, Huntingdon, UK). The second-dimension 
electrophoresis was carried out on a Bio-Rad Protean-II system that contained 
electrophoresis running buffer 25 mM Tris (Sigma, Dorset, UK), 0.2 M glycine 
(Fisher, Leicestershire, UK) and 0.1% SDS (Fisher, Leicestershire, UK) running at 
24 mA/gel (16 mA/gel during the initial stacking) for 3 h 50 min178, 179.  
4.2.4 2D Gel Staining  
Following 2D SDS-PAGE, analytical gels were stained with a modified silver 
staining method. The gels were ‘fixed’ in a fixing solution containing 10% acetic 
acid (Fisher, Leicestershire, UK) and 40% ethanol (Scientific Laboratory Suppliers, 
Nottingham, UK) twice for 15 min. This was followed by sensitizing the gels with a 
solution contained 30% ethanol, 8 mM sodium thiosulphate  (Sigma, Dorset, UK) 
and 0.5 M sodium acetate (Sigma, Dorset, UK) for 30 min.  After a brief deionised 
water wash, the proteins in the gels were allowed to bind with 2.5% silver nitrate 
(Sigma, Dorset, UK) for 20 min. Excess silver nitrate was rinsed off with deionised 
water. The gels were then developed in a developing solution 0.24 M sodium 
carbonate (Fisher, Leicestershire, UK) and 0.04% formaldehyde (Sigma, Dorset, 
UK) until the desired intensity appeared. The reactions were terminated by the 
addition of 0.04 M EDTA (Sigma, Dorset, UK) and incubation for 10 min. The gels 
were finally rinsed in deionised water three times for 5 min.  
Gels stained with silver using protocols which include a cross-linking reagent 
such as formaldehyde proved to be unsuitable for subsequent MALDI-TOF analysis. 
As a result, higher loading (30 µl) replicating gels running under the same conditions 
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were performed. Gels were stained with Imperial Protein Stain (Pierce, 
Northumberland, UK) for the detection of abundant proteins. For less abundant 
proteins, gels were stained with high sensitive mass spec compatible SilverQuest 
silver staining kit (Invitrogen, Paisley, UK). All staining procedures were carried out 
according to the manufacturers’ recommended instructions. Stained gels were 
scrutinized and compared on an illumination light box. After spot matching to 
analytical gels, the protein spots of interest were carefully excised with a clean 
scalpel blade from the gels. Protein spots derived from SilverQuest stained gels 
underwent a further de-staining step as recommended by the manufacturer. 
4.2.5 Image Analysis 
Images of silver stained gels were captured in 16-bit grayscale using a flat 
bed gel scanner (ImageScanner, Amersham, Buckinghamshire, UK). The spots on 
the 2-D gel images were detected and analyzed with the Dymension software 
(Syngene, Cambridge, UK). Background correction was done automatically by the 
default value. Spot detection and spot matching were checked using default 
parameters. However, extensive checking with the matched spots was necessary and 
any mismatches were corrected manually. The detection region of interest (ROI) was 
carefully defined manually and applied to all analyzing groups uniformly. The spot 
filtering parameters were adjusted accordingly to show the optimal true spot patterns. 
Relative spot volumes density were compared between groups using the Student’s t-
test. Whenever a statistically significant value of (p < 0.05) was achieved in the 
comparison, regardless an increase or decrease in spot volumes, the corresponding 
spots were examined and verified. Significant differences between the two groups in 
spot density volumes were expressed as fold changes and were also displayed 
graphically in different colours. The results were presented in a distribution plot 
using the JMP statistical software (JMP, SAS, NC, USA), where a histogram shows 
the number of significant protein spot density volumes according to fold changes, 
and a box and whiskers plot shows the median, two quartiles and the range. 
4.2.6 Trypsin Digestion 
Each 1-D gel was cut into five horizontal strips of equal thickness (~0.5 cm) 
before the gel strips were pixilated into approximately the same size as the gel spots 
excised from the 2-D gel. The gel pieces from 1-D and 2-D gels underwent trypsin 
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digestion. They were washed in 200 mM ammonium bicarbonate (ABC, Sigma, 
Dorset, UK) in 50% acetonitrile (ACN, Aldrich, Dorset, UK) for 30 min at room 
temperature three times to remove the SDS. This was followed by incubation in 300 
ul 20 mM DTT (Sigma, Dorset, UK), 200 mM ABC in 50% ACN at 32oC for 1 h to 
reduce the proteins. The DTT was rinsed off with 300 ul 200 mM ABC in 50% 
ACN, then the gel pieces were incubated in 50 mM IAA (Sigma, Dorset, UK), 200 
mM ABC in 50% ACN at room temperature in the dark for 20 min to alkylate 
sulfhydryl groups of cyteine. The excess IAA was rinsed off with 20mM ABC in 
50% ACN, then the gel pieces were spun down at 12,000g for 2 min. The gel pieces 
were covered in 100% ACN for dehydrate until they turn white. The ACN was 
removed and the gel pieces were allowed to dry. The gel pieces were then placed in 
30 µl of 0.07 µg/µl trypsin (Promega, Southampton, UK) and incubated at 32°C 
overnight. Peptides from the digested pieces were then run on MALDI-TOF MS and 
LC-MS/MS mass spectrometers. The trypsin-digested peptides from each strips of 1-
D SDS-PAGE were also subjected to MALDI-MS analysis. 
4.2.7 MALDI-TOF MS Analysis 
0.5 µl tryptic digest was mixed with 0.5 µl a-cyano-4-hydroxy cinnamic acid 
(CHCA, Sigma, Dorset, UK) matrix on a MALDI target sample plate. The samples 
were then analyzed on a Voyager DE-STR MALDI-TOF MS (Applied Biosystems) 
using a mass range between 800 and 3500 Da under 50 laser pulses. The raw data 
was processed using Data Explorer Software (Applied Biosystems). Processing 
stages involved baseline correction, noise filter/smooth, deisotoping and calibration 
against porcine trypsin autolysis peaks formed at 842 and 2211 Da. The processed 
spectra were converted into a mass list of about 100 masses, searched against the 
public available SwissProt180, MSDB and NCBI non-redundant databases using 
MASCOT (Matrix Science) and Protein Prospector (UCSF).  Due to the fact the 
MSDB and NCBI databases were not curetted and their proteins were not annotated, 
the search results obtained from these two databases were used as reference. A 
custom designed database compiled from extracted FTP file of Ensembl canine 
genome predicted protein sequence (Assembly: CanFam 2.0, May 2006, version 
51.2i; Genebuild Dec 2006, last update Sep 2008) was created181. MASCOT searches 
from the genome database were compared with search results obtained from 
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SwissProt. The MASCOT searching parameters were allowed up to one missed 
cleavage, while the peptide mass tolerance was ± 100 ppm182. 
The results generated from MASCOT MS searches against mammal database 
were saved as htm files, only those proteins found to be significant by MASCOT 
software were carried over for further analysis. The SwissProt Identifier (ID) name, 
protein name, accession number, theoretical molecular weight, theoretical pI value, 
Mowse score, number of peptide match and the percent of coverage were recorded. 
Redundant proteins arising from multi-species comparisons were dealt with on the 
basis of the unique SwissProt Identifier (ID) name. Should the peptide finger printing 
identify homology to a protein from more than one species, then the species with the 
highest significant Mowse score took the precedence. In case the peptide mass 
fingerprinting identified a homologue from more than one species sharing the same 
Mowse scores, then the dog (Canis familiaris) protein took the precedence if it 
existed. Otherwise the protein from the species with highest peptide match received 
priority. Protein isomers and sub-groups were best judged by their peptide matching 
patterns to the entire protein sequence. Any duplication was discarded. 
4.2.8 LC-MS/MS Analysis 
The remaining digest solution was then run on a nanoLC-MS system. The 
nanoLC-MS consisted of a Famos autosampler, Switchos column switching unit and 
an Ultimate nanoLC (Dionex) and LCQdeca mass spectrometer (ThermoFinnigan). 
A 60 µl to 80 µl sample of a tryptic digest was loaded onto a PepMap C18 column (3 
um particle size, 75 um x 15 cm) at a flow rate of 200 ul/min, monitored at 214 nm. 
The column was equilibrated with solvent A (aqueous 0.1% (v/v) formic acid, 
Sigma, Dorset, UK) and eluted with a linear gradient from 10 to 70% solvent B 
(100% acetonitrile containing 0.09% (v/v) formic acid) over 45 min. The LCQdeca 
mass spectrometer was fitted with a nanoLC ESI source and interfaced to the MS 
with a PicoTip (FS-360-20-10-N-20-C12 DOM, New Objective). The HPLC method 
was controlled by Chromeleon software (Dionex). Data dependent acquisition was 
controlled by Xcalibur software and database searching was achieved using 
MASCOT software182, 183. The processed spectra were searched against the 
SwissProt database using MASCOT (Matrix Science). Matched peptide was quoted 
with its observed mass value (Mr), Mr (expt), Mr (calc), Delta, Miss, Score, Expect, 
Rank and peptide sequence (data not shown). Further information on each peptide at 
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amino acid level could be scrutinized through hyperlinks. All proteins with at least 
two significant peptide hits in at least in two samples of the each group were entered 
into an Excel table. The protein name together with its SwissProt ID, accession 
number, molecular weight, Mowse score and the number of matched peptide were 
reported. The location of the protein, whether it is intracellular, extracellular matrix 
or blood borne were validated. 
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4.3 Results 
4.3.1 1-D SDS-PAGE LS-MS/MS and MALDI-ToF-MS 
In both normal and diseased groups, after the proteins were separated in the 
1-D SDS-PAGE gels, the Coomassie Blue stained protein gels appeared as gradient 
smears (Figure 4.1).  
 
 
Figure 4.1. Representative 1D SDS-PAGE gel from the normal group which was divided into 5 strips of 
equal thickness for LC-MS/MS. The molecular weight (MW) markers are indicated on the left. 
 
Each cut out strip from the 1-D gel contained hundreds of trypsin-digested 
peptides. Mascot MS/MS searches against SwissProt mammal database revealed 
largely cross-species protein comparisons. The identified protein, together with its 
Mr, Mowse score and numbers of matched peptide are presented in the list in 
descending order according to their Mowse scores (Figure 4.2).  
 
 
Figure 4.2. Representative Mascot search results showing the probability based Mowse score. The red 
bars outside the green area indicates the matches were significant. 
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The peaks generated from MALDI-MS were searched against SwissProt 
mammalia database via Mascot (Figure 4.3). Proteins found to be significant by 




Figure 4.3. Representative of a MALDI-MS peaks chart from a strip of trypsin digested 1D SDS-PAGE. 
 
A total of 64 proteins were detected with significance by MASCOT in both 
normal and diseased groups. Among them, 40 proteins were found exclusively in the 
normal groups and 4 proteins were found exclusively in the diseased group; 20 
proteins were common in both normal and diseased groups. The name of the protein, 
SwissProt ID, accession number, mass, Mowse score MS/MS signal and number of 
matched peptides together with available peptide match and coverage from MALDI-
MS are listed in the Table 4.1. One notable finding in the diseased group was the 
strong signal of serum albumin in almost every single strip of the gel. 
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Table 4.1. List of significant proteins from 1-D gels identified by LCMS and MALDI-MS through Mascot search against SwissProt.  
N 









N IC Actin, alpha cardiac (Alpha-cardiac actin) ACTC_HUMAN P68032 42334 325 22 14 56 
ND IC Actin, alpha skeletal muscle (Alpha-actin-1) ACTS_BOVIN P68138 42366 113 8 13 50 
N IC Actin, aortic smooth muscle (Alpha-actin-2) ACTA_BOVIN P62739 42381 115 7 12 53 
ND IC Actin, cytoplasmic 1 (Beta-actin) ACTB_CANFA O18840 41923 97 8 10 40 
ND IC 
Annexin A2 (Annexin II) (Lipocortin II) 
(Calpactin I heavy chain) (Chromobindin-8) 
(p36)  ANXA2_BOVIN P04272 38742 75 3 25 57 
ND BB 
Apolipoprotein A-I precursor (Apo-AI) 
(ApoA-I) APOA1_CANFA P02648 30178 283 11 21 66 
N IC 
ATP synthase beta chain, mitochondrial 
precursor (EC 3.6.3.14) ATPB_BOVIN P00829 56249 86 2 17 45 
N IC 
ATP synthase gamma chain, mitochondrial 
precursor (EC 3.6.3.14) ATPG_BOVIN P05631 33108 43 1     
ND EC 
Biglycan precursor (Bone/cartilage 
proteoglycan I) (PG-S1) PGS1_CANFA O02678 41939 164 9 19 53 
ND EC Collagen alpha-1(VI) chain precursor CO6A1_HUMAN P12109 109621 73 3 23 23 
N EC Collagen alpha-3(VI) chain precursor CO6A3_HUMAN P12111 345051 43 2 58 24 
N IC 
Creatine kinase M-type (EC 2.7.3.2) 
(Creatine kinase, M chain) (M-CK) KCRM_CANFA P05123 43223 57 3     
N IC 
Cysteine and glycine-rich protein 3 
(Cysteine-rich protein 3) (CRP3) (LIM 
domain protein,  CSRP3_HUMAN P50461 21867 48 1     
ND EC 
Decorin precursor (Bone proteoglycan II) 
(PG-S2) PGS2_CANFA Q29393 40297 147 7 7 27 
N IC Desmin DESM_CANFA Q5XFN2 53214 86 2 19 55 
D IC 
DnaJ homolog subfamily C member 13 




Extracellular matrix protein FRAS1 
precursor FRAS1_HUMAN Q86XX4 453936 38 2     
N EC 
Fibromodulin precursor (FM) (Collagen-
binding 59 kDa protein) (Keratan sulfate 
proteoglyca FMOD_MOUSE P50608 43427 74 3     
D EC Fibronectin (FN) (Fragment) FINC_CANFA Q28275 58235 40 2     
N IC 
Glyceraldehyde-3-phosphate 
dehydrogenase (EC 1.2.1.12) (GAPDH) G3P_CANFA Q28259 35935 248 9 13 50 
ND BB 
Haptoglobin [Contains: Haptoglobin alpha 
chain; Haptoglobin beta chain] HPT_CANFA P19006 36890 38 3 23 48 
N IC 
Heat-shock protein beta-1 (HspB1) (Heat 
shock 27 kDa protein) (HSP 27) HSPB1_CANFA P42929 22925 53 1     
N BB 
Hemoglobin alpha subunit (Hemoglobin 
alpha chain) (Alpha-globin) HBA_CANFA P60529 15322 184 7 3 41 
N BB 
Hemoglobin beta subunit (Hemoglobin beta 
chain) (Beta-globin) HBB_CANFA P60524 16100 278 13 11 82 
N IC 
Hermansky-Pudlak syndrome 3 protein 
homolog (Cocoa protein) HPS3_MOUSE Q91VB4 115074 46 2     
ND IC Histone H2A type 1-B H2A1B_HUMAN P04908 14033 109 3     
ND IC Histone H2A type 2-A (H2A.2) H2A2A_HUMAN Q6FI13 13956 119 5     
N IC Histone H2B F (H2B 291A) H2B1_MOUSE P10853 13797 128 4     
N IC Histone H2B.f (H2B/f) (H2B.1) H2BF_HUMAN P33778 13811 125 7     
ND BB Ig heavy chain V region GOM HV01_CANFA P01784   46 1     
ND BB Ig heavy chain V region MOO HV02_CANFA P01785 12809 46 1     
ND EC 
Keratin, type I cytoskeletal 10 (Cytokeratin-
10) (CK-10) (Keratin-10) (K10) K1C10_HUMAN P13645 59711 62 3 25 39 
ND EC 
Keratin, type II cytoskeletal 1 (Cytokeratin-
1) (CK-1) (Keratin-1) (K1) (67 kDa 
cytokerati K2C1_HUMAN P04264 66018 92 3 23 41 
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N IC 
Lactotransferrin precursor (EC 3.4.21.-) 
(Lactoferrin) (Fragment) TRFL_HORSE O77811 77938 39 1     
ND EC 
Lumican (Keratan sulfate proteoglycan 
lumican) (KSPG lumican) (Fragment) LUM_PIG Q9TTB4 16676 49 4     
N IC 
Malate dehydrogenase, mitochondrial 
precursor (EC 1.1.1.37) MDHM_MOUSE P08249 36030 63 2 11 46 
N EC 
Microfibril-associated glycoprotein 4 
precursor MFAP4_MOUSE Q9D1H9 29261 55 3     
ND EC 
Mimecan precursor (Osteoglycin) 
[Contains: Corneal keratan sulfate 
proteoglycan 25 core pr MIME_BOVIN P19879 34530 259 7     
N IC Myoglobin MYG_CANFA P63113 17195 78 3     
N IC 
Myosin heavy chain, cardiac muscle alpha 
isoform (MyHC-alpha) MYH6_HUMAN P13533 224349 128 5 62 36 
N IC 
Myosin heavy chain, cardiac muscle beta 
isoform (MyHC-beta) MYH7_RAT P02564 223743 122 5 67 35 
N IC 
Myosin light polypeptide 4 (Myosin light 
chain 1, atrial isoform) MYL4_RAT P17209 21252 196 7 10 55 
N IC 
Neuropeptide S receptor (G-protein coupled 
receptor 154) GP154_RAT P0C0L6   43 2     
ND IC 
Oxygen-regulated protein 1 (Retinitis 
pigmentosa RP1 protein) (Retinitis 
pigmentosa 1 protein) RP1_HUMAN P56715 243362 39 5     
ND EC 
Periostin precursor (PN) (Osteoblast-
specific factor 2) (OSF-2) POSTN_HUMAN Q15063 93883 99 6 16 27 
N IC Peripherin PERI_HUMAN P41219 53960 48 2     
N IC 
Peroxiredoxin-1 (EC 1.11.1.15) 
(Thioredoxin peroxidase 2) (Thioredoxin-
dependent peroxide  PRDX1_HUMAN  Q06830 22324 48 1     
N EC 
Prolargin precursor (Proline-arginine-rich 
end leucine-rich repeat protein) PRELP_HUMAN P51888 44181 51 2     
D IC Ribosome-binding protein 1 (Ribosome RRBP1_HUMAN Q9P2E9 152780 37 1     
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receptor protein) (180 kDa ribosome 
receptor homolog) 
N EC Sacsin SACS_MOUSE Q9JLC8 441437 46 3 71 20 
N IC 
Serine/threonine-protein kinase TAO3 (EC 
2.7.11.1) (Thousand and one amino acid 
protein 3) TAOK3_HUMAN Q9H2K8 105796 43 1     
N BB 
Serotransferrin (Transferrin) (Siderophilin) 
(Beta-1 metal-binding globulin) TRFE_PIG P09571 78971 49 2     
ND BB Serum albumin precursor (Allergen Can f 3) ALBU_CANFA P49822 70556 682 40 31 54 
N IC 
Superoxide dismutase [Cu-Zn] (EC 
1.15.1.1) SODC_CALJA  Q8HXP8 15920 38 1     
D IC 
Transformation/transcription domain-
associated protein (350/400 kDa PCAF-
associated factor TRRAP_HUMAN Q9Y4A5 441752 51 4 91 27 
N IC/EC 
Transforming growth factor-beta-induced 
protein ig-h3 precursor (Beta ig-h3) 
(Kerato-epith BGH3_PIG O11780 75042 49 2     
N IC 
Triosephosphate isomerase (EC 5.3.1.1) 
(TIM) (Triose-phosphate isomerase) TPIS_CANFA P54714 26852 85 3     
N IC 
Tropomyosin 1 alpha chain (Alpha-
tropomyosin) TPM1_HUMAN P09493 32746 195 8     
N IC 
Tropomyosin beta chain (Tropomyosin 2) 
(Beta-tropomyosin) TPM2_HUMAN P07951 32945 121 4     
N IC 
Troponin I, cardiac muscle (Cardiac 
troponin I) TNNI3_CANFA Q8MKD5 23938 41 1     
N IC 
Tubulin alpha-ubiquitous chain (Alpha-
tubulin ubiquitous) (Tubulin K-alpha-1) TBAK_HUMAN P68363 50804 42 2     
N IC Tubulin beta chain TBB_PIG P02554 50285 48 3 15 46 
N IC Ubiquitin UBIQ_BOVIN P62990 8560 38 1     
ND IC Vimentin VIME_BOVIN P48616 53570 528 26 15 39 
N: Normal, D: Diseased; IC: Intracellular, EC: Extracellular, BB: Blood Borne.
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4.3.2 2-D SDS-PAGE and MALDI-MS 
In all groups, the majority of the protein spots resolved on 2-D gel separation 
were scattered across the entire molecular weight range in between pH 4-8. The 
consistency in spot resolution and reproducibility between gels within each group 
was very good. However, when comparing between groups, the two horizontal bands 
(at approx 55 and 25 kDa), normally associated with IgG heavy and light chains, 
became more prominent and extended towards the basic end of the gel during the 
disease progression.   
Spot detection and matching functions of the Dymension software identified 
a total of 1880 protein spots from the normal group, 1705 protein spots from the 
moderate group and 1687 protein spots from the severe group on their 2-D gel 
patterns.  
When comparing the protein spots between groups based on spot density 
volume, after manual corrections, expression in 25 protein spots were found different 
at a significant level (p<0.05) from normal group to moderate group, including 10 











- 5 - 4 - 3 - 2 - 1 0 1 2 3 4 5 6 7
Fold Change: Normal vs Moderate
 
Figure 4.4. The distribution of protein spots found to be significantly different between normal and 
moderate groups. The plot shows the fold change of protein spots from normal group to moderate 
group. The x-axis is the fold change in density volume and y-axis is the number of counts (n=25). 
 
Another 25 protein spots were found to be significantly different from 
moderate to severe group, including 8 up-regulated in diseased and 17 down-
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Figure 4.5. The distribution of protein spots found to be significantly different between moderate and 
severe groups. The plot shows the fold change of protein spots from moderate to severe group. The x-
axis is the fold change in density volume and y-axis is the number of counts (n=25). 
 
A significant difference in expression was found in 37 spots between normal 
and severe groups, including 9 up-regulated in diseased and 28 down-regulated 
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Figure 4.6. The distribution of protein spots found to be significantly different between normal and 
severe groups. The plot shows the fold change of protein spots from normal to severe group. The x-
axis is the fold change in density volume and y-axis is the number of counts (n=37). 
 
Initially, abundant protein spots were chosen for tryptic peptide mapping to 
generate a reference map for canine mitral valve. Additional protein spots observed 
to change during the disease states were also selected. Together, the proteins 
identified via peptide mass fingerprinting were used as landmarks to establish the 
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protein-profiling mapping. A total of 60 protein spots at different positions were 
analyzed by tryptic peptide mapping. 22 spots that were positively identified and 
conspicuous on the normal group gels are shown in Figure 4.7.  
 
 
Figure 4.7. Two-dimensional electrophoretic map for normal canine mitral valve. First-
dimensional separation with immobilized pH gradient strips (18 cm, pH range: 3–10); second 
dimension was by SDS-PAGE (10% acrylamide; 16 × 20 cm gels); proteins were visualized 
by silver staining. Protein spots were identified by tryptic peptide mapping from matched 
Coomassie blue-stained and SilverQuest stained gels. Identified proteins are labeled in with 
the corresponding SwissProt gene name: see Table 4.2 below for key.  
 
The spots are indicated by their SwissProt gene names on a representative gel 
from the normal group (Table 4.2). Only the peptide mass fingerprint search shown 









Table 4.2. Protein identification for normal canine mitral valve. 







glycoprotein 73947277 56264 5.38 126 12 35 
ACTE_STRPU Actin cytoskeleton P53474 41877 5.32 70 14 51 
ALBU_CANFA Albumin 3319897 67857 5.36 92 12 21 
ALBU_CANFA Albumin 55742764 70556 5.52 296 34 59 
ALBU_CANFA Serum albumin 7397495 70558 5.51 111 13 23 
APOA_CANFA Apolipoprotein A-I  73955106 30163 5.28 162 18 58 
APOH_CANFA Apolipoprotein 54792721 38378 8.51 165 8 30 
APR11_BOVIN 
Actinrelated 








helicase O00571 73597 6.73 71 20 37 
ERC2_CANFA 
Cytimetrix protein 
p100  73985242 99732 6.41 48 15 11 
HPT_CANFA 
Haptoglobin 
heavy chain 258499 27269 5.80 136 13 40 
HSP27_CANFA 
Heat shock 27kDa 
protein 50979116 22925 6.23 65 7 29 
K1C10_CANFA Keratin 1 Q6EIZ0 57847 5.09 48 13 23 
MLRI_HUMAN 
Myosin regulatory 
LC-2 atrial Q01449 19607 4.83 62 11 67 
MYL4_CANFA 
Myosin light 
polypeptide 4 57091013 21159 4.97 106 10 54 
TBPA_CANFA 
Transthyretin 
Precursor 57089193 15972 6.42 34 3 34 
TPM1_CANFA 
Tropomyosin 1 




4 73990148 80444 7.56 67 13 16 
VIME_CANFA 
Vimentin isoform 
10 73948974 53210 5.01 163 19 43 
VIME_CANFA 
Vimentin isoform 
12 73948978 53622 5.06 305 37 66 
VIME_CANFA 
Vimentin isoform 
7 73948968 49854 5.13 76 11 30 
 
The 2-D separation pattern from the moderate diseased group showed a high 
degree of similarity to the normal group. The positions of landmark protein spots 
closely matched the corresponding spots in the normal group. However, one striking 
feature was the emerging of the two horizontal bands of spots across pH 5.5 to 9.0, 
one at approximately Mr 50- to 60 kDal; another at approximately Mr 20- to 30 
kDal. The intensities of the tropomyosin, apolipoprotein and myosin light chain 4 
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spots were reduced in comparison with normal. The different isoforms of vimentin 
spots were no longer apparent (Figure 4.8). 
 
 
Figure 4.8. Two-dimensional electrophoretic map for moderately diseased mitral valve. First-
dimensional separation with immobilized pH gradient strips (18 cm, pH range: 3–10); second 
dimension was by SDS-PAGE (10% acrylamide; 16 × 20 cm gels); proteins were visualized by silver 
staining.  
 
The 2-D separation pattern from the severely diseased groups resembled the 
moderately disease to a certain degree, and was clearly different from the normal. 
The two horizontal bands of spots clusters became more pronounced. Many 
landmark protein spots were identifiable. In particular, the spots corresponding to α-
actin, albumin and haptoglobin were more intense than the normal and moderately 
diseased (Figure 4.9). Mascot search against a customer-created database made from 
Ensembl dog genome predicted peptides, has further identified six significant 
tentative protein spots (Table 4.3) in the severely diseased valves. These six 
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identified protein spots were not visible in the normal group. Although two of the 
spots, namely FILIP and FANK were shown weakly stained with silver staining, but 
they were highly distinguishable on the corresponding SilverQuest stained gels. 
 
Figure 4.9. Two-dimensional electrophoretic map for severely diseased mitral valve. First-
dimensional separation with immobilized pH gradient strips (18 cm, pH range: 3–10); second 
dimension was by SDS-PAGE (10% acrylamide; 16 × 20 cm gels); proteins were visualized 
by silver staining. Protein spots were identified by tryptic peptide mapping from matched 
SilverQuest stained gels. Identified proteins from canine genome sequence are labeled in 
with the corresponding SwissProt gene name: see Table below for key.  
 
Table 4.3. Proteins identified via searching against Ensembl canine genome predicted protein 
sequence. 
SwissProt Protein Score Peptide 
Match 
ALBU Albumin 54 11 
FANK Fibronectin Type 3/Ankyrin repeat domain 56 11 
FILIP Filamin A interacting protein 52 23 
KLC3 Kinesin light chain 3 62 13 
NRAP Nubulin related anchoring protein 60 27 
ZW10 Centromere/kinetochore protein 62 20 
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Superimposing the warped average gel image from each group using 
Dymension software, the spots in common or differential could be represented in 
contrast colours (Figure 4.10). Two areas of interest were further scrutinized. Two 
protein spots were found differently expressed in the normal, but absent in the 
severely diseased. 
 
Figure 4.10. Dymension software generated 2-D protein spot pattern from superimposed average spots 
in normal and severely diseased groups. The green colour shows the spots increased in intensity, the 
red colour shows the spots in decreased in intensity, and the black represents unchanged spots. 
 
In an area around 40kDa, the spot for tropomyosin was present in the normal 
valves, but down regulated in the moderately diseased valves, and the spot was not 










Figure 4.11. Panel showing how the tropomysin spot was present in the normal, down regulated in the 
moderate and absent in the severely diseased. 
 
In another area around 20kDa, the spot for myosin regulatory light chain 2 
was detected in the normal valves, but drastically down regulated in the moderately 
diseased valves and disappeared in the severely diseased valves (Figure 4.12). 
 
Normal  Moderate 
 
Severe 
Figure 4.12. Panel showing how the myosin regulatory light chain 2 spot was present in the normal, 
down regulated in the moderate and absent in the severely diseased. 
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4.4 Discussion  
This study was undertaken to establish the protein expression profiling in the 
canine mitral valve and to identify proteins that are associated with MMVD. 
Altogether, sixty-four (64) proteins of significance were detected from 1-D gels and 
twenty-two (22) protein spots were positively identified on 2-D gels. Two contractile 
regulatory proteins, namely tropomyosin and myosin regulatory light chain-2 were 
found to be expressed in the normal valves, but down regulated in the moderately 
diseased valves and absent in the diseased. In additional six tentative proteins were 
identified only on the 2-D gels of the diseased valves. 
Recently, the genome expression patterns of the mitral valve from dogs with 
MMVD was reported147. In that study, the transcriptional activities of 23,851 canine 
genes were examined by using oligonucleotide microarray; 229 transcripts (0.96%) 
were found differentially expressed in diseased valves. However, as the levels of 
mRNA do not necessarily correlate with protein synthesis184, the functional 
significance of any gene expression can not be accurately evaluated185. The 
proteomics commodity of gel electrophoresis has the capacity to physically separate 
the proteins found in the mitral valve186. Combining this with mass spectrometry, the 
total protein complement can be characterized182. In this way gene expression at the 
protein level can best represent the pathophysiological mechanisms involved in 
MMVD. As there is likely to be a inherited component in this disease, and a 
polygenic mode of inheritance is suspected in dogs63, finding only a small proportion 
of proteins with significant levels of fold difference in expression between each of 
the two groups (normal and diseased) is highly informative. For example, only 44 
proteins from the qualitative 1-D LC-MS/MS and 37 proteins from quantitative 2-D 
MALDI were found significantly differentially expressed between the normal and 
severely diseased group. These results have brought into perspective those genes 
associate with MMVD that could lead to novel targets for drug development.  
The global approach of proteomics presents an advantage in viewing the 
interrelationship between proteins in any particular tissue. However, in the dog its 
proteins (proteome) are not well characterized at present. Previously attempts to 
identify the dog heart proteins on 2-D gel using peptide mass fingerprinting have 
encountered the same problem187. Due to lack of entries for dog gene products in the 
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current protein databases, protein identification in the current study relied heavily on 
the cross-species comparison of protein sequences. To illustrate this problem, only 
18 out of the 64  (28%) proteins identified from 1-D gel LC-MS/MS were identified 
from the dog databases. While peptide mass fingerprinting can be applied 
successfully for cross-species identification of protein, even a single variation in one 
amino acid residue could affect that protein function, for example alteration of 
enzyme cleavage sites and influence the results.  
As the quantity of protein loaded onto each of the 2-D gels were adjusted to 
weight, any variations in spot intensity between gels would suggest that there was 
proportionally more insoluble material in the gels with apparently lower intensity. 
However, since the spots were quantified relative to the total spot volume, this 
provides a correction for loading effects. 
The repository type of database such as the Mass Spectrometry Protein 
Sequence Database (MSDB) are a rich source for peptide mass fingerprinting 
analysis188. However, as a non-curated database, search results often generated high 
redundancy with little information to the sequence. The National Centre of 
Biotechnology Information non-redundant (NCBInr) database is a comprehensive 
but similarly non-curated protein database. Searched results from NCBInr sometimes 
included protein mixtures, making protein identification difficult. Furthermore, high 
noise signal for the protein keratin was experienced in the data obtained from 
NCBInr. Swiss-Prot is a curated protein sequence database with minimal level of 
redundancy. The protein sequences in Swiss-Prot are manually annotated and 
constantly reviewed180. Nevertheless, interpreting the protein identification and 
associated annotation was sometimes problematic due to synonym usage and multi-
isoforms of the proteins. To achieve the most accurate protein identification work in 
the current study, the Swiss-Prot database was taken as standard. Only the proteins 
identified in Swiss-Prot above the significant level were chosen. Having said that, the 
search results obtained from all three databases did correspond to each other 
resonably well, with a protein identified in Swiss-Prot likewise being found in 
MSDB and NCBInr. The main obstacle to protein comparison from different 
databases was the fact that the identifier, such as the accession number, from one 
database could not be reconciled with the identifier from another database. 
Hopefully, with the ongoing expansion of Swiss-Prot the establishment of UniProt 
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and the integration of predicted protein sequences form the dog genome project this 
problem could be addressed. 
In view of the inadequacy of the current databases, a custom designed 
database compiled from extracted files of ENSEMBL canine genome predicted 
protein sequence was created and was housed in the Institute of Molecular Biology, 
University of Edinburgh server. However, searching against this database was not as 
straightforward as hoped. Results form Mascot peptide mass fingerprint search 
revealed only the ENSEMBL gene transcript code and the gene name was not 
revealed. To obtain the gene name required a further search in ENSEMBL. The gene 
product was confirmed by an additional blast search using gene sequence against the 
coding sequence. Nonetheless, six protein spots were identified on the 2-D gels of 
severely diseased group using the dog genome database. 
Based on the results of the current study, the protein expression profile found 
in the canine mitral valve could be categorised into intracellular (n=41), extracellular 
(n=15) and blood borne (n=8). The following discussion will comment on each of 
the proteins of most interest in turn. The intracellular class could be sub-divided into 
proteins responsible for cytoskeleton formation and organisation and contractility, 
and proteins involved in transcription, cell signalling and energy production. An 
obstacle to applying proteomics analysis was the heterogeneous cellular composition 
of the mitral valve. It is likely that the fibroblast, SMC, VEC, macrophage, mast cells 
and fat cells all contributed to the intracellular protein category80. Therefore, 
proteomics was neither suitable in identifying the cell type in mitral valve tissue that 
expresses the proteins, nor in confirming the protein of interest is altered in a 
particular cell type. However, the changes in protein levels may reflect changes in 
the populations of cells according to the states of the disease.  
Similar to human mitral valve prolapse, myxomatous degeneration of the 
mitral valve in dogs is associated with cell phenotypic alteration, changing from an 
interstitial cell predominantly of fibroblast to a myofibroblast phenotype27, 44, 80, 93. 
The increase in density and size of the actin spot and diminishing of vimentin isomer 
spots associated with disease progression were appreciated on 2-D gels. This 
supports the phenotypic changes represented by the increasing expression of actin in 
myofibroblast44, 80. In may be possible that the over expression of actin filament in 
diseased valve could provide contractile strength in response to mechanical valve 
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failure33, 189. Actins in myofibroblasts also play a role in mediating the formation of 
focal adhesion in ECM146. The actin associated cell–matrix adhesion transmits the 
intracellular contractile force to the substrate and detects the level of stress in the 
matrix190. External signals are relayed into the cell and the myofibroblast responds 
by expressing specific ECM components that then participate in tissue modeling191-
193. α-SMA is transiently expressed in vascular wound healing194. When tissue is 
being reconstituted in normal healing wound, myofibroblasts disappear through an 
apoptotic process. If this process as in fibrocontractive disease is missing, the 
persistence of contractile activity leads to continuous matrix remodeling and 
retraction. The focal adhesion maturation during myofibroblast differentiation 
requires reciprocal proportions of two actin isomers, cytoplasmic actin and α-
SMA190. Four different isotypes of actin were identified from 1-D LC/MS. Two of 
the isotypes, β-1 cytoplasmic and α-actin 1 were common in both normal and 
diseased valves, whereas the α-cardiac and α-2 aortic were found in the normal 
valves only. It is not known which isotypes or what proportion of each isotype is 
optimal for normal mitral valve function, and so how this differential expression 
might contribute to valve disease cannot be stated. Further studies are required to 
confirm these apparent changes in actin isotype expression. 
The intermediate filament vimentin is one major protein found in all 
mesenchymal cells. Previous studies using 2D electrophoresis have shown vascular 
smooth muscle vimentin appears as two isoelectric variants140. Vimentin is highly 
associated with α-actin in vascular tissue195. Three vimentin spots were positively 
identified on 2-D gels in this study, but the significance of this finding cannot be 
stated. It has been proposed that the vimentin and actin composition reflects a 
differential pathway and may be related to special function and pathological 
disorders140. Further sequence study could explore the functionality of the different 
isoforms and their roles in MMVD. 
Two different tropomyosin (TPM) isoforms, namely 1-α and β were 
positively identified in the normal valve, were partially absent from the moderately 
affected valves, but neither were detected in the severely diseased. On the 2-D gels, 
the down regulation of TPM 1-α in the disease process was readily visible. TPM is 
an actin binding protein196. It is widely distributed in skeletal muscle, smooth muscle 
and non-muscle cells. In mammals, there are at least 20 TPM isoforms197. The 
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isoforms are generated from four genes through alternative promoter and alternative 
splice at transcription198, 199. The different isoforms exhibit distinct biochemical 
properties that appear to be performing cell type specific functions200-202. The role of 
TPM is well understood in skeletal muscle, where it regulates actin-myosin 
interaction during contraction203. However, its corresponding role in non-muscle 
cells remains obscure. Investigation from in-vitro and in-vivo experiments suggested 
the multiple isoforms of TPM in non-muscle cells are required for actin filament 
stability, intracellular granule movement, cell shape determination and cytokinesis204, 
205. As there is clear evidence of a contribution of cellular phenotypic alteration in 
the pathogenesis of MMVD, it is this role that is worth considering in the context of 
MMVD. Since the muscle at the base of the leaflet was dissected away, TPM from 
cardiomyocytes was not expected to contribute to the TPM pool.  Previously, the 
TPM α and β isoforms from dog’s carotid have been identified as two separate spots 
on 2-D gel electrophoresis196. The carotid arteries contain predominantly a smooth 
muscle cell (SMC) type. The high homology of non-muscle TPM to skeletal TPM, 
and its interaction with actin in the presence of ATP and Ca2+ has suggested a role in 
cell contractility206. In the absence of actin, experimental work has shown a direct 
interaction between tropomyosin and myosin in smooth muscle cells, thus further 
supporting its role in modifying contractile properties in smooth muscle207. The loss 
of TPM in the latter stages of the disease might compromise the contractile function 
of VICs and any contribution they might make to mechanical stability. 
Myosin light chain 2 (MLC2) is a contractile regulatory protein and was 
identified in the normal but lacking in the severely diseased. The gene expression of 
MLC2 along with other contractile related proteins have been discovered in the of 
interstitial cell cultures from human mitral valve208. Mutation of MLC2 is associated 
with various type of cardiomyopathy209, 210, and it is believed MLC2 is an integral 
part of the myofilaments, loss of which abolishes myofilament assembly resulting in 
embryonic lethality in zebrafish211. The phosphorylation of this protein is essential in 
maintain normal cardiac function during development. Mutation in the 
phosphorylation site leads to dilation and severe tricuspid valve insufficiency212. Of 
possible more relevance to MMVD are studies on vascular SMCs in wound repair 
where it has been shown low-density lipoprotein (LDL) infiltrates the vessel wall and 
becomes aggregated in the ECM proteoglycan. The aggregated LDL induces a 
 184 
differential phenotypic pattern of MLC as revealed in the proteome. Lower levels of 
phosphorylated MLC are found in LDL exposed SMC213. By analogy, it is likely 
during the MMVD process that damaged endothelium no longer modulates the 
infiltration of LDL. Increasing in LDL receptor expression has been linked to 
MMVD151. This idea is supported by the evidence of increasing level of LDL carrier 
apolipoprotein in the disease. Once inside the tissue, the LDL has the potential to 
alter the MLC2 expression and hinder the MLC2 phosphorylation mechanism.  
Heat shock protein 27 (HSP27) was positively identified on 2-D gels in all 
groups on 2-D gels, although less obvious, in the diseased groups. HSP27 is a stress 
inducible cytosolic protein that is present in many normal cells. The synthesis of 
HSP27 is induced by environmental and pathophysiological stresses. Besides its 
putative role in thermo-resistance, HSP27 may be involved in the survival and 
recovery of cells when exposed to stressful conditions214. HSP27 is also associated 
with the contractile proteins actin, myosin and TPM in SMCs215, and it is in this role 
its differential expression may contribute to MMVD changes. Phosphorylation of 
HSP27 enhances its association with actin and TPM216. The phosphorylated HSP27 
modulates the dissociation of caldesmon from TPM leading to contraction in 
SMC217. Interestingly in dogs with mitral regurgitation, survival signaling stimulates 
the activation of HSP27 to counter apoptosis in the left ventriclar myocardium. β-
adrenergic blockade prevents this activation of HSP27218.  
The contribution of changes to the contractile proteins and their modifiers in 
the MMVD proteome is worth considering. Human floppy mitral valve is a 
complication of mitral valve prolapse in part caused by myxomatous degeneration, 
and often leads to severe mitral regurgitation and left ventricular dysfunction109, 219, 
220. Myxomatous mitral valve leaflets have been shown to be more extensible than 
normal13, 221. Although the mitral valve mechanics in dog was not investigated in the 
current study, mitral valve mechanical dynamics in other animal models have shown 
the leaflets experience large anisotropic strains and high strain rate during systole. 
The leaflet functionally behaves as an anisotropic quasi-elastic material222, 223, and 
undergoes deformation until the stretching reaches a plateau. It has been suggested 
this plateau phase is a result of full stretching of leaflet upon closure74, 224. During the 
MMVD process, the VICs changes from a relatively quiescent synthetic fibroblast 
phenotype to a more activated contractile myofibroblast phenotype. Each phenotype 
 185 
is characterized by expression of a unique set of structural and contractile proteins, 
and of different isoforms that correlate to different gene expression patterns225. TGF-
β is usually considered the inducer of the differentiation of fibroblasts into 
myofibroblasts94, 144, 226, while α-SMA is a prominent phenotypic feature of and 
contributor to the contractile properties of myofibroblasts. TGF-β, furthermore, can 
induce actin-associated proteins that may contribute to the contractile properties of 
the myofibroblast, while TPM and HSP27 also can contibute to cellular contractile 
function227. From this we can see a role for each individual differentially expressed 
protein, and the potential for close interaction between such changes, in MMVD, but 
their possible contribution to aetiopathogenesis cannot be stated. 
Another consideration is the potential role for cysteine and glycine-rich 
proteins found in the normal valve in mechanical stretch sensing228. Proteins 
involved in contractility (actin, TPM, MLC2 and HSP27) together with proteins 
responsible for energy production (ATP synthases and creatine kinase) suggest the 
contractile properties are important in normal functionality of the mitral valve during 
the cardiac cycle. Contraction of VICs could regulate the return of the mitral valve to 
its original configuration after systole229. In diseased valve, while contractile 
myofibroblasts participate in mitral valve repair and remodeling, down regulation of 
the contractile regulatory proteins TPM and MLC2 in diseased valves could hamper 
the contractile mechanism and further promote MMVD.  
In the previous chapter, using an antibody against smooth muscle myosin for 
immunophenotyping, small number of myosin positive cells was found exclusively 
associated with vessel walls, regardless the grade of disease. However, in the 
proteomics study MLC2 was found to be expressed in the normal, but down 
regulated in the diseased valves. It is necessary to explain this disparity. Myosin is 
composed of 6 subunits; 2 myosin heavy chains, 2 essential light chains and 2 
regulatory light chains (MLC2)210. The antibody employed specifically targeted the 
only smooth muscle myosin heavy chains (SM-1 and SM-2). It did not cross-react 
with skeletal, cardiac or non-muscle myosin. Myosin heavy chains were identified 
from LC/MS in the normal valve, but at non-significant low level in the diseased. 
The exact modes of the contractile apparatus in smooth muscle are not clear. It is 
known that the smooth muscle does not have troponin, but instead calponin is 
expressed at the late stage of cell development230, 231.  
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A putative filamin A interacting protein (FILIP) was found in the severely 
diseased mitral valves. The functional characteristic of FILIP has recently been 
reported. Over expression of FILIP in vitro results in inhibition of cell proliferation 
and migration232, 233. FILIP as its name literately suggests is a filamin (FLN) 
associated protein. FLN is a cytoplasmic protein cross-linking actin into a 3-D 
network structure234. Unfortunately identification of FLN was not found altered by 
mass spec, probably due to its large size. FLN has been shown to be in competitive 
binding with tropomyosin235, 236 and is required for cell migration237 and mutation in 
the gene coding for FLN has been found in human MMVD238. Whether or not 
defective FLN and over expression of FILIP contribute to myxomatous areas in 
valve leaflets requires further investigation. 
VICs manifest their phenotypic plasticity in response to change in 
environment and functional requirement, acquiring different structure and 
morphologies239. Proteins governing gene transcription such as histones could bring 
about these changes, and there was reduced expression of histones in the diseased 
mitral valves. Histones are DNA interacting proteins responsible for the chromatin 
structure240. The fundamental unit of chromatin is nucleosome, an octamer consisting 
two molecules of each of the histones H2A, H2B, H2 and H4241. Histone proteins 
and their modification play a vital role in the regulation and expression of genes. The 
cellular level of H2B histone is linked to the control of the cell cycle and the onset of 
differentiation242. Gene activation and repression is regulated by acetylation and 
deacetylation for the histone modifications243. Transformation transcription domain 
associated protein (TRRAP) is a cofactor for histone acetyltransferase. TRRAP 
appears to be responsible for the recruitment of the histone acetyltransferase to 
chromatin during transcription, replication and DNA repair. The ability of TRRAP to 
coordinate distinct chromatin based processes suggests its deregulation may 
contribute to disease244. The presence of these H2B histone variants in the normal 
valve but not diseased and TRRAP in the diseased valve but absent in normal might 
suggest a higher level of control at gene transcription.   
Other proteins that were positively identified in the normal valves possess a 
“protective” function. The serine threonine protein kinase has a role in cell survival 
and under stress conditions245. Peroxiredoxin is involved in redox regulation of the 
cell, eliminating harmful peroxides generated during metabolism246. Superoxide 
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dismutase catalyzes destruction of free radicals superoxide produced within the cell.  
The superoxide is a common radical which is toxic to cells. Superoxide dismutase 
acts as an anti-oxidant in the body247, and is known to protect against endothelial 
dysfunction in the heart248. To what extent changes in these proteins affect the 
diseased valve is not known, but can be speculated to have adverse effects on cell 
function. 
The functional mechanical dynamics of the mitral valve are intricately linked 
to the composition of its ECM249. Alterations in ECM contents have been found in 
the equivalent human disease118. The histological changes in MMVD are disruption 
of the fibrosa layer with fragmentation of collagen bundles and an associated 
myxomatous degeneration17. Normal mitral valves contain mainly collagen I, III and 
V. However, the results from collagen composition analysis in human MMVD are 
contradictory and so difficult to interpret77, 78, 115. X-ray diffraction has shown the 
loss of collagen in visibly diseased areas of valves, changes in fibril alignment and 
total tissue volume in canine MMVD35. In addition, visibly normal areas, often co-
exist in close proximity to diseased areas in diseased valves suggesting the collagen 
change is patchy even at the histological level. Collagen abnormality is suspected to 
contribute to the pathological processes that occur in diseased leaflets for two 
reasons. Firstly, collagen is the major component of the ECM bearing stress and 
strain250. Secondly, mitral valve prolapse is a complication to some inherited 
connective tissue disorders such as in Marfan syndrome and Ehlers-Danlos 
syndrome67, 69, 251. Despite this, while linkage analysis using human pedigrees for 
mitral valve prolapse has traced a marker mapping to chromosome 16p252, and 
another genotypic linkage study has mapped a locus for mitral valve prolapse on 
chromosome 13253, the genes encoding collagen in valve tissue have not been linked 
to mitral valve prolapse254 and furthermore, mutations in the collagen I, III and V 
genes were found not to be responsible for mitral valve prolapse. However, more 
recent understanding of single nucleotide polymorphism has questioned these 
findings and a collagen III polymorphism has been linked to mitral valve prolapse in 
people255. 
Allied with the collagens and the organisation of the ECM are fibronectin and 
members of the small leucine rich proteoglycans family (SLRP), and these ECM 
components with collagen binding domains were identified in canine mitral valve 
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proteome. The proteomics work presents a picture of an intricate mitral valve ECM 
that requires all the components to be present in the correct proportions to permit 
normal mechanical functions. It is the relationships and interactions between 
different ECM components that are critical to the structural and functional of the 
mitral valve. The current understanding of the normal mitral valve is that there is a 
differential localisation and distribution of the ECM components resulting directly 
from VIC regional synthetic heterogeneity34, 111, 124, 239, 256, and this is affected by 
mitral valve leaflet response to loading and accommodation of physical stresses that 
occur throughout the cardiac cycle223, 257, 258.  
Fibronectin (FN) is a high molecular weight multi-domain ECM 
glycoprotein, that binds to cell surface receptor integrins and to other structural 
elements, including collagen, glycosaminoglycan and fibrin259.  Expression of FN by 
both mitral valve interstitial cells and endothelial cells has been demonstrated in 
vitro260, 261. FN also plays a role in wound healing by providing suitable substrate for 
cell migration262, 263. FN is known to interact with TGF-β by regulating matrix 
assembly of latent TGF-β binding protein264 and FN along with laminin have a role 
in sequestering and presenting TGF-β so controlling VIC differentiation to 
myofibroblasts144, 265, 266. FN also has been shown to stimulate VIC adhesion and 
expression of α-SMA144, 267. Once differentiated, myofibroblasts exert tension on the 
ECM resulting in realignment of FN fibrils92. Up regulation of FN in diseased valves 
could promote VIC migration towards injured sites and induce fibroblast to 
myofibroblast differentiation. In a previous chapter using immunohistochemistry, FN 
was found densely accumulated near the surfaces in the distal zone of the leaflet, but 
decreased in myxomatous areas. This corresponds with observations in 
morphological studies where increasing α-SMA cell numbers are found near the 
surfaces in diseased valves, but there is a decrease in cell numbers in the 
myxomatous areas in the spongiosa layer. 
The small leucine rich proteoglycans (SLRP) are a family of proteins that 
share a common repeats of leucine rich structural motif. They are present in the ECM 
and linked to members of the GAG family. The four SLRPs (biglycan, decorin, 
fibromodulin and lumincan) identified in the mitral valve in this study fall into two 
classes. Class I comprises of biglycan and decorin, and Class II includes 
fibromodulin and lumincan268. Fibromodulin was the only one found to be absent in 
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the diseased valves. SLRPs interact with different types of collagen in ECM269. In 
vitro, they were shown to regulate collagen fibrillogenesis, an important process in 
development and tissue repair. SLRP deficient mice developed a wide array of 
connective tissue disorders, resulting primarily from the abnormal collagen 
fibrillogenesis270. Biglycan and decorin can bind to collagen VI in a competitive 
manner and it was interesting to note collagen VI was absent in the diseased valves. 
While collagen VI is not a major contributor to the total collagen content of the 
valve, it is a major component of the microfibril network and interacts with cell 
membrane integrin271. Collagen VI with fibronectin may act as anchor point linking 
the basement membrane of interstitial cells272. It is thought these proteoglycans play 
a regulatory role in the process of microfibril assembly273.  Moreover, collagen 
phagocytosis by fibroblast is regulated by decorin274. Over expression of mRNA for 
decorin has been detected in MMVD and it has been suggested over production of 
decorin accounts for the defective organization of collagen and contributes to 
fragility of the diseased tissue125. Fibromodulin is known to interact with type I and 
type II collagen275. Fibromodulin and its close relative lumincan bind to the same 
region on collagen type I fibril, suggesting they have a function related to the 
regulation of collagen organization276. Decorin, biglycan and fibromodulin all 
interact with TGF-β, with fibromodulin showing the highest affinity. They may 
regulate TGF-β activities by sequestering TGF-β within the ECM from cells277. In 
this study, absence of the strong TGF-β binding fibromodulin in the diseased valves 
corresponds with the presumed TGF-β induced transformation of fibroblasts to 
myofibroblasts. Interestingly, TGF-β was also identified in the normal valve 
proteome, and it may be that TGF-β is bound to fibromodulin in the ECM reservoir, 
and so limiting its availability for fibroblast in transformation.  
Currently, there is no strong evidence suggesting that MMVD involves an 
inflammatory process, and this would appear also to be the case in human 
myxomatous mitral valve degeneration150, 158. Genetic polymorphism in the 
interleukin gene has not been linked to human mitral valve prolapse278. However, a 
recent genomic expression study has shown the up-regulation of genes for 
inflammation and immunity in dogs with MMVD147. In the early part of this thesis, 
mast cells and macrophages were identified in mitral valve of dogs with and without 
MMVD80. The significance of the increase in IgG found during the disease process is 
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not known. Presumably, the IgG derived from circulating IgG entered through 
damaged endothelium. Their exact functions require further study.  
This proteomics study has revealed the following were associated with 
MMVD: the intracellular proteins involved in contractile regulatory, gene activation, 
stress relief, anti-oxidant and motility; down regulation of collagen type VI and 
fibromodulin, but up-regulation in fibronectin in the ECM; possibly blood borne 
LDL attached to apolipoprotein. These proteins could potentially yield novel 
biomarkers reflecting MMVD, establishing detection strategies and response to 
therapeutic treatments279. While this has been a limited discussion on the function of 
the individual differentially expressed proteins found in this proteomic study, it can 
be appreciated that reasonable conclusions can be made as to how proteome changes 
fit into our understanding of this disease. The combined morphological, cellular and 
proteomic data support a dyscollagenesis explanation for what is happening in 
diseased valves but does not point directly to causality. 
Lastly, this proteomic study reiterates the potential application of the canine 
disease as a model of disease in human and veterinary medicine. The dog model has 
been used widely in early research studying cardiovascular physiology pertinent to 
human. Dog models have made the greatest contribution to medical advance in 
cardiology, from development of heart lung machine, heart valve repair and heart 
transplant. In 2004, the dog was the fifth mammal to have its entire genome 
sequenced and the dog genome places itself closer to humans in the evolutionary tree 
than mouse or rat181. Canine MMVD has a strong resemblance in human mitral valve 
prolapse. The parallel of these two diseases in different aspects were astonishing and 
has been discussed in detail71. In proteomics, cardiac tissue from human and dog co-
migrate on 2-D gels and a higher success rate in being identified compared to the rat 
and mouse280. Overall, the dog would appear to represent a good model for study of 
the phenotypic to genotypic relationships of this disease in human281. 
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5 Chapter 5 Polymerase chain reaction 
5.1 Introduction 
The reverse transcription polymerase chain reaction (RT-PCR) is a common 
method used to compare expression of the mRNA of a specific gene. In previous 
chapters using antibodies against specific phenotypic markers and protein 
electrophoresis incorporating mass spectrometry, many proteins potentially 
associated with MMVD were identified. In order to validate the findings of the 
immunohistochemistry and proteomics generated data, gene expression for eight 
selected proteins of interest (vimentin, α-SMA, tropomyosin, myosin light 
polypeptide 4, MMP-13, biglycan and fibrillin) were examined using RT-PCR. To 
quantify gene expression, a housekeeping gene that is constitutively expressed was 
used as an internal control. The control gene is essential to correct the sampling 
difference. By referring to the control gene, the mRNA level is normalized thus 
making comparisons between groups possible. In this study, three commonly used 
housekeeping genes glyceraldehyde 3-phosphate dehydrogenase (GAPDH), 
ribosomal protein L19 (RPL19) and 18S rRNA were analyzed as references for gene 
expression in canine MMVD. All the primers used in PCR amplification were 
purpose designed canine specific oligonucleotide primers.  
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5.2 Materials and Methods 
5.2.1 Total RNA isolation 
A total of eighteen dog mitral valve tissue samples were allocated to three 
groups according to the severity of the disease as follows: six healthy normal 
(Whitney’s type 0), six moderately diseased (corresponding to Whitney’s type I and 
II) and six severely diseased (corresponding to Whitney’s type III and IV). The 
mitral valve tissue samples stored in RNAlater (Ambion, Huntington, UK) were 
removed from -20° C storage and thawed at room temperature. Any excessive 
muscle and/or chordae tendinae were quickly trimmed off. The remaining tissues 
were diced into small pieces using a sterile scalpel blade. About 30 mg of the tissue 
was transferred into a 2.0 ml tube containing 1.4 mm ceramic spheres (Lysing Matrix 
D, QBioGene, Cambridge, UK). The remaining RNA isolation was carried out using 
an RNeasy Fibrous Tissue Mini kit (Qiagen, West Sussex, UK) with slight 
modifications. Complete cell disruption was carried out in 900 µl Buffer RLT on a 
FastPrep FP120 mixer mill, (Thermo Electron Corporation, Berkshire, UK). The 
lysate was loaded onto a QIAshredder column (Qiagen, West Sussex, UK) placed in 
a 2 ml collection tube and centrifuged for 2 min at 10,000 g. The collected 
homogenate was mixed with 10 µl of proteinase K (Qiagen, West Sussex, UK) 
solution and placed in 55° C water bath for 10 min to remove the proteins. After the 
proteinase K digestion, the homogenate was centrifuged for 3 min at 10,000 g. The 
supernatant was transferred into a new 2 ml microcentrifuge tube and mixed with 
half volume of ethanol. Up to 700 µl of the sample was loaded into the RNeasy Mini 
Spin Column in a 2 ml collection tube before centrifuging at 10,000 g for 1 min. The 
flow through was discarded. This step was repeated for the remaining sample and the 
flow through were discarded. 350 µl of Buffer RW1 was pipetted into the RNeasy 
Spin Column and centrifuged at 10,000 g for 1 min to wash the column. 10 µl of 
DNase 1 stock solution was mixed with 70 µl Buffer RDD (Qiagen, West Sussex, 
UK), the DNase mixture was pipetted directly onto the RNA sitting on the silica gel 
in the RNeasy Spin Column. The DNase digestion was incubated at room 
temperature for 15 min. 350 µl of Buffer RW1 was pipetted into the RNeasy Spin 
Column, the column was washed by centrifuge at 10,000 g for 1 min. The flow 
through was discarded. The RNeasy Spin Column was further washed by loading 
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two successions of 500 µl Buffer RPE into the column and centrifuging at 10,000 g 
for 1 min. To ensure no ethanol was carried over, the RNeasy Spin Column was 
place in a new 2 ml collection tube and centrifuged at 10,000. Finally, the RNeasy 
Spin Column was placed in a new 1.5 ml collection tube. 100 µl of RNase-free water 
was added in the RNeasy Spin Column and centrifuged at 10,000 g for 1 min to elute 
the RNA. 
5.2.2 RNA quantification  
RNA was accurately quantified by measuring its absorbance in a NanoDrop 
ND-1000 UV-Vis spectrophotometer (NanoDrop Techologies, Labtech, East Sussex, 
UK). The optical density (OD) of RNA was measured at its peak absorbance 
wavelength of 260 nm. The concentrations of RNA samples were calculated 
automatically in ng/µl. The RNA samples were stored at -70°C until further reaction. 
5.2.3 Reverse transcription of RNA  
Approximately 100 ng of RNA samples were reverse transcribed to 
complementary DNA (cDNA) in a final reaction volume of 20 µl containing 5 mM 
MgCl2, 1X Reverse Transcription Buffer (10 mM Tris-HCl pH 9.0 at 25°C, 50 mM 
KCl, 0.1% Triton® X-100), 1 mM each dNTP, 1 unit/µl Recombinant RNasin® 
Ribonuclease Inhibitor, 15 unit/µl AMV Reverse Transcriptase, and 0.5 µg 
Oligo(dT)15 primers (Reverse Transcription System, Promega, Southampton, UK) 
and incubated for 1 hr at 42°C and then for 5 min at 99°C to terminate the reaction 
on a thermo cycler (TechGene, Techne, Staffordshire, UK). The cDNA solutions 
were then diluted to 50 µl with RNase free water (Promega, Southampton, UK). The 
cDNA preparations were stored at -20°C. 
5.2.4 Primer design 
Canine specific oligonucleotide primers to amplify the genes of interest were 
designed from searching the published genes sequences using Ensembl282 and/or 
EntrezGene (National Centre for Biotechnology Information, National Institute of 
Health). The primer sequences were determined in the coding regions of the target 
mRNAs with the online Primer3 primer design software283 with settings (size opt 20; 
Tm 60°C; PCR product size ranges 250 to 500 base pairs) to maximise specificity and 
priming efficiency at the optimal temperature, whilst avoiding secondary structure 
formation and self annealing. The primer sequences were screened against other 
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known sequences to eliminate unwanted cross reactivity via BLAST (National 
Centre for Biotechnology Information). The oligonucleotide primers syntheses were 
performed by Operon Biotechnologies (Cologne, Germany). The oligonucleotide 
primers were first reconstituted to 100 µM according to the manufacturer’s 
instructions before being diluted to 2 µM in DNase-free water. The oligonucleotide 
primers were stored in -20°C until used. 
 


































































































5.2.5 Polymerase chain reaction (PCR) 
PCR amplifications were carried out in 50 µl volumes containing 5 µl of 
cDNA template, 0.4 µM of each of left and right primers, 1.25 U Taq polymerase 
(Roche, East Sussex, UK), 0.2 mM of each deoxyribonuceotide triphosphates 
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(dNTPs) in 1X PCR reaction buffer composed of 10 mM Tris-Hcl and 1.5 mM 
Mg2Cl2 (Roche, East Sussex, UK). The PCR conditions were chosen to maximize the 
reaction rate. The PCR reaction conditions consisted of the initial denaturing at 94°C 
for 2 min, then in cycles of denaturing at 94°C for 40 sec, primer annealing at 60°C 
for 40 sec and elongation at 72°C for 2 min, before a final elongation at 72°C for 7 
min; at the end of the reactions the temperature was brought down to 10°C 
(GeneAmp PCR System 2400, Perkin Elmer, Buckinghamshire, UK). Negative 
controls without cDNA templates were included in every reaction.  
5.2.6 PCR analysis by electrophoresis 
10 µl of each PCR reaction product was mixed with 2 µl of the gel loading 
dye and eletrophoresed through a 1.2% w/v agarose gel (Invitrogen, Paisley, UK) in 
Tris-acetate-EDTA (TAE) buffer containing 0.5 µg ethidium bromide (Sigma, 
Dorset, UK) running for 45 min at 100 V using a Horizon 11-14 Gel Electrophoresis 
System (Whatman, Kent, UK). 1kb DNA ladder was included in each gel for 
molecular size indication. The eletrophoresed gels were placed in the imaging 
chamber of a Kodak Digital Image Station 440CF (Kodak, Rochester, NY, USA). 
The gels were exposed under ultra-violet light at 580 nm for 3 cycles of 20 s, the 
images were captured using the Kodak 1D 3.6 software (Kodak, Rochester, NY, 
USA).  
5.2.7 Semi-quantitative PCR by densitometry  
The optimal numbers of PCR cycles for each primer set were estimated 
empirically, by running the PCR for varying cycle numbers and plotting the results to 
determine cycle number corresponding to the linear amplification phase. This 
rendered comparison of amplified DNA between samples possible. All images were 
analyzed with ImageJ (National Institute of Health, USA) to determine integrated 
pixel density as a measure of the amount of PCR amplification product formed.  
5.2.8 Statistical analysis 
The statistical method used is similar to the statistical method described in 
Chapter 2. The densitometric data are expressed as means ± standard error of the 
means. Inferential statistical analysis involved one-way analysis of variance ANOVA 
testing, a p-value less than 0.05 was considered as being statistically significant. 
Means comparisons between groups were subjected to each pair student’s t-test. Due 
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to the number of samples in this study, the non-parametric Wilcoxon ranked score 
was applied to validate the significance level and Chi2 were reported along side the 
p-value. In the case that ANOVA of group means yielded no statistical difference, 
that is when p>0.05, then the least significant number of power were calculated. 




5.3.1 RNA quantification 
RNA quantification has shown five samples, three in the normal group, one 
in each of the moderately diseased and severely diseased groups had very low total 
RNA concentration below 10 ng/µl. Due to their low RNA concentrations, they were 
excluded for further analysis. 
5.3.2 Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
The gene expression level for the housekeeping gene GAPDH was 
inconsistent between samples. The RT-PCR amplification produced a segment of 
GAPDH that is 464 bp in length. The variable expression of GAPDH was obvious by 
visual inspection. One of the samples in the severely diseased group had no visible 
band on the gel (Figure 5.1). Triplicates of RT-PCR amplifications for GAPDH 
yielded identical results proving the GAPDH expression was indeed variable 
between samples. This inconsistency in mRNA expression renders GAPDH 
unsuitable to be use as a reference gene. No further analysis was justifiable. 
 
 
Figure 5.1. The gel electrophoresis picture shows the RT-PCR products for the housekeeping gene 
GAPDH (464 bp) after 29 cycles. The variable expression of GAPDH between samples was visible; 
one sample in the severe group has virtually no visible mRNA. 
 
5.3.3 Ribosomal protein L19 
The RT-PCR for the housekeeping gene RPL19 produced a fragment 479 bp 
in length. The level of RPL19 expression was much more consistent across all 




Figure 5.2. The gel electrophoresis picture shows the RT-PCR products for the housekeeping gene 
RPL19 (479 bp) after 32 cycles. The bands on the gel show a consistent RPL19 expression across all 
samples. 
 
Semi-quantitative analyses using densitometry showed the expressions of 
RPL19 in all three groups were closely matched. Although the expression in the 
normal group was slightly higher, there was no significant difference (p=0.6998) in 


































frGroup  Mean 
Normal A 42208.333 
Severe A 38298.800 




Figure 5.3. Densitometric analysis of the RPL19 gene expression. The results from ANOVA, t-test, 
Wilcoxon ranked test and LSN are presented. 
 
5.3.4 18S ribosomal RNA 
The RT-PCR for the housekeeping gene 18S rRNA produced a fragment of 
273 bp in length (Figure 5.4). The amplified 18S rRNA products appeared as distinct 
bands uniformly aligned on the gel after 22 cycles. That was fewer amplification 
cycles than were required for GAPDH (29 cycles) and RPL19 (32 cycles). Therefore, 
the 18S rRNA expression level was much higher compared to GAPDH and RPL19.  
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Figure 5.4. The gel electrophoresis picture shows the RT-PCR products for the housekeeping gene 
18S rRNA (273 bp) after 22 cycles. The bands on the gel show a consistent 18S rRNA expression 
across all samples. 
 
The densitometric analysis of 18S rRNA expression has shown the mRNA 
concentrations were evenly matched in all groups, as indicated by the high p-value 
(0.8867) and larger LSN (322.91) (Figure 5.5). The constant transcription of 18S 
rRNA in canine mitral valve with or without MMVD has made 18S rRNA a suitable 
reference gene. Therefore, the expression levels of other genes were normalized 




































Group  Mean 
Moderate A 24384.600 
Normal A 24188.333 




Figure 5.5. Densitometric analysis of the 18S rRNA gene expression. The results from ANOVA, t-test, 
Wilcoxon ranked test and LSN are presented. 
 
5.3.5 Vimentin 
The RT-PCR for vimentin produced a fragment of 490 bp. Variations in band 
intensities between samples were recognized (Figure 5.6).  
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Figure 5.6. The gel electrophoresis picture shows the RT-PCR products for the vimentin gene (490 bp) 
after 28 cycles. 
 
Analysis of the normalized densitometry values, normalised against 18S 
rRNA showed the vimentin expression was slightly higher in the normal group, 
followed by the severely diseased group, and the moderately diseased group had the 
lowest expression level. However, no significant difference was achieved using 
ANOVA (p=0.3949) and no difference was found in between group comparison 

































Group  Mean 
Normal A 1.1078917 
Severe A 0.9843864 




Figure 5.7. Densitometric analysis of the normalized vimentin gene expression. The results from 
ANOVA, t-test, Wilcoxon ranked test and LSN are presented. 
 
5.3.6 Smooth muscle α-actin (α-SMA) 
The RT-PCR for (α-SMA) produced a 449 bp fragment in all samples 
(Figure 5.8).  
 
 
Figure 5.8. The gel electrophoresis picture shows the RT-PCR products for the α-SMA gene (449 bp) 
after 28 cycles. 
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Analysis of the normalized densitometry showed the α-SMA expression level 
in the normal group was the highest, followed by the severely diseased group 
whereas the moderately diseased group showed the lowest level of expression. The 
sample distribution in the moderately diseased groups covered a wide range. Both 

































Group  Mean 
Normal A 0.90588275 
Severe A 0.78651207 




Figure 5.9. Densitometric analysis of the normalized smooth muscle α-actin gene expression. The 
results from ANOVA, t-test, Wilcoxon ranked test and LSN are presented. 
 
5.3.7 Tropomyosin (TPM) 
RT-PCR for TPM amplified a 279 bp fragment. Weaker bands were visible 
on the gel from the moderately diseased groups (Figure 5.10). 
 
 
Figure 5.10. The gel electrophoresis picture shows the RT-PCR products for the tropomyosin gene 
(279 bp) after 30 cycles. 
 
Analysis of the normalized densitometry values revealed the expression level 
of TMP in severely diseased group was the highest followed by the normal group. 
The moderately diseased group had the lowest expression level. No difference was 

































Group  Mean 
Severe A 0.75284532 
Normal A 0.66555601 




Figure 5.11. Densitometric analysis of the normalized tropomyosin gene expression. The results from 
ANOVA, t-test, Wilcoxon ranked test and LSN are presented. 
 
5.3.8 Myosin light polypeptide 4 (MYL-4) 
RT-PCR for MYL-4 produced a 426 bp fragment. The intensity of PCR 
product bands was considerably weaker in the moderately diseased group (Figure 
5.12). 
 
Figure 5.12. The gel electrophoresis picture shows the RT-PCR products for the myosin light 
polypeptide 4 gene (426 bp) after 28 cycles. 
 
Analysis of normalized densitometry values has showed the MYL-4 
expression was highest in the severely disease group, followed by the normal group 
and was lowest in the moderately disease groups. Although the p=0.0829 from 
ANOVA is quite low, it did not reach a significant different level. Between group 
comparisons using the t-test has found the severely diseased group was significantly 



































Group   Mean 
Severe A   0.88630832 
Normal A B 0.79435731 




Figure 5.13. Densitometric analysis of the normalized myosin light polypeptide-4 gene expression. The 
results from ANOVA, t-test, Wilcoxon ranked test and LSN are presented. 
 
5.3.9 Biglycan 
RT-PCR for biglycan produced a fragment of 486 bp in length. Variation in band 
intensities between samples was evident. The bands in the moderately diseased group 
appeared faint (Figure 5.14). 
 
Figure 5.14. The gel electrophoresis picture shows the RT-PCR products for the biglycan gene (486 
bp) after 31 cycles. 
 
Analysis of normalized densitometry showed the biglycan expression level in 
the normal groups was slightly higher than the severely diseased. The expression 
level in the moderately diseased was at the lowest. No significant difference was 


































Group  Mean 
Normal A 0.81687501 
Severe A 0.71221670 




Figure 5.15. Densitometric analysis of the normalized biglycan gene expression. The results from 
ANOVA, t-test, Wilcoxon ranked test and LSN are presented. 
 
5.3.10 Fibronectin (FN) 
RT-PCR for FN produced a 307 bp fragment. Variation in band intensity 
between samples was evident (Figure 5.16).  
 
Figure 5.16. The gel electrophoresis picture shows the RT-PCR products for the fibronectin gene (307 
bp) after 28 cycles. 
 
Analysis of normalized densitometry has shown the highest FN expression 
level was in the severely diseased, then the normal and lastly the moderately diseased 

































Group  Mean 
Severe A 0.51737561 
Normal A 0.42558810 




Figure 5.17. Densitometric analysis of the normalized fibronectin gene expression. The results from 
ANOVA, t-test, Wilcoxon ranked test and LSN are presented. 
 
5.3.11 Fibrillin (FBN) 
RT-PCR for FBN produced a fragment of 318 bp in length.  The variation in 
band intensity between samples was recognized (Figure 5.18).  
 
Figure 5.18. The gel electrophoresis picture shows the RT-PCR products for the fibrillin gene (318 bp) 
after 31 cycles. 
 
Analysis of densitometry has shown the highest FBN expression in the 
normal, markedly attenuated in the severely diseased and low in the moderately 

































F ib r i l l i n
 
Level  Mean 
Normal A 0.13061076 
Severe A 0.11327050 




Figure 5.19. Densitometric analysis of the normalized fibrillin gene expression. The results from 
ANOVA, t-test, Wilcoxon ranked test and LSN are presented. 
 
5.3.12 MMP-13 
The RT-PCR for MMP-13 produced no visible bands on the gel after 35 
cycles. After 55 cycles of amplification, two bands appeared in the normal group, 
and apart from the expected 496 bp fragment there was an additional band measured 
about 310 bp. The moderately disease group did not produce the expected 496 bp 
fragment, but produced a 310 bp fragment instead. Neither the 496 bp nor 310 bp 
fragment were found in the severely diseased, instead it produced a unique fragment 
about 600 bp in length (Figure 5.20). The erratic expression patterns and low 
expression level in MMP-13 rendered further analysis impossible. 
 
Figure 5.20. The gel electrophoresis picture shows the RT-PCR products for the MMP-13 gene after 55 
cycles. The normal (N) contains two bands, the expected 496 bp and a fragment about 310 bp. The 
moderately diseased lacking the expected 496 bp fragment but produced a 310 bp fragment instead. 
The severely disease also lacking the expected 496 bp fragment but it produced a unique fragment 




Previous Chapters in this thesis have identified changes in the expression of 
proteins potentially associated with MMVD. This study forms a pilot experiment to 
investigate the gene expression in the mitral valve associated with MMVD. The 
primary aim of this study is to validate the results obtained from the 
immunophenotypic and proteomics studies. Eight genes of interest were selected and 
their expression levels in normal and diseased states were investigated. Confirmation 
of expression of these genes also served another purpose since positive gene 
expression would clear concern arising due to technical limitations in other studies. 
For example, in the immunohistochemistry study, almost all the commercially 
available antibodies were designed against human or mouse antigens and seldom 
against the canine antigens. Although before purchase, a specific antibody was 
scrutinized, evaluated and compared to other similar antibodies on the market, often 
the decision on one antibody, but not another was based on personal opinion rather 
than experience, even in the case where an antibody had been reported to cross react 
with dogs. The financial implications of checking multiple antibodies against the 
same antigen also had to be considered. In the proteomics study, many proteins were 
identified through cross species comparison of protein sequences. Using canine 
specific oligonucleotides primers to amplify transcriptional mRNAs in this study the 
expression of a particular protein in the dog could be ascertained.  
Unfortunately, five samples with low levels of RNA concentrations had to be 
excluded in this study. Losing these samples, especially three in the normal group 
has affected the statistical powers in the samples groups. It is known that the 
temperature and time-course after tissue removal are factors influencing RNA 
degradation284, 285. It is possible the time-course between the tissue collection and 
tissue preservation in RNA stabilization reagent was not tolerated in these samples, 
so the RNA had degraded.   
Since a suitable reference gene for the canine mitral valve system was not 
known, the first task was to find a suitable endogenous reference gene as control286, 
287. A variable expressed gene would end up with misleading results288. Previous 
study had shown the β-actin cannot be used as a control gene in ovine VICs289. Three 
common housekeeping genes GAPDH, RPL-19 and 18S rRNA were evaluated for 
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expression in normal, moderately diseased and severely diseased states. It could be 
shown that the 18S rRNA gene expression appeared almost constant throughout all 
stages of MMVD. The expression of RPL-19 was reasonably consistent. In contrast, 
the expression of GAPDH was too variable and deemed unsuitable to be considered 
as a reference gene for canine MMVD work. It is known that the RNA for 18S rRNA 
is more tolerant to degradation than the RNA for GAPDH290, and this may explain 
the difference found. 
The gene expression for vimentin, α-SMA, TPM, MYL-4, biglycan, FN, 
FBN MMP-13 were demonstrated in canine mitral valve using RT-PCR. Their 
functions and possible roles related to MMVD were discussed in previous Chapters. 
Unfortunately, ANOVA analyses did not detected statistical differences in any of the 
gene expressions as the disease progressed (normal to moderate to severe). The least 
significant numbers (LSN) indicated an inadequate number in the sampling pool. If 
there were an increase by just two samples in each group or six or seven samples in 
the total pool, the statistical analyses might give a different outcome. Limitations of 
time and the problem of clinical tissue availability prevented large number of 
samples being examined.  
While expression of some genes was in agreement with the results already 
reported in the early Chapters of this thesis (increased FN [section 3.3.10] in severely 
diseased valves for example), others results contradicted the earlier work (decreased 
actin [section 3.3.3] and increased in TPM [section 4.3.2] expressions). However, to 
presume functionality of a protein based on its transcriptional level is an incorrect 
way of looking at a complex biological system, since once an mRNA has been 
transcribed, it undergoes a series of downstream splicings and modifications which 
might not necessary result in protein expression291. Moreover, isoforms with high 
sequence homology add to the complication. However, gene expression can provide 
much valuable information on the level of gene activity in MMVD valves184. Since 
the MMVD has a heritable component, understanding at gene expression would 
provide useful information prior to closer inspection of the genome292. Even though 
the RT-PCR products in this study were not sequenced, with the canine genome fully 
sequenced and some of the single nucleotide polymorphisms (SNPS) are now 
known293, genetic approaches using genetic markers or candidate gene 
methodologies can now be used to understand MMVD at molecular level294.  
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6 Conclusion 
Prior to undertaking this study there was limited information on various 
aspects of the pathobiology of canine MMVD. This study has expanded our 
understanding of MMVD and has provided data on morphological changes, cellular 
alteration and functional protein expression. Together such data allows a more 
complete understanding of what happens to the valve with this disease, how these 
changes occur over time and inform possible explanations for the cause of MMVD in 
the dog and humans. 
1. This study once again highlighted the prevalence of myxomatous mitral valve 
disease in older dogs.  Although categorising the dogs according to grade of 
disease was in line with previously published data, dogs entering the study were 
generally older and often diseased. In fact, no aged dog was found to be disease 
free and we seldom encountered healthy dogs without any evidence of valvular 
disease. Therefore, it is difficult to say if the frequency of the disease grades 
reflects the wider spectrum of the entire population. Additionally the opportunity 
to age-match groups was not a feasible option considering the close age-
association of the disease. 
2. The destruction of the ordered fibrosa tissue and fibro-elastic proliferation 
accompanied by glycosylaminoglycan accumulation in the diseased leaflets was 
clearly demonstrated and can be easily understood to compromise mitral valve 
function. The thickening of the leaflets near the free edge (zone of apposition of 
the leaflets) was confirmed, and it is suspected that repeated trauma at time of 
valve closure is implicated in this finding, and in itself could be the initiating 
cause of MMVD. The progressive nature of the disease was manifested in the 
gradual expansion of the spongiosa at the distal zone as disease severity 
increased with age. Similar to human mitral valve prolapse, the posterior leaflets 
were found to be more severely affected than anterior. The posterior leaflet in 
dogs would appear to degenerate at a more accelerated rate than the anterior 
leaflet.  
3. We had hypothesised that interstitial cells would play an important role in this 
disease, since these cells determine the nature of the extracellular matrix. In 
contrast to human mitral valve disease, where increased interstitial cell numbers 
were found27, in dogs the cell numbers in the myxomatous areas were not 
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significantly different irrespective of the severity of the disease. However, the 
fibrosa tissues adjacent to myxomatous areas in the distal zone were found to 
have increased cell numbers or at least patchy accumulations of cells. These 
areas were close to the site of valve closure and might reflect a response to 
friction or stress injury. It was apparent that cells accumulate close to the valve 
edge and these cells have an activated myofibroblast phenotype (α-SMA +/Vim-
), while the number of quiescent fibroblasts (Vim-) decreases. This was clear 
evidence of interstitial cell phenotypic alteration, possibly coupled with cell 
migration and translocation to the valve edge, and this could also be identified on 
TEM. Fat cell numbers were also found to increase in diseased valves and might 
be an additional source of fibroblasts. Lastly there was a small increase in mast 
cells, macrophages and desmin-positive chondrocyte-like cells, but their exact 
role in MMVD cannot be stated with certainty. The desmin-positive cells may be 
further evidence for interstitial cell capacity to switch phenotypic. 
4. Endothelial cell abnormalities, including detachment, denuding and apoptosis, 
were clearly seen in diseased valves, with additional areas of basement 
membrane damage and loss and ECM extrusion. Interestingly such changes, 
although to a more minor degree, could be seen in normal valves, suggesting 
endothelial damage and repair is an ongoing process. Interstitial cells could also 
be seen in close proximity to the damaged endothelium, with cells even touching 
and occasionally incorporating into the endothelium itself. 
5. Stromal damage could be readily appreciated on histological sections, with a 
quantifiable loss of connective tissue in myxomatous regions, and on TEM and 
SEM, with a likely concomitant increase in glycosaminoglycan content. On SEM 
the disorganisation of collagen could be clearly seen and at high power TEM 
abnormal collagen bundle formation, and extrusion of pro-collagen that failed to 
be organise into collagen fibrils could be identified, all suggesting a 
dyscollagenesis abnormality. 
6. Several proteins and classes of protein were found to be differentially expressed 
when comparing diseased and normal valves. Not unexpectedly, several were 
constituent parts of, or important in the formation, laying down and organisation 
of the extra-cellular matrix. However, which proteins might have been altered 
could not have been deduced intuitively. The SLRPs were particularly interesting 
considering their crucial role in matrix production, but also the necessity for 
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close interaction with each other to allow this process to function properly. This 
means that reduced expression of one SLRP alone could have adverse effects on 
the function of other SLRPs and other connective tissue constituents (collagen, 
elastin and other proteoglycans). An additional interesting group of altered 
proteins were those involved in contractility and cell architecture. These proteins 
also have pivotal roles in cell function. The main effect of loss of these proteins 
would be on interstitial cell function, migration, cell division and differentiation.  
 The underlying cause of MMVD in dogs and humans is unknown. There is 
evidence to show it may be due to over-expression of certain catabolic enzymes by 
activated contractile and secretory myofibroblasts, but the initiating cause is not 
understood. Using the combined data of this study and data form other studies, the 
following paradigm can be proposed:  
Under normal circumstances of valve growth and development, a stage is 
reached where there is a low level of remodelling and repair of the leaflet and this 
extends during early and mature adult life. At this stage VICs are relatively 
quiescent, but processes manage the replacement of valve matrix and can repair 
endothelial damage when needed. With progression to adulthood the continual 
trauma to the valve edge caused by valve closure results in endothelial damage that 
cannot be readily repaired. The damaged endothelium signals to the valve stromal 
cells, which alter their phenotype to a more secretory and contractile form (activated 
myofibroblasts), and the cells migrate toward the damaged valve surface. Extra-
cellular matrix production is compromised by a combination of excess production of 
catalytic enzymes (MMPs) and the failure to produce enough collagen to meet 
turnover demand, and organise the collagen which is produced into collagen fibrils 
and collagen bundles. Eventually, there is expansion of the lose connective tissue 
component of the valve and an overall loss of valve mechanical integrity. The 
resulting shear stress cause by regurgitating blood flow damages the endothelium 
further and the process continues unchecked.   
 
Suggested Future Work 
1. In a clinical study of this nature there is invariably a problem the collection of 
a sufficient number of samples to ensure adequate statistical power of 
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analysis and the first stage in any further work should be to increase the 
number of samples and confirm the observations made. 
2. A key element of the hypothesis outlined earlier is the role of endothelial cell 
trauma as the trigger for phenotypic alteration of valve stromal cells. The 
nature of this interaction and in particular signal transduction between 
endothelial cells and VICs could be investigated in normal and diseased 
valves using molecular techniques. 
3. Another possible consequence of endothelial cell trauma is the genesis of an 
inflammatory response and the potential role of inflammatory disease in 
MMVD needs to be investigated further using a combination of 
immunohistochemistry and Western blots. 
4. This work has confirmed the occurrence of changes in the protein matrix as a 
result of remodelling, repair and replacement and the proteomics studies 
could be expanded using shorter-range pH gradient strips in 2-D gels to 
produce more detailed studies of the expression of important matrix proteins. 
5. In addition morphogenesis of the cytosolic structure of interstitial cells could 
be studied at the ultrastructural level using TEM at higher magnifications. 
6. Finally, subtractive hybridization techniques could be employed to identify 
the differentially expressed genes associated with MMVD and the genome 
examined for these genes. 
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